US20020161394A1 - Aortic filter catheter - Google Patents
Aortic filter catheter Download PDFInfo
- Publication number
- US20020161394A1 US20020161394A1 US10/108,245 US10824502A US2002161394A1 US 20020161394 A1 US20020161394 A1 US 20020161394A1 US 10824502 A US10824502 A US 10824502A US 2002161394 A1 US2002161394 A1 US 2002161394A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- filter
- aortic
- filter assembly
- embolic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
- A61F2/014—Retrograde blood flow filters, i.e. device inserted against the blood flow direction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/011—Instruments for their placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/018—Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/3008—Properties of materials and coating materials radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30092—Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0023—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
- A61F2210/0033—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply electrically, e.g. heated by resistor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0067—Three-dimensional shapes conical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/008—Quadric-shaped paraboloidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0023—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
Definitions
- the present invention relates generally to a catheter or cannula for infusion of oxygenated blood or other fluids into a patient for cardiopulmonary support and cerebral protection. More particularly, it relates to an arterial perfusion catheter with a deployable embolic filter for protecting a patient from adverse effects due to emboli that are dislodged during cardiopulmonary bypass.
- Cardiopulmonary bypass is an important enabling technology that has helped to make these advances possible.
- CABG coronary artery bypass grafting
- CPB cardiopulmonary bypass
- Chief among these concerns is the potential for stroke or neurologic deficit associated with heart surgery and with cardiopulmonary bypass.
- One of the likely causes of stroke and of neurologic deficit is the release of emboli into the blood stream during heart surgery.
- Potential embolic materials include atherosclerotic plaques or calcific plaques from within the ascending aorta or cardiac valves and thrombus or clots from within the chambers of the heart. These potential emboli may be dislodged during surgical manipulation of the heart and the ascending aorta or due to high velocity jetting (sometimes called the “sandblasting effect”) from the aortic perfusion cannula. Air that enters the heart chambers or the blood stream during surgery through open incisions or through the aortic perfusion cannula is another source of potential emboli. Emboli that lodge in the brain may cause a stroke or other neurologic deficit.
- Vena cava filters are devices that are implanted into a patient's inferior vena cava for capturing thromboemboli and preventing them from entering the right heart and migrating into the pulmonary arteries. These are generally designed for permanent implantation and are only intended to capture relatively large thrombi, typically those over a centimeter in diameter, that could cause a major pulmonary embolism.
- Vena cava filters are also not adapted for simultaneously providing arterial blood perfusion in connection with cardiopulmonary bypass.
- the present invention takes the form of a perfusion filter catheter or cannula having an embolic filter assembly mounted on an elongated tubular catheter shaft.
- the elongated tubular catheter shaft is adapted for introduction into a patient's ascending aorta either by a peripheral arterial approach or by a direct aortic puncture.
- a fine filter mesh for capturing macroemboli and/or microemboli is mounted on the embolic filter assembly.
- the embolic filter assembly has an undeployed state in which the filter is compressed or wrapped tightly around the catheter shaft and a deployed state in which the embolic filter assembly expands to the size of the aortic lumen and seals against the inner wall of the aorta.
- the embolic filter assembly can be passively or actively deployable. Various mechanisms are disclosed for both passive and active deployment of the embolic filter assembly.
- an outer tube may cover the embolic filter assembly when it is in the undeployed state.
- Radiopaque markers and/or sonoreflective markers may be located on the catheter and/or the embolic filter assembly.
- a perfusion lumen extends through the elongated tubular catheter shaft to one or more perfusion ports upstream of the embolic filter assembly. Oxygenated blood is perfused through the perfusion lumen and any embolic materials that might be dislodged are captured in the deployed embolic filter assembly.
- the surface area of the filter mesh be greater than twice the cross-sectional area of the aortic lumen, more preferably three, four, five or six times greater than luminal cross section of the aorta.
- the embolic filter assembly is also configured to hold at least a majority of the filter mesh away from the aortic wall when deployed to maximize the effective filter surface area.
- the embolic filter assembly configurations described include an elongated cone, a frustum of a cone, a trumpet-shape, a modified trumpet-shape, and helically, circumferentially and longitudinally convoluted shapes. Further configurations are described having standoff members for centering the embolic filter assembly within the aorta and for holding at least a majority of the filter mesh away from the aortic walls when deployed.
- Embodiments are also described that combine the perfusion filter catheter with an aortic occlusion device, which may be a toroidal balloon, an expandable balloon or a selectively deployable external catheter flow control valve.
- the combined device allows percutaneous transluminal administration of cardiopulmonary bypass and cardioplegic arrest with protection from undesirable embolic events.
- An embodiment of the perfusion filter catheter is described having an aortic transillumination system for locating and monitoring the position and the deployment state of the catheter and the embolic filter assembly without fluoroscopy.
- the perfusion filter catheter is introduced into the patient's aorta with the embolic filter assembly in a collapsed state either by a peripheral arterial approach or by a direct aortic puncture.
- the embolic filter assembly is advanced across the aortic arch and into the ascending aorta.
- the embolic filter assembly is either actively or passively deployed.
- the position of the catheter and the deployment state of the embolic filter assembly may be monitored using fluoroscopy, ultrasound, transesophageal echography (TEE) or aortic transillumination.
- embolic filter assembly Once the embolic filter assembly is deployed, oxygenated blood may be infused into the aorta through the perfusion lumen. Any potential emboli are captured by the embolic filter assembly and prevented from entering the neurovasculature or other branches downstream. After use, the embolic filter assembly is returned to the collapsed position and the catheter is withdrawn from the patient.
- FIGS. 1 - 3 show a perfusion filter catheter configured for retrograde deployment via a peripheral arterial access point.
- FIG. 1 is a cutaway perspective view of the perfusion filter catheter deployed within the aorta via femoral artery access.
- FIG. 2 shows the distal end of the catheter with the embolic filter assembly in a deployed state.
- FIG. 3 shows the distal end of the catheter with the embolic filter assembly in a collapsed state for insertion or withdrawal of the device from the patient.
- FIGS. 4 - 6 show a method of passively deploying an embolic filter assembly on a perfusion filter catheter.
- FIGS. 7, 7A, 8 and 8 A show a flow-assisted method of passively deploying an embolic filter assembly on a perfusion filter catheter.
- FIGS. 9 - 11 show a method of passively deploying a self-expanding and self-supporting embolic filter assembly on a perfusion filter catheter.
- FIGS. 12 - 14 show a method of actively deploying an embolic filter assembly with a collapsible outer hoop and a plurality of actuation wires.
- FIGS. 15 - 17 show a method of actively deploying an embolic filter assembly with an inflatable filter support structure.
- FIGS. 18 - 20 show a method of actively deploying a spiral fluted embolic filter assembly by twisting or furling the embolic filter assembly around an inner catheter shaft.
- FIGS. 21 - 23 show a method of actively deploying a circumferentially pleated embolic filter assembly on a perfusion filter catheter.
- FIG. 24 shows a perfusion filter catheter adapted for retrograde deployment via subclavian artery access.
- FIGS. 25 - 27 show a perfusion filter catheter adapted for antegrade deployment via direct aortic puncture.
- FIGS. 28 and 29 show a perfusion filter catheter having an embolic filter assembly with a graded porosity filter screen.
- FIGS. 30 and 30A show a perfusion filter catheter having a longitudinally fluted embolic filter assembly.
- FIGS. 31 and 31A show a perfusion filter catheter having a longitudinally ribbed embolic filter assembly.
- FIG. 32 shows a perfusion filter catheter having an embolic filter assembly that is surrounded by a cage of longitudinally oriented standoff members.
- FIG. 33 shows a perfusion filter catheter having an embolic filter assembly that is surrounded by a cage of coiled wire standoff members.
- FIG. 34 shows a perfusion filter catheter having an embolic filter assembly that is surrounded by a cage of coarse netting.
- FIG. 35 shows a cutaway view of a perfusion filter catheter having an embolic filter assembly that is surrounded by a fender made from a porous foam or a fibrous network.
- FIGS. 36 and 37 show an alternate embodiment of a perfusion filter catheter with a passively deployed embolic filter assembly.
- FIGS. 38 - 41 show an alternate embodiment of a perfusion filter catheter with an actively deployed embolic filter assembly having a filter support structure with a preshaped, superelastic actuation wire.
- FIGS. 42 and 43 show another alternate embodiment of a perfusion filter catheter with an actively deployed embolic filter assembly having a filter support structure with a preshaped, superelastic wire purse string loop.
- FIGS. 44 and 45 show another alternate embodiment of a perfusion filter catheter with an actively deployed inflatable embolic filter assembly.
- FIGS. 46 - 50 show the operation of an embodiment of a perfusion filter catheter that combines an embolic filter assembly with a toroidal balloon aortic occlusion device.
- FIG. 51 shows an embodiment of a perfusion filter catheter that combines an embolic filter assembly with an inflatable balloon aortic occlusion device.
- FIG. 52 shows an embodiment of a perfusion filter catheter that combines an embolic filter assembly with a selectively deployable external catheter flow control valve.
- FIG. 53 shows an embodiment of a perfusion filter catheter with an embolic filter assembly having areas of different filter porosity.
- FIG. 54 shows an embodiment of a perfusion filter catheter with a fiberoptic system for aortic transillumination.
- FIGS. 1 - 3 show a perfusion filter catheter 100 according to the present invention configured for retrograde deployment via a peripheral arterial access point.
- FIG. 1 is a cutaway perspective view of the perfusion filter catheter 100 deployed within the aorta of a patient via femoral artery access.
- FIG. 2 shows the distal end of the catheter 100 with the embolic filter assembly 102 in a deployed state.
- FIG. 3 shows the distal end of the catheter with the embolic filter assembly 102 ′ in a collapsed state for insertion or withdrawal of the device from the patient.
- the perfusion filter catheter 100 includes an elongated tubular catheter shaft 104 with a proximal end 108 and distal end 110 .
- the catheter shaft 104 is preferably extruded of a flexible thermoplastic material or a thermoplastic elastomer. Suitable materials for the catheter shaft 104 include, but are not limited to, polyvinylchloride, polyurethane, polyethylene, polypropylene, polyamides (nylons), and alloys or copolymers thereof, as well as braided, coiled or counterwound wire or filament reinforced composites.
- the tubular catheter shaft 104 may have a single lumen or multilumen construction.
- the catheter 100 has a single perfusion lumen 106 extending from the proximal end 108 to the distal end 110 of the catheter shaft 104 .
- the perfusion lumen 106 is open at the distal end 110 of the catheter shaft 104 .
- the distal end 110 of the catheter shaft 104 may have a simple beveled or rounded distal edge, as shown, or it may include additional side ports or a flow diffuser to reduce jetting when oxygenated blood is infused through the perfusion lumen 106 .
- the proximal end 108 of the elongated tubular catheter shaft 104 is adapted for connecting the perfusion lumen 106 to a cardiopulmonary bypass pump or other source of oxygenated blood using standard barb connectors or other connectors, such as a standard luer fitting (not shown).
- the catheter shaft 104 is made with thin walled construction to maximize the internal diameter and therefore the flow rate of the perfusion lumen 106 for a given outside diameter and length of the catheter shaft 104 .
- Thin walled construction also allows the outside diameter of the catheter shaft 104 to be minimized in order to reduce the invasiveness of the procedure and to reduce trauma at the insertion site.
- the perfusion lumen 106 should be configured to allow sufficient blood flow to preserve organ function without hemolysis or other damage to the blood.
- a catheter shaft 104 of 18-24 French size (6-8 mm outside diameter) is sufficient to deliver the requisite 3-4 liters of oxygenated blood to preserve organ function.
- the size of the catheter shaft 104 can be reduced to 9-18 French size (3-6 mm outside diameter) for delivering 0.5-3 liters of oxygenated blood to preserve organ function.
- the catheter shaft 104 should have a length sufficient to reach from the arterial access point where it is inserted to the ascending aorta of the patient.
- the catheter shaft 104 preferably has a length from approximately 80-120 cm.
- a deployable embolic filter assembly 102 is located just proximal to the distal end 110 of the catheter shaft 104 .
- the embolic filter assembly 102 includes a filter screen 112 made of a fine mesh material.
- the fine mesh material of the filter screen 112 may be a woven or knitted fabric, such as Dacron polyester or nylon mesh, or other textile fabrics, or it may be a nonwoven fabric, such as a spun bonded polyolefin or expanded polytetrafluoroethylene or other nonwoven materials.
- the fine mesh material of the filter screen 112 may be woven, knitted or otherwise formed from monofilament or multifilament fibers.
- the fine mesh material of the filter screen 112 may also be a fine wire mesh or a combination of wire and textile fibers.
- the fine mesh material of the filter screen 112 may be an open cell foam material.
- the fine mesh material of the filter screen 112 must be nontoxic and hemocompatible, that is, non-thrombogenic and non-hemolytic.
- the fine mesh material of the filter screen 112 has a high percentage of open space, with a uniform pore size.
- the pore size of the filter screen 112 can be chosen to capture macroemboli only or to capture macroemboli and microemboli. In most cases the pore size of the filter screen 112 will preferably be in the range of 1-200 micrometers.
- the pore size of the filter screen 112 will preferably be in the range of 50-200 micrometers, more preferably in the range of 80-100 micrometers.
- the pore size of the filter screen 112 will preferably be in the range of 1-100 micrometers, more preferably in the range of 5-20 micrometers.
- a larger pore size e.g. up to 1000 micrometers (1 mm) or larger, would also be useful.
- a combination of filter materials having different pore sizes may be used.
- the material of the filter screen in each embodiment of the filter catheter may be made of or coated with an adherent material or substance to capture or hold embolic debris which comes into contact with the filter screen within the embolic filter assembly.
- adherent materials include, but are not limited to, known biocompatible adhesives and bioadhesive materials or substances, which are hemocompatible and non-thrombogenic. Such materials are known to those having ordinary skill in the art and are described in, among other references, U.S. Pat. Nos. 4,768,523, 5,055,046, 5,066,709, 5,197,973, 5,225,196, 5,374,431, 5,578,310, 5,645,062, 5,648,167, 5,651,982, and 5,665,477.
- only the upstream side of the elements of the filter screen are coated with the adherent material to positively capture the embolic debris which comes in contact with the upstream side of the filter screen after entering the filter assembly.
- Other bioactive substances for example, heparin or thrombolytic agents, may be impregnated into or coated on the surface of the filter screen material or incorporated into an adhesive coating.
- the embolic filter assembly 102 is movable between a collapsed state, as shown in FIG. 3, and an expanded or deployed state, as shown in FIGS. 1 and 2.
- the filter screen 112 may be attached directly to the catheter shaft 104 and it may constitute the entire embolic filter assembly 102 , particularly if the filter screen 112 is made of a resilient or semirigid fabric that has enough body to be self-supporting in the deployed state.
- the embolic filter assembly 102 will also include a filter support structure 114 , particularly if a highly flexible or flaccid material is used for the filter screen 112 .
- the filter support structure 114 attaches and supports the filter screen 112 on the catheter shaft 104 .
- the filter support structure 114 is constructed with an outer hoop 116 and a plurality of struts 118 which extend approximately radially from a ring-shaped hub 126 that is mounted on the catheter shaft 104 .
- four struts 118 are shown, however, two, three or more struts 118 may be used.
- the open distal end 122 of the filter screen 112 is attached to the outer hoop 116 and the proximal end 120 of the filter screen 112 is sealingly attached to the catheter shaft 104 .
- the outer hoop 116 of the filter support structure 114 holds the open distal end 122 of the filter screen 112 against the inner wall of the aorta, as shown in FIG. 1.
- the outer hoop 116 of the filter support structure 114 and the distal end 122 of the filter screen 112 have a diameter of approximately 2.5 to 4 cm, plus or minus 0.5 cm. Larger and smaller diameter filter support structures 114 may be made to accommodate patients with distended or Marfan syndrome aortas or for pediatric patients.
- the embolic filter assembly 102 may be deployed by a passive means or by an active means.
- Passive means for deploying the embolic filter assembly 102 could include using the elastic memory of the filter screen 112 and/or the filter support structure 114 to deploy the embolic filter assembly 102 , and/or using pressure from the blood flow in the aorta to deploy the embolic filter assembly 102 .
- active means for deploying the embolic filter assembly 102 could include one or more actuation members within the catheter shaft 104 for mechanically actuating the filter support structure 114 to deploy the embolic filter assembly 102 from the proximal end 108 of the catheter 100 .
- Shape memory materials may also be used as actuation members for deploying the embolic filter assembly 102 .
- active means for deploying the embolic filter assembly 102 could include one or more lumens within the catheter shaft 104 for hydraulically actuating the filter support structure 114 to deploy the embolic filter assembly 102 .
- Passive means may be used to augment the action of the active deployment means.
- an outer tube 124 may be provided to cover the embolic filter assembly 102 when it is in the collapsed state in order to create a smooth outer surface for insertion and withdrawal of the catheter 100 and to prevent premature deployment of the embolic filter assembly 102 , particularly if passive deployment means are used.
- the perfusion filter catheter 100 is prepared for use by folding or compressing the embolic filter assembly 102 into a collapsed state within the outer tube 124 , as shown in FIG. 3.
- the distal end 110 of the catheter 100 is inserted into the aorta in a retrograde fashion. Preferably, this is done through a peripheral arterial access, such as the femoral artery or subclavian artery, using the Seldinger technique or an arterial cutdown.
- the catheter 100 may be introduced directly through an incision into the descending aorta after the aorta has been surgically exposed.
- the embolic filter assembly 102 is advanced up the descending aorta and across the aortic arch while in the collapsed state.
- the position of the catheter 100 may be monitored using fluoroscopy or ultrasound, such as transesophageal echography (TEE).
- Appropriate markers which may include radiopaque markers and/or sonoreflective markers, may be located on the distal end 110 of the catheter 100 and/or the embolic filter assembly 102 to enhance imaging and to show the position of the catheter 100 and the deployment state of the embolic filter assembly 102 .
- a distal portion of the catheter shaft 104 may be precurved to match the curvature of the aortic arch to aid in placement and stabilization of the catheter 100 and the embolic filter assembly 102 within the aorta.
- oxygenated blood may be infused through the perfusion lumen 106 to augment cardiac output of the beating heart or to establish cardiopulmonary bypass so that the heart can be arrested. Any potential emboli are captured by the filter screen 112 and prevented from entering the neurovasculature or other branches downstream.
- the embolic filter assembly 102 is returned to the collapsed position and the catheter 100 is withdrawn from the patient.
- the embolic filter assembly 102 is configured so that, when it is in the deployed state, at least a majority of the filter screen 112 is held away from the aortic walls so that flow through the pores of the filter screen 112 is not occluded by contact with the aortic wall. In addition, this also assures that blood flow into the side branches of the aorta will not be obstructed by the filter screen 112 . In this way, each side branch of the aorta will receive the benefit of flow through the full surface area of the filter screen 112 so that blood flow is not restricted by the area of the ostium of each side branch. In the illustrative embodiment of FIGS.
- the filter screen 112 has a roughly conical shape with an open distal end 122 .
- the conical shape holds the fine mesh material of the filter screen 112 away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of the filter screen 112 .
- FIGS. 4 - 11 show various methods of passively deploying the embolic filter assembly 102
- FIGS. 12 - 23 show various methods of actively deploying the embolic filter assembly 102
- FIGS. 4 - 6 show one method of passively deploying the embolic filter assembly 102 .
- the outer hoop 116 and the struts 118 of the filter support structure 114 are made of an elastic or superelastic metal or polymer, for example a superelastic nickel/titanium alloy, which is easily deformed into the collapsed state and which expands passively from the collapsed state to the deployed state.
- the struts 118 are folded back in the proximal direction and the outer hoop 116 is folded against the catheter shaft 104 along with the material of the filter screen 112 .
- the outer tube 124 is placed over the folded embolic filter assembly 102 to hold it in the collapsed position.
- the outer tube 124 is pulled back, as shown in FIG. 5, to release the folded embolic filter assembly 102 .
- the outer hoop 116 and struts 118 expand the filter screen 112 to its deployed position, shown in FIG.
- the embolic filter assembly 102 is returned to the collapsed position by advancing the outer tube 124 distally over the filter screen 112 and the filter support structure 114 , then the catheter 100 is withdrawn from the patient.
- FIGS. 7, 7A, 8 and 8 A show another method of passively deploying an embolic filter assembly 132 on a perfusion filter catheter 130 .
- the filter support structure includes a plurality of struts 136 which are hinged or flexibly attached at their inner, proximal ends to the catheter shaft 134 .
- the struts 136 may be made of either a metal or a polymer.
- the distal end 138 of the filter screen 140 is attached to the struts 136 along an outer, distal portion of the struts 136 .
- the proximal end 146 of the filter screen 140 is sealingly attached to the catheter shaft 134 .
- the portion of the filter screen 140 attached to the struts 136 forms a skirt 142 along the distal edge of the filter assembly 132 .
- the remaining portion of the filter screen 140 forms a filter pocket 144 along the proximal end of the filter assembly 132 .
- the skirt 142 and the filter pocket 144 may be made of the same filter material or they may be made of different filter materials having different porosities.
- the skirt 142 of the filter screen 140 may even be made of a nonporous material.
- FIG. 7A is a cutaway view of the catheter 130 with the embolic filter assembly 132 in the collapsed position.
- the material of the filter screen 140 is folded around or in between the struts 136 .
- the outer tube 148 is placed over the folded embolic filter assembly 132 to hold it in the collapsed position. Once the perfusion filter catheter 130 is in position within the patient's aorta, the outer tube 148 is pulled back, as shown in FIG. 8, to release the folded embolic filter assembly 132 .
- FIG. 8A is a cutaway view of the catheter 130 with the embolic filter assembly 132 in the deployed position.
- the struts 136 may be resiliently biased toward the deployed position to assist in passive deployment of the embolic filter assembly 132 .
- the skirt 142 of the filter screen 140 naturally and atraumatically seals against the aortic wall.
- the passive deployment of the skirt 142 also naturally compensates for patient-to-patient variations in aortic luminal diameter.
- the filter pocket 144 of the embolic filter assembly 132 is held away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of the filter screen 140 .
- FIGS. 9 - 11 show another method of passively deploying an embolic filter assembly 152 on a perfusion filter catheter 150 .
- the filter screen 154 is self-expanding and self-supporting, so no separate filter support structure is needed.
- the embolic filter assembly 152 includes resilient wires or filaments 156 that are interwoven with the fibers of the filter screen 154 .
- the resilient wires or filaments 156 may be attached to the interior or exterior surface of the filter screen 154 fabric.
- the resilient wires or filaments 156 may be made of either a polymer or a metal, such as an elastic or superelastic alloy.
- the resilient wires or filaments 156 are woven at an angle to the longitudinal axis of the embolic filter assembly 152 , so that the embolic filter assembly 152 can expand and contract in diameter by changing the angle of the wires or filaments 156 .
- the angle between the wires or filaments 156 and the longitudinal axis of the embolic filter assembly 152 increases and the embolic filter assembly 152 may also foreshorten.
- the resilient wires or filaments 156 urge the embolic filter assembly 152 to expand to the deployed position.
- the proximal end 158 of the filter screen 154 is sealingly attached to the catheter shaft 162 .
- the perfusion filter catheter 150 is shown in FIG. 9 with the embolic filter assembly 152 compressed into the collapsed position.
- the embolic filter assembly 152 compresses in diameter smoothly without folding as the resilient wires or filaments 156 and the fibers of the filter screen 154 decrease their angle with respect to the longitudinal axis of the embolic filter assembly 152 .
- An outer tube 164 holds the embolic filter assembly 152 in the collapsed position. Once the perfusion filter catheter 150 is in position within the patient's aorta, the outer tube 164 is pulled back, which allows the embolic filter assembly 152 to expand, as shown in FIG. 10.
- FIG. 11 shows the embolic filter assembly 152 fully expanded in the deployed position.
- the resilient wires or filaments 156 are preformed so that, when deployed, the filter screen 154 has a roughly conical shape with an open distal end 160 .
- the conical shape holds the filter screen 154 away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of the filter screen 154 .
- the distal end 160 of the embolic filter assembly 152 seals against the aortic wall.
- the self-expanding aspect of the embolic filter assembly 152 naturally compensates for patient-to-patient variations in aortic luminal diameter.
- the resilient wires or filaments 156 may be preformed to other geometries so that the filter screen 154 of the embolic filter assembly 152 assumes a different configuration when deployed, including each of the other configurations discussed within this patent specification.
- FIGS. 12 - 14 show one method of actively deploying an embolic filter assembly 168 on a perfusion filter catheter 166 .
- the filter support structure 170 includes a collapsible outer hoop 172 and a plurality of actuation wires 174 .
- the distal end 176 of the filter screen 180 is attached to the outer hoop 172 and the proximal end 182 of the filter screen 180 is sealingly attached to the catheter shaft 184 .
- the actuation wires 174 are slidably received within actuation wire lumens 186 located in the outer wall of the catheter shaft 184 .
- the actuation wires 174 exit the actuation wire lumens 186 through side ports 188 located near the distal end of the catheter shaft 184 .
- the actuation wires 174 and the outer hoop 172 are each made of a resilient polymer or a metal, such as stainless steel, nickel/titanium alloy or the like.
- the perfusion filter catheter 166 is shown in FIG. 12 with the embolic filter assembly 168 compressed into the collapsed position.
- the actuation wires 174 are withdrawn into the actuation wire lumens 186 through the side ports 188 and the outer hoop 172 is folded or collapsed against the catheter shaft 184 .
- the material of the filter screen 180 is folded or collapsed around the catheter shaft 184 .
- An outer tube 190 covers the embolic filter assembly 168 in the collapsed position to facilitate insertion of the catheter 166 .
- FIG. 14 shows the embolic filter assembly 168 fully expanded in the deployed position.
- the filter screen 180 is configured as a frustum of a cone with an open distal end 176 .
- the outer hoop 172 at the distal end 176 of the filter screen 180 seals against the aortic wall.
- FIGS. 15 - 17 show another method of actively deploying an embolic filter assembly 202 on a perfusion filter catheter 200 .
- the filter support structure 204 includes an outer hoop 206 and a plurality of struts 208 , which are all interconnected hollow tubular members.
- the outer hoop 206 and the struts 208 are made of a flexible polymeric material.
- the filter support structure 204 is connected to an inflation lumen 210 , which parallels the perfusion lumen 218 within the catheter shaft 212 .
- the inflation lumen 210 branches off from the catheter shaft 212 to a side arm 214 with a luer fitting 216 for connecting to a syringe or other inflation device.
- this embodiment of the embolic filter assembly 202 is shown with a trumpet-shaped filter screen 220 .
- the filter screen 220 includes a skirt portion 222 extending distally from a proximal, filter pocket 224 .
- the skirt portion 222 is in the shape of a frustum of a cone with an open distal end, which is attached to the outer hoop 206 .
- the filter pocket 224 is roughly cylindrical in shape with a closed proximal end, which is sealingly attached to the catheter shaft 212 .
- the skirt 222 and the filter pocket 224 may be made of the same filter material or they may be made of different filter materials having different porosities.
- the skirt 222 of the filter screen 220 may even be made of a nonporous material.
- the perfusion filter catheter 200 is shown in FIG. 17 with the embolic filter assembly 202 folded into a collapsed position.
- the outer hoop 206 and the struts 208 of the filter support structure 204 are deflated and the material of the filter screen 220 is folded or collapsed around the catheter shaft 212 .
- An outer tube 226 covers the embolic filter assembly 202 in the collapsed position to facilitate insertion of the catheter 200 .
- the outer tube 226 may have a slit or a weakened longitudinal tear line along its length to facilitate removal of the outer tube 226 over the side arm 214 at the proximal end of the catheter 200 .
- the outer tube 226 is pulled back to expose the embolic filter assembly 202 .
- the embolic filter assembly 202 is deployed by inflating the outer hoop 206 and the struts 208 with fluid injected through the inflation lumen 210 to actively expand the filter support structure 204 , as shown in FIG. 16.
- the outer hoop 206 of the filter support structure 204 seals against the inner wall of the aorta, as shown in FIG. 15.
- at least the outer wall of the outer hoop 206 is somewhat compliant when inflated in order to compensate for patient-to-patient variations in aortic luminal diameter.
- FIGS. 18 - 20 show another method of actively deploying an embolic filter assembly 232 on a perfusion filter catheter 230 .
- the filter support structure 234 includes an outer hoop 236 and a plurality of struts 238 , which are connected to an inner catheter shaft 240 .
- the outer hoop 236 and the struts 238 may be made of a resilient polymer or metal, for example a superelastic nickel/titanium alloy.
- the distal end 242 of the filter screen 244 is attached to the outer hoop 236 .
- the proximal end 246 of the filter screen 244 is sealingly attached to an outer catheter shaft 250 .
- the inner catheter shaft 240 is slidably and rotatably received within the outer catheter shaft 250 .
- the filter screen 244 has one or more spiral grooves or flutes 248 that wind helically around the filter screen 244 .
- the embolic filter assembly 232 is folded into the collapsed position shown in FIG. 20 by extending and rotating the inner catheter shaft 240 in a first direction with respect to the outer catheter shaft 250 . This collapses the filter support structure 234 back against the inner catheter shaft 240 and furls the filter screen 244 around the inner catheter shaft 240 . The spiral flutes 248 in the filter screen 244 help it to collapse smoothly around the inner catheter shaft 240 .
- An outer tube 252 covers the embolic filter assembly 232 in the collapsed position to facilitate insertion of the catheter 230 . Once the perfusion filter catheter 230 is in position within the patient's aorta, the outer tube 252 is pulled back to expose the embolic filter assembly 232 .
- the embolic filter assembly 232 is deployed by rotating the inner catheter shaft 240 in the opposite direction with respect to the outer catheter shaft 250 and allowing it to retract slightly, as shown in FIG. 19.
- the filter support structure 234 and the filter screen 244 will expand within the aorta and the distal end 242 of the filter screen 244 will seal against the aortic wall, as shown in FIG. 18.
- the spiral flutes 248 of the embolic filter assembly 232 hold most of the filter screen 244 away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of the filter screen 244 .
- the embolic filter assembly 232 is returned to the collapsed position as described above and the catheter 230 is withdrawn from the patient.
- the coaxial arrangement of the inner catheter shaft 240 and the outer catheter shaft 250 in this embodiment of the perfusion filter catheter 230 creates an annular space that can optionally be used as a lumen 258 to aspirate potential emboli that are captured by the filter screen 244 .
- a side arm 254 with a luer fitting and a sliding hemostasis valve 256 may be added to the proximal end of the outer catheter shaft 250 , as shown in FIG. 18.
- FIGS. 21 - 23 show another method of actively deploying an embolic filter assembly 262 on a perfusion filter catheter 260 .
- the filter support structure 234 includes an outer hoop 266 and a plurality of struts 268 , which are connected to an inner catheter shaft 270 .
- the outer hoop 266 and the struts 268 may be made of a resilient polymer or metal, for example a superelastic nickel/titanium alloy.
- the distal end 272 of the filter screen 274 is attached to the outer hoop 266 .
- the proximal end 276 of the filter screen 274 is sealingly attached to an outer catheter shaft 280 .
- the inner catheter shaft 270 is slidably received within the outer catheter shaft 280 .
- the filter screen 274 has a series of circumferential pleats 278 that give the filter screen 274 an accordion appearance.
- the embolic filter assembly 262 is folded into the collapsed position shown in FIG. 23 by extending the inner catheter shaft 270 distally with respect to the outer catheter shaft 280 . This collapses the filter support structure 264 back against the inner catheter shaft 270 and collapses the circumferential pleats 248 of the filter screen 274 against the inner catheter shaft 270 .
- An outer tube 282 covers the embolic filter assembly 262 in the collapsed position to facilitate insertion of the catheter 260 . Once the perfusion filter catheter 260 is in position within the patient's aorta, the outer tube 282 is pulled back to expose the embolic filter assembly 262 .
- the embolic filter assembly 262 is deployed by retracting the inner catheter shaft 270 proximally with respect to the outer catheter shaft 280 , as shown in FIG. 22.
- the filter support structure 264 and the filter screen 274 will expand within the aorta and the distal end 272 of the filter screen 274 will seal against the aortic wall, as shown in FIG. 21.
- the circumferential pleats 278 of the embolic filter assembly 262 hold the majority of the filter screen 274 away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of the filter screen 274 .
- the embolic filter assembly 262 is returned to the collapsed position as described above and the catheter 260 is withdrawn from the patient.
- the coaxial arrangement of the inner catheter shaft 270 and the outer catheter shaft 280 in this embodiment of the perfusion filter catheter 260 creates an annular space that can optionally be used as a lumen 288 to aspirate potential emboli that are captured by the filter screen 274 .
- a side arm 284 with a luer fitting and a sliding hemostasis valve 286 may be added to the proximal end of the outer catheter shaft 280 , as shown in FIG. 21.
- Active deployment of the embolic filter assembly can also be accomplished with any of the preceding embodiments by using shape memory materials, such as a nickel/titanium alloy, to construct the filter support structure and/or the actuation members.
- shape memory materials such as a nickel/titanium alloy
- the transition temperature of the shape memory material should be chosen to be close to normal body temperature so that extreme temperature variations will not be necessary for deployment.
- the shape memory material of the filter support structure should be annealed in the deployed position to confer a shape memory in this configuration. Then, the embolic filter assembly should be cooled below the transition temperature of the shape memory material, so that the filter support structure is malleable and can be shaped into a collapsed position. Depending on the transition temperature, this can be done at room temperature or in iced saline solution.
- an outer tube can be placed over the embolic filter assembly to facilitate catheter insertion and to avoid premature deployment.
- the outer tube is pulled back to expose the embolic filter assembly and the filter support structure is heated above the transition temperature to deploy the embolic filter assembly.
- the filter support structure can be passively heated by body heat (accounting, of course, for decreased body temperature during hypothermic cardiopulmonary support methods) or it can be self-heated by applying an electrical current through the filter support structure. When heated, the filter support structure expands to its annealed configuration within the aorta.
- the embolic filter assembly is returned to the collapsed position by advancing the outer tube distally over the filter screen and the filter support structure, then the catheter is withdrawn from the patient.
- perfusion filter catheter of the present invention showed retrograde deployment of the device within the aorta via femoral artery access.
- Each of the described embodiments of the perfusion filter catheter can also be adapted for retrograde deployment via subclavian artery access or for antegrade or retrograde deployment via direct aortic puncture.
- FIG. 24 shows a perfusion filter catheter 290 which is adapted for retrograde deployment via subclavian artery access.
- the perfusion filter catheter 290 is depicted with a trumpet-style, passively-deployed embolic filter assembly 292 .
- the perfusion filter catheter 290 has a tubular catheter shaft 294 with a length of approximately 60-90 cm. Because of the shorter length, as compared to the femoral version of the catheter, the outside diameter of the catheter shaft 294 can be reduced to 12-18 French size (4-6 mm outside diameter) for delivering the 3-4 liters of oxygenated blood needed to preserve organ function.
- the reduced diameter of the catheter shaft 294 is especially advantageous for subclavian artery delivery of the catheter 290 .
- the outer tube 296 may be adapted for use as an introducer sheath by the addition of an optional hemostasis valve 298 at the proximal end of the outer tube 296 . This eliminates the need for a separate introducer sheath for introducing the catheter 290 into the circulatory system.
- the perfusion filter catheter 290 is introduced into the subclavian artery with the embolic filter assembly 292 in a collapsed state within the outer tube 296 , using the Seldinger technique or an arterial cutdown.
- the embolic filter assembly 292 is advanced across the aortic arch while in the collapsed state.
- the position of the catheter 292 may be monitored using fluoroscopy or ultrasound, such as transesophageal echography (TEE).
- Radiopaque markers and/or sonoreflective markers may be located on the catheter 290 and/or the embolic filter assembly 292 to enhance imaging and to show the position of the catheter 290 and the deployment state of the embolic filter assembly 292 .
- the outer tube 296 is withdrawn and the embolic filter assembly 292 is either actively or passively deployed, as shown in FIG. 24.
- oxygenated blood may be infused into the aorta through the tubular catheter shaft 294 .
- Any potential emboli are captured by the embolic filter assembly 292 and prevented from entering the neurovasculature or other branches downstream.
- the embolic filter assembly 292 is returned to the collapsed position and the catheter 290 is withdrawn from the patient.
- Retrograde deployment of the perfusion filter catheter 290 via direct aortic puncture is quite similar to introduction via subclavian artery access, except that the catheter 290 is introduced directly into the descending aorta after it has been surgically exposed, for example during open-chest or minimally invasive cardiac surgery. Because of the direct aortic insertion, the length and the diameter of the catheter shaft 294 may be further reduced.
- FIGS. 25 - 27 show a perfusion filter catheter 300 which is adapted for antegrade deployment via direct aortic puncture.
- the perfusion filter catheter 300 is depicted with a hybrid-style embolic filter assembly 302 , which is a compromise between the conical filter screen and the trumpet-style filter screen previously described.
- the catheter shaft 304 can be reduced to a length of approximately 20-60 cm and an outside diameter of approximately 12-18 French size (4-6 mm outside diameter) for delivering the 3-4 liters of oxygenated blood needed to preserve organ function during cardiopulmonary bypass.
- the catheter shaft 304 need not extend all the way to the distal end of the filter screen 310 .
- the filter screen 310 may be entirely supported by the filter support structure 312 , particularly if the embolic filter assembly 302 is to be passively deployed.
- a small diameter filter support member 314 may extend from the catheter shaft 304 to the distal end of the filter screen 310 .
- the filter support member 314 may be slidably and/or rotatably received within the catheter shaft 304 . Either of these configurations allows the embolic filter assembly 302 to be folded or compressed to a size as small as the diameter of the catheter shaft 304 to facilitate insertion of the catheter 300 .
- an outer tube 316 may be placed over the folded embolic filter assembly 302 to hold it in the collapsed position.
- the ascending aorta of the patient is surgically exposed, using open-chest or minimally invasive surgical techniques.
- a purse string suture 318 is placed in the ascending aorta and an aortotomy incision is made through the aortic wall.
- the catheter 300 with the embolic filter assembly 302 in the collapsed position within the outer tube 316 , is inserted through the aortotomy and advanced antegrade into the aortic arch.
- the outer tube 316 is withdrawn and the embolic filter assembly 302 is either actively or passively deployed, as shown in FIG. 25.
- oxygenated blood may be infused into the aorta through the tubular catheter shaft 304 .
- Any potential emboli are captured by the embolic filter assembly 302 and prevented from entering the neurovasculature or other branches downstream.
- the embolic filter assembly 302 is returned to the collapsed position, the catheter 300 is withdrawn from the patient, and the purse string suture 318 is tightened to close the aortotomy.
- each of the passive and active deployment methods described above may be used interchangeably or together in combinations with each of the embodiments of the perfusion filter catheter and each of catheter insertion methods which are described above and below.
- many of the features of the embodiments described may be used in various combinations with one another to create new embodiments, which are considered to be a part of this disclosure, as it would be too cumbersome to describe all of the numerous possible combinations and subcombinations of the disclosed features.
- each of the described embodiments may be passively or actively deployed by the methods described above.
- Each embodiment of the perfusion filter catheter described can also be adapted for retrograde deployment via peripheral arterial access, such as femoral or subclavian artery access, or for antegrade or retrograde deployment via direct aortic puncture.
- FIGS. 28 and 29 show a perfusion filter catheter 320 having an embolic filter assembly 322 with a graded porosity filter screen 324 .
- the filter screen 324 is attached to a filter support structure 326 mounted on a catheter shaft 328 for antegrade or retrograde deployment.
- the filter screen 324 may be made in each of the configurations disclosed herein or any other convenient shape.
- the filter screen 324 in this embodiment is depicted as being in the shape of a frustum of a cone.
- the filter screen 324 has an upstream end 330 and a downstream end 332 .
- the upstream end 330 of the filter screen 324 has a finer filter mesh than the downstream end 332 .
- the pore size of the filter screen 324 may make a gradual transition from the upstream end 330 to the downstream end 332 or there may be two or more discrete zones of varying pore size.
- the filter mesh on the upstream end 330 has a pore size of approximately 5-50 micrometers for capturing microemboli and macroemboli and the filter mesh on the downstream end 332 has a pore size of approximately 50-100 micrometers for capturing macroemboli only.
- the pore size of the filter screen 324 has been greatly exaggerated in FIG. 28 for clarity of illustration.
- the perfuision filter catheter 320 is introduced into the aorta with the embolic filter assembly 322 in a collapsed state within an outer tube 334 , using one of the methods described above.
- the embolic filter assembly 322 is advanced across the aortic arch while in the collapsed state.
- the outer tube 334 is withdrawn and the embolic filter assembly 322 is either actively or passively deployed, as shown in FIG. 29.
- the embolic filter assembly 292 is dimensioned so that when it is deployed, the upstream end 330 of the filter screen 324 is positioned in the vicinity of the ostia for the brachiocephalic artery and the left common carotid artery and the downstream end 332 of the filter screen 324 is positioned downstream of this position, preferably in the descending aorta.
- This configuration assures that all of the perfusate which is destined for the neurovasculature must pass through the finer, upstream end 330 of the filter screen 324 to remove all microemboli and macroemboli.
- the perfusate which is destined for the viscera and the lower limbs, which are more tolerant of small emboli, need only pass through the downstream end 332 of the filter screen 324 , so as to remove at least the macroemboli.
- FIG. 30 shows a perfusion filter catheter 340 having a longitudinally fluted embolic filter assembly 342 .
- the embolic filter assembly 342 has a filter screen 344 that is attached at its open distal end 352 to a filter support structure 346 mounted on a catheter shaft 348 for antegrade or retrograde deployment.
- the filter screen 344 has a plurality of longitudinally oriented folds or flutes 350 .
- FIG. 30A is a cutaway section of the embolic filter assembly 342 cut along line 30 A in FIG. 30 in order to better show the longitudinal flutes 350 .
- the longitudinal flutes 350 provide additional surface area to the filter screen 344 to reduce pressure drop from blood flow across the embolic filter assembly 342 .
- the longitudinal flutes 350 also serve to hold a majority of the filter screen 344 away from the aortic wall and away from the ostia of the arch vessels.
- the longitudinally fluted embolic filter assembly 342 can be adapted for passive or active deployment by any of the methods described above.
- FIG. 31 shows a perfusion filter catheter 360 having a longitudinally ribbed embolic filter assembly 362 .
- the embolic filter assembly 362 has a filter screen 364 that is attached at its open distal end 372 to a filter support structure 366 mounted on a catheter shaft 368 for antegrade or retrograde deployment.
- the filter screen 364 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen.
- the embolic filter assembly 362 has a plurality of longitudinally oriented ribs 370 positioned around the exterior of the filter screen 364 .
- FIG. 31A is a cutaway section of the embolic filter assembly 362 cut along line 31 A in FIG. 31 in order to better show the longitudinally oriented ribs 370 .
- the longitudinal ribs 370 serve as standoff members to center the filter screen 364 within the aorta so as hold a majority of the filter screen 364 away from the aortic wall and away from the ostia of the arch vessels.
- the longitudinally ribbed embolic filter assembly 362 can be adapted for passive or active deployment by any of the methods described above.
- FIG. 32 shows a perfusion filter catheter 380 having an embolic filter assembly 382 that is surrounded by a cage 394 of standoff members 396 .
- the embolic filter assembly 382 has a filter screen 384 that is attached at its open distal end 392 to a filter support structure 386 mounted on a catheter shaft 388 for antegrade or retrograde deployment.
- the filter screen 384 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen.
- the embolic filter assembly 382 further includes a plurality of standoff members 396 that form a cage 394 surrounding the filter screen 384 .
- the standoff members 396 may be made of a resilient polymer or metal, such as an elastic or superelastic alloy, or a shape-memory material.
- the geometry of the standoff members 396 is quite variable.
- FIG. 32 depicts the standoff members 396 as a plurality of longitudinally oriented wires which, together, form a roughly cylindrical cage 394 .
- Other possible configurations include circumferential members, diagonal members, and combinations thereof.
- the standoff members 396 of the cage 394 serve to center the filter screen 384 within the aorta so as hold a majority of the filter screen 384 away from the aortic wall and away from the ostia of the arch vessels.
- the embolic filter assembly 382 and the standoff members 396 of the cage 394 can be adapted for passive or active deployment by any of the methods described above.
- FIG. 33 shows a perfusion filter catheter 400 having an embolic filter assembly 402 that is 10 surrounded by a cage 414 of coiled wire standoff members 416 .
- the embolic filter assembly 402 has a filter screen 404 that is attached at its open distal end 412 to a filter support structure 406 mounted on a catheter shaft 408 for antegrade or retrograde deployment.
- the filter screen 404 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen.
- the embolic filter assembly 402 further includes a plurality of loosely coiled wire standoff members 416 which form a cage 414 surrounding the filter screen 404 .
- the coiled standoff members 416 may be made of a resilient polymer or metal, such as an elastic or superelastic alloy, or a shape-memory material.
- the coiled standoff members 416 of the cage 414 serve to center the filter screen 404 within the aorta so as hold a majority of the filter screen 404 away from the aortic wall and away from the ostia of the arch vessels.
- the embolic filter assembly 402 and the standoff members 416 of the cage 414 can be adapted for passive or active deployment by any of the methods described above.
- FIG. 34 shows a perfusion filter catheter 420 having an embolic filter assembly 422 that is surrounded by a cage 434 of coarse netting 436 .
- the embolic filter assembly 422 has a filter screen 424 that is attached at its open distal end 432 to a filter support structure 426 mounted on a catheter shaft 428 for antegrade or retrograde deployment.
- the filter screen 424 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen.
- the embolic filter assembly 422 further includes a coarse netting 436 , which forms a roughly cylindrical cage 434 surrounding the filter screen 424 .
- the netting 436 may be made of a resilient polymer or metal, such as an elastic or superelastic alloy, or a shape-memory material.
- the netting 436 of the cage 434 serves to center the filter screen 424 within the aorta so as hold a majority of the filter screen 424 away from the aortic wall and away from the ostia of the arch vessels.
- the embolic filter assembly 422 and the coarse netting 436 of the cage 434 can be adapted for passive or active deployment by any of the methods described above.
- FIG. 35 shows a cutaway view of a perfusion filter catheter 440 having an embolic filter assembly 442 that is surrounded by a fender 454 made from a porous foam or a fibrous network 456 .
- the embolic filter assembly 442 has a filter screen 444 that is attached at its open distal end 452 to a filter support structure 446 mounted on a catheter shaft 448 for antegrade or retrograde deployment.
- the filter screen 444 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen.
- the embolic filter assembly 442 further includes a roughly cylindrical fender 454 made from a highly porous foam or a fibrous network 456 , which surrounds the filter screen 444 .
- the fender 454 may be made of a highly porous open cell polymer foam or a network of polymeric fibers.
- the fender 454 serves to center the filter screen 444 within the aorta so as hold a majority of the filter screen 444 away from the aortic wall and away from the ostia of the arch vessels.
- the embolic filter assembly 442 and the fender 454 can be adapted for passive or active deployment or a combination thereof.
- FIGS. 36 and 37 show an alternate embodiment of a perfusion filter catheter 460 with a passively deployed embolic filter assembly 462 .
- the embolic filter assembly 462 has a filter screen 464 that is attached at its open distal end 474 to a filter support structure 466 mounted on a catheter shaft 468 for antegrade or retrograde deployment.
- the proximal end 476 of the filter screen 464 is sealingly attached to the catheter shaft 468 .
- the filter screen 464 may be configured as a conical, trumpet or other style of filter screen.
- the filter support structure 466 has an outer hoop 470 which is attached by a perpendicular leg 472 to the catheter shaft 468 .
- the outer hoop 470 is made of a resilient polymer or metal, such as an elastic or superelastic alloy, or possibly a shape-memory material.
- the filter support structure 466 in this embodiment, has no struts.
- the distal end 478 of the catheter shaft 468 may be curved toward the center of the outer hoop 470 to help center the perfusion port 480 located at the distal end of the catheter shaft 468 within the aorta when the catheter 460 is deployed.
- the perfusion port 480 may optionally include additional side ports or a flow diffuser, as shown, to reduce jetting when oxygenated blood is infused through the perfusion lumen 482 .
- the perfusion filter catheter 460 is prepared for use by bending the outer hoop 470 in the proximal direction or wrapping it around the catheter shaft 468 , then folding or wrapping the material of the filter screen 464 around the catheter shaft 468 .
- An outer tube 484 is placed over the embolic filter assembly 462 to hold it in the collapsed position, as shown in FIG. 37.
- the catheter 460 is introduced and the embolic filter assembly 462 is advanced across the aortic arch while in the collapsed state.
- the outer tube 484 When the distal end 474 of the embolic filter assembly 462 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, the outer tube 484 is withdrawn and the resilient outer hoop 470 expands to deploy the embolic filter assembly 462 , as shown in FIG. 36. The outer hoop 470 and the distal end 474 of the filter screen 464 will seal against the aortic wall.
- the embolic filter assembly 462 is returned to the collapsed position by advancing the outer tube 484 distally over the filter screen 464 and the filter support structure 466 , then the catheter 460 is withdrawn from the patient.
- FIGS. 38 - 41 show an alternate embodiment of a perfusion filter catheter 490 with an actively deployed embolic filter assembly 492 .
- the embolic filter assembly 492 has a filter screen 494 with a sewn tubular channel 496 which extends circumferentially around the open distal end 498 of the filter screen 494 .
- the distal end 498 of the filter screen 494 is attached on one side to the catheter shaft 504 , and the proximal end 506 of the filter screen 494 is sealingly attached to the catheter shaft 504 .
- the filter screen 494 may be configured as a conical, trumpet or other style of filter screen.
- the filter support structure in this embodiment consists of a preshaped, superelastic actuation wire 500 , which, when the embolic filter assembly 492 is in the collapsed state, resides in a second lumen 502 within the catheter shaft 504 .
- the actuation wire 500 has a bead or small loop 508 at its distal end to create a blunt, non-piercing tip.
- the second lumen 502 of the catheter shaft 504 communicates with the tubular channel 496 at the distal end 498 of the filter screen 494 .
- the actuation wire 500 When the actuation wire 500 is extended, it forms a hoop as it passes through the tubular channel 496 of the filter screen 494 .
- the distal end 510 of the catheter shaft 504 may be curved toward the center of the embolic filter assembly 492 to help center the perfusion port 510 located at the distal end of the catheter shaft 504 within the aorta when the catheter 490 is deployed.
- the perfusion port 510 may optionally include additional side ports or a flow diffuser, as shown, to reduce jetting when oxygenated blood is infused through the perfusion lumen 512 during cardiopulmonary bypass.
- the perfusion filter catheter 490 is prepared for use by withdrawing the actuation wire 500 into the second lumen 502 , then folding or wrapping the flexible material of the filter screen 494 around the catheter shaft 504 .
- an outer tube 514 may be placed over the embolic filter assembly 492 to hold it in the collapsed position, as shown in FIG. 38.
- the catheter 490 is introduced and the embolic filter assembly 492 is advanced across the aortic arch while in the collapsed state.
- the outer tube 514 is withdrawn, which allows the filter screen 494 to unwrap from the catheter shaft 504 , as shown in FIG. 39.
- the preshaped, superelastic actuation wire 500 is advanced distally so that it begins to form a hoop as it passes through the tubular channel 496 at the distal end 498 of the filter screen 494 , as shown in FIG. 40.
- the actuation wire 500 is further advanced until it forms a complete hoop, as shown in FIG. 41, thereby sealing the distal end 498 of the filter screen 494 against the aortic wall.
- the embolic filter assembly 492 is returned to the collapsed position as described above, then the catheter 490 is withdrawn from the patient.
- FIGS. 42 and 43 show another alternate embodiment of a perfusion filter catheter 520 with an actively deployed embolic filter assembly 522 .
- the embolic filter assembly 522 has a filter screen 524 with a sewn tubular channel 526 which extends circumferentially around the open distal end 528 of the filter screen 524 .
- the distal end 528 of the filter screen 524 is attached on one side to the catheter shaft 534 , and the proximal end 536 of the filter screen 524 is sealingly attached to the catheter shaft 534 .
- the filter screen 524 may be configured as a conical, trumpet or other style of filter screen.
- the filter support structure in this embodiment consists of a preshaped, elastic or superelastic wire loop 530 .
- the wire loop 530 passes through the tubular channel 526 at the distal end 528 of the filter screen 524 .
- the wire loop 530 is withdrawn into a second lumen 532 within the catheter shaft 534 , as shown in FIG. 42.
- the wire loop 530 acts as a purse string to close the filter screen 524 tightly around the catheter shaft 534 .
- the wire loop 530 is advanced distally, it forms a hoop that holds the distal end 528 of the filter screen 524 open, as shown in FIG. 43.
- the distal end 540 of the catheter shaft 534 may be curved toward the center of the embolic filter assembly 522 to help center the perfusion port 542 located at the distal end of the catheter shaft 534 within the aorta when the catheter 520 is deployed.
- the perfusion port 540 may optionally include additional side ports or a flow diffuser, as shown, to reduce jetting when oxygenated blood is infused through the perfusion lumen 544 during cardiopulmonary bypass.
- the perfusion filter catheter 520 is prepared for use by withdrawing the wire loop 530 into the second lumen 532 , then folding or wrapping the flexible material of the filter screen 524 around the catheter shaft 534 .
- an outer tube 538 may be placed over the embolic filter assembly 522 to hold it in the collapsed position. The catheter 520 is introduced and the embolic filter assembly 522 is advanced across the aortic arch while in the collapsed state.
- the outer tube 538 is withdrawn, and the preshaped, superelastic wire loop 530 is advanced distally so that it forms a hoop that holds the distal end 528 of the filter screen 524 open and seals against the aortic wall.
- the inherent adjustability of the wire loop 530 used to deploy the embolic filter assembly 522 naturally compensates for patient-to-patient variations in aortic luminal diameter.
- the embolic filter assembly 522 is returned to the collapsed position by withdrawing the wire loop 530 into the second lumen 532 . This closes the filter screen 524 like a purse string to capture any potential emboli that are in the embolic filter assembly 522 . Then, the catheter 520 is withdrawn from the patient.
- FIGS. 44 and 45 show another alternate embodiment of a perfusion filter catheter 550 with an actively deployed embolic filter assembly 552 .
- the embolic filter assembly 552 has a filter screen 554 with an open distal end 558 that is attached to a toroidal balloon 560 .
- the toroidal balloon 560 is attached on one side to the catheter shaft 564 and it is fluidly connected to an inflation lumen 562 within the catheter shaft 564 .
- the proximal end 566 of the filter screen 554 is sealingly attached to the catheter shaft 564 .
- the filter screen 554 may be configured as a conical, trumpet or other style of filter screen.
- the distal end 570 of the catheter shaft 564 may be curved toward the center of the embolic filter assembly 552 to help center the perfusion port 572 located at the distal end of the catheter shaft 564 within the aorta when the catheter 550 is deployed.
- the perfusion port 570 may optionally include additional side ports or a flow diffuser, as shown, to reduce jetting when oxygenated blood is infused through the perfusion lumen 574 during cardiopulmonary bypass.
- the perfusion filter catheter 550 is prepared for use by deflating the toroidal balloon 560 , then folding or wrapping the deflated toroidal balloon 560 and the filter screen 554 around the catheter shaft 564 .
- an outer tube 564 may be placed over the embolic filter assembly 552 to hold it in the collapsed position, as shown in FIG. 44.
- the catheter 550 is introduced and the embolic filter assembly 552 is advanced across the aortic arch while in the collapsed state.
- the outer tube 564 is pulled back to expose the embolic filter assembly 552 .
- the embolic filter assembly 202 is deployed by inflating the toroidal balloon 560 with fluid injected through the inflation lumen 562 , as shown in FIG. 45.
- the toroidal balloon 560 seals against the inner wall of the aorta.
- at least the outer wall of the toroidal balloon 560 is somewhat compliant when inflated in order to compensate for patient-to-patient variations in aortic luminal diameter.
- the toroidal balloon 560 is deflated and the catheter 550 is withdrawn from the patient.
- the embolic filter assembly of the perfusion filter catheter be deployed continuously throughout the entire period of cardiopulmonary bypass or extracorporeal perfusion. It is most critical, however, that the embolic filter assembly be deployed during periods when the potential for embolization is the highest, such as during manipulations of the heart and the aorta, during clamping and unclamping of the aorta and during the initial period after the heart is restarted following cardioplegic arrest. It has been previously stated that, for continuous deployment of a filter device in the aortic lumen, it is desirable for the filter mesh to have a surface area of 3-10 in 2 .
- the shallow, cone-shaped aortic filter devices illustrated in the known prior art only manage to provide surface areas at the lower end of this desired range in the largest of human aortas (approximately 3.0-3.9 in 2 in aortas of 3.5-4.0 cm diameter estimated based on the drawings and descriptions in the prior art disclosures) and in no cases are there embodiments disclosed which could provide surface areas in the middle and upper end of this range or that could even meet the minimum limit of this desired range in more typically sized aortas in the range of 2.5-3.5 cm diameter. Consequently, it is the opinion of the present inventors that the prior art does not provide an adequate solution to the technical problem that it illuminates.
- the solution to this dilemma is to provide a filter assembly that has a greater ratio of filter surface area to the cross-sectional area of the aortic lumen.
- the cross-sectional area of the aortic lumen being approximately equal to the area of the open upstream end of the embolic filter assembly at its deployed diameter within the aorta.
- the embolic filter assembly should provide a ratio of the filter surface area to the cross-sectional area of the aortic lumen of greater than approximately 2, more preferably greater than 3, more preferably greater than 4, more preferably greater than 5 and most preferably greater than 6.
- ratios of the filter surface area to the cross-sectional area of the aortic lumen it is possible to achieve a filter mesh surface area of 3-10 in 2 or greater in all typical adult human aortas ranging from 2.0 to 4.0 cm in diameter.
- ratios of the filter surface area to the cross-sectional area of the aortic lumen of 8, 10, 12 and even greater are readily achievable. Higher ratios such as these are desirable as they allow a very fine filter mesh to be utilized to effectively capture both macroemboli and microemboli without compromising the aortic blood flow.
- an embolic filter assembly structure or other means that maximizes the effective surface area of the filter mesh by holding at least a majority of the filter mesh away from the aortic wall or any other structures that might potentially obstruct flow through the filter mesh.
- FIGS. 1 - 3 there is illustrated an embolic filter assembly that is approximately conical in shape.
- a conical filter assembly In order to achieve a ratio of the filter surface area to the cross-sectional area of the aortic lumen of greater than approximately 2, a conical filter assembly must have a filter length L of greater than the aortic diameter D.
- a conical filter assembly To achieve a ratio of the filter surface area to the cross-sectional area of the aortic lumen of greater than approximately 4, a conical filter assembly must have a filter length L of greater than twice the aortic diameter D. To achieve a ratio of the filter surface area to the cross-sectional area of the aortic lumen of greater than approximately 6, a conical filter assembly must have a filter length L of greater than three times the aortic diameter D. With these ratios of the filter surface area to the cross-sectional area of the aortic lumen, it is possible to achieve a filter mesh surface area of 3-10 in 2 or greater in all typical adult human aortas ranging from 2.0 to 4.0 cm in diameter. Greater length to diameter ratios will provide more improved ratios of the filter surface area to the cross-sectional area of the aortic lumen.
- FIGS. 7 - 8 , 15 - 17 and 25 - 27 there are illustrated embolic filter assemblies having an approximately trumpet-shaped geometry that includes an approximately conical upstream section connected to an approximately cylindrical extension with a closed downstream end.
- This geometry provides an improvement in the ratio of the filter surface area to the cross-sectional area of the aortic lumen of approximately 15 to 50 percent compared with the simple conical geometry.
- Further improvements of the ratio of the filter surface area to the cross-sectional area of the aortic lumen can be realized with the convoluted embolic filter assemblies illustrated in FIGS. 18 - 20 , 20 - 23 and 30 . With these convoluted geometries, ratios of the filter surface area to the cross-sectional area of the aortic lumen of 2-12 or even greater can be achieved.
- Each of the embodiments of the invention described herein may be used for administration of standard cardiopulmonary bypass and cardioplegic arrest by combining the aortic filter catheter with a standard aortic crossclamp and a standard arterial perfusion cannula inserted into the ascending aorta between the crossclamp and the embolic filter assembly.
- the aortic filter catheter includes an integral perfusion lumen
- the CPB system can be simplified by the eliminating the separate arterial perfusion cannula.
- the CPB system can be further simplified by incorporating an aortic occlusion device into the aortic filter catheter and eliminating the aortic crossclamp.
- Such a system would allow percutaneous transluminal administration of cardiopulmonary bypass and cardioplegic arrest with protection from undesirable embolic events.
- FIGS. 46 - 50 show the operation of an embodiment of a perfusion filter catheter 600 that combines an embolic filter assembly 602 with a toroidal balloon aortic occlusion device 604 .
- the embolic filter assembly 602 and the toroidal balloon aortic occlusion device 604 are mounted on an elongated catheter shaft 606 that may be adapted for peripheral introduction via the femoral artery or subclavian artery or for central insertion directly into the ascending aorta.
- the toroidal balloon aortic occlusion device 604 is connected to an inflation lumen within the elongated catheter shaft 606 .
- a cardioplegia lumen which may also serve as a guidewire lumen, connects to a cardioplegia port 608 at the distal end of the catheter shaft 606 .
- a perfusion lumen connects to one or more perfusion ports 610 located on the catheter shaft 606 downstream from the toroidal balloon aortic occlusion device 604 , but upstream of the embolic filter assembly 602 .
- FIG. 46 shows the perfusion filter catheter 600 in the collapsed or undeployed state with the embolic filter assembly 602 and the toroidal balloon aortic occlusion device 604 collapsed or folded about the elongated catheter shaft 606 .
- the perfuision filter catheter 600 is inserted in the collapsed state and advanced into the patient's ascending aorta until the embolic filter assembly 602 is positioned between the coronary ostia and the brachiocephalic artery.
- the toroidal balloon aortic occlusion device 604 is then inflated to expand and deploy the embolic filter assembly 602 , as shown in FIG. 47.
- the embolic filter assembly 602 may assume a simple conical shape or, more preferably, one of the surface area increasing geometries described above.
- the embolic filter assembly 602 may include a structure or other means to hold the filter material apart from the aortic wall to maximize the effective filter area.
- the toroidal balloon aortic occlusion device 604 When it is desired to initiate cardioplegic arrest, the toroidal balloon aortic occlusion device 604 is further inflated until it expands inward to occlude the aortic lumen, as shown in FIG. 48. A cardioplegic agent is infused through the cardioplegia port 608 and into the coronary arteries to arrest the heart. Oxygenated blood continues to be infused through the perfusion ports 610 . After completion of the surgical procedure, the toroidal balloon aortic occlusion device 604 is partially deflated, leaving the embolic filter assembly 602 deployed, as shown in FIG. 49. Oxygenated blood enters the coronary arteries to restart the heart beating.
- embolic filter assembly 602 If any embolic materials 612 are dislodged during manipulation of the heart or when the heart resumes beating, they will be captured by the embolic filter assembly 602 .
- the toroidal balloon aortic occlusion device 604 is deflated to collapse the embolic filter assembly 602 , as shown in FIG. 50. Any potential emboli are trapped within the embolic filter assembly 602 and can be removed along with the catheter 600 .
- FIG. 51 shows an embodiment of a perfusion filter catheter 620 that combines an embolic filter assembly 622 with an inflatable balloon aortic occlusion device 624 .
- the embolic filter assembly 622 may be any one of the actively or passively deployed embolic filter assemblies described herein.
- the inflatable balloon aortic occlusion device 624 is an 5 elastomeric balloon of sufficient inflated diameter to occlude the ascending aorta and is mounted on the elongated catheter shaft 626 upstream of the embolic filter assembly 622 .
- the inflatable balloon aortic occlusion device 624 may be positioned to occlude the inlet end of the embolic filter assembly 622 to minimize the area of contact between the perfusion filter catheter 620 and the aortic wall.
- the inflatable balloon aortic occlusion device 624 is connected to an inflation lumen within the elongated catheter shaft 626 .
- a cardioplegia lumen which may also serve as a guidewire lumen, connects to a cardioplegia port 628 at the distal end of the catheter shaft 626 .
- a perfusion lumen connects to one or more perfusion ports 630 located on the catheter shaft 626 downstream from the inflatable balloon aortic occlusion device 624 , but upstream of the embolic filter assembly 622 .
- the operation of the perfusion filter catheter 620 of FIG. 51 is quite similar to that described for the embodiment of FIGS. 46 - 50 .
- FIG. 52 shows an embodiment of a perfusion filter catheter 640 that combines an embolic filter assembly 642 with a selectively deployable external catheter flow control valve 644 .
- the embolic filter assembly 642 may be any one of the actively or passively deployed embolic filter assemblies described herein.
- the selectively deployable external catheter flow control valve 644 is mounted on the elongated catheter shaft 646 upstream of the embolic filter assembly 642 .
- the selectively deployable external catheter flow control valve 644 may be positioned to occlude the inlet end of the embolic filter assembly 642 to minimize the area of contact between the perfusion filter catheter 640 and the aortic wall.
- the elongated catheter shaft 646 may include one or more deployment lumens as needed for actuating the external catheter flow control valve 644 .
- a cardioplegia lumen which may also serve as a guidewire lumen, connects to a cardioplegia port 648 at the distal end of the catheter shaft 646 .
- a perfusion lumen connects to one or more perfusion ports 650 located on the catheter shaft 646 downstream from the external catheter flow control valve 644 , but upstream of the embolic filter assembly 622 .
- the operation of the perfusion filter catheter 640 of FIG. 52 is quite similar to that described for the embodiment of FIGS. 46 - 50 .
- FIG. 53 shows an additional feature of the present invention that may be used in combination with many of the features and embodiments previously described.
- FIG. 53 shows an embodiment of a perfusion filter catheter 660 with an embolic filter assembly 662 having areas of different filter porosity.
- the embolic filter assembly 662 is mounted on an elongated catheter shaft 666 that may be adapted for peripheral introduction via the femoral artery or subclavian artery or for central insertion directly into the ascending aorta.
- the embolic filter assembly 662 may resemble any one of the actively or passively deployed embolic filter assemblies described herein.
- the embolic filter assembly 662 assumes one of the surface area increasing geometries described above, such as a trumpet-style embolic filter assembly 662 as shown.
- the embolic filter assembly 662 is divided along a longitudinal dividing line into areas of different filter porosity.
- the embolic filter assembly 662 has an upper portion 664 of finer porosity facing toward the aortic arch vessels and a lower portion 668 of courser porosity facing away from the aortic arch vessels.
- the elongated catheter shaft 666 will have a preformed curve to help orient the upper portion 664 and the lower portion 668 of the embolic filter assembly 662 in the proper position once deployed.
- the filter mesh of the upper portion 664 may be selected to exclude both macroemboli and microemboli, and the filter mesh of the lower portion 668 may be selected to exclude macroemboli only.
- the upper portion 664 may be impermeable so as to act like a shunt to direct potential emboli downstream away from the aortic arch vessels.
- FIG. 54 shows an embodiment of a perfusion filter catheter 670 with a fiberoptic system for aortic transillumination.
- a first optical fiber 684 is positioned near a distal end of the perfusion filter catheter 670 , upstream of the embolic filter assembly 672 , so that it will emit a first laterally directed beam of light.
- a second optical fiber 672 is positioned on the outer rim of the filter support structure 674 so that it will emit a second laterally directed beam of light.
- An optical coupling 682 at the proximal end of the perfusion filter catheter 670 connects the optical fibers 684 , 672 to a light source 680 by way of an optical cable 678 .
- the light beams emitted by the optical fibers 684 , 672 are visible through the aortic wall and can be used to locate and monitor the position and the deployment state of the perfusion filter catheter 670 and the embolic filter assembly 672 .
- one or more optical fibers or other light emitting devices may be positioned on the aortic occlusion device to locate and monitor its position and state of deployment.
- the features and embodiments of the present invention may also be combined with a bumper location device for facilitating catheter insertion and positioning by providing tactile feedback when the catheter device contacts the aortic valve.
- Bumper location devices suitable for this application are described in commonly owned, copending U.S. patent application Ser. Nos. 60/060,158, filed Sep. 26, 1997, and No. 60/073,681, filed Feb. 4, 1998, which are hereby incorporated by reference in their entirety.
Abstract
Description
- This application is a divisional of U.S. patent application Ser. No. 09/158,405, filed Sep. 22, 1998, now U.S. Pat. No. 6,361,545, which claims the benefit of U.S. Provisional Application, serial No. 60/060,117, filed Sep. 26, 1997, which are hereby incorporated by reference in their entirety.
- The present invention relates generally to a catheter or cannula for infusion of oxygenated blood or other fluids into a patient for cardiopulmonary support and cerebral protection. More particularly, it relates to an arterial perfusion catheter with a deployable embolic filter for protecting a patient from adverse effects due to emboli that are dislodged during cardiopulmonary bypass.
- Over the past decades tremendous advances have been made in the area of heart surgery, including such life saving surgical procedures as coronary artery bypass grafting (CABG) and cardiac valve repair or replacement surgery. Cardiopulmonary bypass (CPB) is an important enabling technology that has helped to make these advances possible. Recently, however, there has been a growing awareness within the medical community and among the patient population of the potential sequelae or adverse affects of heart surgery and of cardiopulmonary bypass. Chief among these concerns is the potential for stroke or neurologic deficit associated with heart surgery and with cardiopulmonary bypass. One of the likely causes of stroke and of neurologic deficit is the release of emboli into the blood stream during heart surgery. Potential embolic materials include atherosclerotic plaques or calcific plaques from within the ascending aorta or cardiac valves and thrombus or clots from within the chambers of the heart. These potential emboli may be dislodged during surgical manipulation of the heart and the ascending aorta or due to high velocity jetting (sometimes called the “sandblasting effect”) from the aortic perfusion cannula. Air that enters the heart chambers or the blood stream during surgery through open incisions or through the aortic perfusion cannula is another source of potential emboli. Emboli that lodge in the brain may cause a stroke or other neurologic deficit. Clinical studies have shown a correlation between the number and size of emboli passing through the carotid arteries and the frequency and severity of neurologic damage. At least one study has found that frank strokes seem to be associated with macroemboli larger than approximately 100 micrometers in size, whereas more subtle neurologic deficits seem to be associated with multiple microemboli smaller than approximately 100 micrometers in size. In order to improve the outcome of cardiac surgery and to avoid adverse neurological effects it would be very beneficial to eliminate or reduce the potential of such cerebral embolic events.
- Several medical journal articles have been published relating to cerebral embolization and adverse cerebral outcomes associated with cardiac surgery, e.g.: Determination or Size of Aortic Emboli and Embolic Load During Coronary Artery Bypass Grafting; Barbut et al.; Ann Thorac Surg 1997;63; 1262-7; Aortic Atheromatosis and Risks of Cerebral Embolization; Barbut et al.; J Card & Vasc Anesth, Vol 10, No 1, 1996: pp 24; Aortic Atheroma is Related to Outcome but not Numbers of Emboli During Coronary Bypass; Barbut et al.; Ann Thorac Surg 1997;64;454-9; Adverse Cerebral Outcomes After Coronary Artery Bypass Surgery; Roach et al.; New England J of Med, Vol 335, No 25, 1996: pp 1857-1863; Signs of Brain Cell Injury During Open Heart Operations: Past and Present; Aberg; Ann Thorac Surg 1995;59; 1312-5; The Role of CPB Management in Neurobehavioral Outcomes After Cardiac Surgery; Murkin; Ann Thorac Surg 1995;59;1308-11; Risk Factors for Cerebral Injury and Cardiac Surgery; Mills; Ann Thorac Surg 1995;59;1296-9; Brain Microemboli Associated with Cardiopulmonary Bypass: A Histologic and Magnetic Resonance Imaging Study; Moody et al.; Ann Thorac Surg 1995;59;1304-7; CNS Dysfunction After Cardiac Surgery: Defining the Problem; Murkin; Ann Thorac Surg 1995;59; 1287+Statement of Consensus on Assessment of Neurobehavioral Outcomes After Cardiac Surgery; Murkin et al.; Ann Thorac Surg 1995;59;1289-95; Heart-Brain Interactions: Neurocardiology Comes of Age; Sherman et al.; Mayo Clin Proc 62:1158-1160, 1987; Cerebral Hemodynamics After Low-Flow Versus No-Flow Procedures; van der Linden; Ann Thorac Surg 1995;59;1321-5; Predictors of Cognitive Decline After Cardiac Operation; Newman et al.; Ann Thorac Surg 1995;59;1326-30; Cardiopulmonary Bypass: Perioperative Cerebral Blood Flow and Postoperative Cognitive Deficit; Venn et al.; Ann Thorac Surg 1995;59; 1331-5; Long-Term Neurologic Outcome After Cardiac Operation; Sotaniemi; Ann Thorac Surg 1995;59;1336-9; and Macroemboli and Microemboli During Cardiopulmonary Bypass; Blauth; Ann Thorac Surg 1995;59;1300-3.
- The patent literature includes several references relating to vascular filter devices for reducing or eliminating the potential of embolization. These and all other patents and patent applications referred to herein are hereby incorporated herein by reference in their entirety.
- The following U.S. patents relate to vena cava filters: U.S. Pat. Nos. 5,549,626, 5,415,630, 5,152,777, 5,375,612, 4,793,348, 4,817,600, 4,969,891, 5,059,205, 5,324,304, 5,108,418, 4,494,531. Vena cava filters are devices that are implanted into a patient's inferior vena cava for capturing thromboemboli and preventing them from entering the right heart and migrating into the pulmonary arteries. These are generally designed for permanent implantation and are only intended to capture relatively large thrombi, typically those over a centimeter in diameter, that could cause a major pulmonary embolism. As such, these are unsuitable for temporary deployment within a patient's aorta or for capturing macroemboli or microemboli associated with adverse neurological outcomes. Vena cava filters are also not adapted for simultaneously providing arterial blood perfusion in connection with cardiopulmonary bypass.
- The following U.S. patents relate to vascular filter devices: U.S. Pat. Nos. 5,496,277, 5,108,419, 4,723,549, 3,996,938. These filter devices are not of a size suitable for deployment within a patient's aorta, nor would they provide sufficient filter surface area to allow aortic blood flow at normal physiologic flow rates without an unacceptably high pressure drop across the filter. Furthermore, these filter devices are not adapted for simultaneously providing arterial blood perfusion in connection with cardiopulmonary bypass devices.
- The following U.S. patents relate to aortic filters or aortic filters associated with atherectomy devices: U.S. Pat. Nos. 5,662,671, 5,769,816. The following international patent applications relate to aortic filters or aortic filters associated with atherectomy devices: WO 97/17100, WO 97/42879, WO 98/02084. The following international patent application relates to a carotid artery filter: WO 98/24377. This family of U.S. and international patents includes considerable discussion on the mathematical relationship between blood flow rate, pressure drop, filter pore size and filter area and concludes that, for use in the aorta, it is desirable for the filter mesh to have a surface area of 3-10 in2, more preferably 4-9 in2, 5-8 in2 or 6-8 in2, and most preferably 7-8 in2. While these patents state that this characteristic is desirable, none of the filter structures disclosed in the drawings and description of these patents appears capable of providing a filter surface area within these stated ranges when deployed within an average-sized human aorta. Accordingly, it would be desirable to provide a filter structure or other means that solves this technical problem by increasing the effective surface area of the filter mesh to allow blood flow at normal physiologic flow rates without an unacceptably high pressure drop.
- In keeping with the foregoing discussion, the present invention takes the form of a perfusion filter catheter or cannula having an embolic filter assembly mounted on an elongated tubular catheter shaft. The elongated tubular catheter shaft is adapted for introduction into a patient's ascending aorta either by a peripheral arterial approach or by a direct aortic puncture. A fine filter mesh for capturing macroemboli and/or microemboli is mounted on the embolic filter assembly. The embolic filter assembly has an undeployed state in which the filter is compressed or wrapped tightly around the catheter shaft and a deployed state in which the embolic filter assembly expands to the size of the aortic lumen and seals against the inner wall of the aorta. The embolic filter assembly can be passively or actively deployable. Various mechanisms are disclosed for both passive and active deployment of the embolic filter assembly. Optionally, an outer tube may cover the embolic filter assembly when it is in the undeployed state. Radiopaque markers and/or sonoreflective markers, may be located on the catheter and/or the embolic filter assembly. Preferably, a perfusion lumen extends through the elongated tubular catheter shaft to one or more perfusion ports upstream of the embolic filter assembly. Oxygenated blood is perfused through the perfusion lumen and any embolic materials that might be dislodged are captured in the deployed embolic filter assembly.
- In order to provide a sufficient flow rate of oxygenated blood for support of all critical organ systems through the filter without excessive pressure drop, it is preferred that the surface area of the filter mesh be greater than twice the cross-sectional area of the aortic lumen, more preferably three, four, five or six times greater than luminal cross section of the aorta. Preferably, the embolic filter assembly is also configured to hold at least a majority of the filter mesh away from the aortic wall when deployed to maximize the effective filter surface area. Several possible configurations are described for the embolic filter assembly that meet these parameters. The embolic filter assembly configurations described include an elongated cone, a frustum of a cone, a trumpet-shape, a modified trumpet-shape, and helically, circumferentially and longitudinally convoluted shapes. Further configurations are described having standoff members for centering the embolic filter assembly within the aorta and for holding at least a majority of the filter mesh away from the aortic walls when deployed.
- Embodiments are also described that combine the perfusion filter catheter with an aortic occlusion device, which may be a toroidal balloon, an expandable balloon or a selectively deployable external catheter flow control valve. The combined device allows percutaneous transluminal administration of cardiopulmonary bypass and cardioplegic arrest with protection from undesirable embolic events. An embodiment of the perfusion filter catheter is described having an aortic transillumination system for locating and monitoring the position and the deployment state of the catheter and the embolic filter assembly without fluoroscopy.
- In use, the perfusion filter catheter is introduced into the patient's aorta with the embolic filter assembly in a collapsed state either by a peripheral arterial approach or by a direct aortic puncture. The embolic filter assembly is advanced across the aortic arch and into the ascending aorta. When the embolic filter assembly is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, the embolic filter assembly is either actively or passively deployed. The position of the catheter and the deployment state of the embolic filter assembly may be monitored using fluoroscopy, ultrasound, transesophageal echography (TEE) or aortic transillumination. Once the embolic filter assembly is deployed, oxygenated blood may be infused into the aorta through the perfusion lumen. Any potential emboli are captured by the embolic filter assembly and prevented from entering the neurovasculature or other branches downstream. After use, the embolic filter assembly is returned to the collapsed position and the catheter is withdrawn from the patient.
- FIGS.1-3 show a perfusion filter catheter configured for retrograde deployment via a peripheral arterial access point.
- FIG. 1 is a cutaway perspective view of the perfusion filter catheter deployed within the aorta via femoral artery access.
- FIG. 2 shows the distal end of the catheter with the embolic filter assembly in a deployed state.
- FIG. 3 shows the distal end of the catheter with the embolic filter assembly in a collapsed state for insertion or withdrawal of the device from the patient.
- FIGS.4-6 show a method of passively deploying an embolic filter assembly on a perfusion filter catheter.
- FIGS. 7, 7A,8 and 8A show a flow-assisted method of passively deploying an embolic filter assembly on a perfusion filter catheter.
- FIGS.9-11 show a method of passively deploying a self-expanding and self-supporting embolic filter assembly on a perfusion filter catheter.
- FIGS.12-14 show a method of actively deploying an embolic filter assembly with a collapsible outer hoop and a plurality of actuation wires.
- FIGS.15-17 show a method of actively deploying an embolic filter assembly with an inflatable filter support structure.
- FIGS.18-20 show a method of actively deploying a spiral fluted embolic filter assembly by twisting or furling the embolic filter assembly around an inner catheter shaft.
- FIGS.21-23 show a method of actively deploying a circumferentially pleated embolic filter assembly on a perfusion filter catheter.
- FIG. 24 shows a perfusion filter catheter adapted for retrograde deployment via subclavian artery access.
- FIGS.25-27 show a perfusion filter catheter adapted for antegrade deployment via direct aortic puncture.
- FIGS. 28 and 29 show a perfusion filter catheter having an embolic filter assembly with a graded porosity filter screen.
- FIGS. 30 and 30A show a perfusion filter catheter having a longitudinally fluted embolic filter assembly.
- FIGS. 31 and 31A show a perfusion filter catheter having a longitudinally ribbed embolic filter assembly.
- FIG. 32 shows a perfusion filter catheter having an embolic filter assembly that is surrounded by a cage of longitudinally oriented standoff members.
- FIG. 33 shows a perfusion filter catheter having an embolic filter assembly that is surrounded by a cage of coiled wire standoff members.
- FIG. 34 shows a perfusion filter catheter having an embolic filter assembly that is surrounded by a cage of coarse netting.
- FIG. 35 shows a cutaway view of a perfusion filter catheter having an embolic filter assembly that is surrounded by a fender made from a porous foam or a fibrous network.
- FIGS. 36 and 37 show an alternate embodiment of a perfusion filter catheter with a passively deployed embolic filter assembly.
- FIGS.38-41 show an alternate embodiment of a perfusion filter catheter with an actively deployed embolic filter assembly having a filter support structure with a preshaped, superelastic actuation wire.
- FIGS. 42 and 43 show another alternate embodiment of a perfusion filter catheter with an actively deployed embolic filter assembly having a filter support structure with a preshaped, superelastic wire purse string loop.
- FIGS. 44 and 45 show another alternate embodiment of a perfusion filter catheter with an actively deployed inflatable embolic filter assembly.
- FIGS.46-50 show the operation of an embodiment of a perfusion filter catheter that combines an embolic filter assembly with a toroidal balloon aortic occlusion device.
- FIG. 51 shows an embodiment of a perfusion filter catheter that combines an embolic filter assembly with an inflatable balloon aortic occlusion device.
- FIG. 52 shows an embodiment of a perfusion filter catheter that combines an embolic filter assembly with a selectively deployable external catheter flow control valve.
- FIG. 53 shows an embodiment of a perfusion filter catheter with an embolic filter assembly having areas of different filter porosity.
- FIG. 54 shows an embodiment of a perfusion filter catheter with a fiberoptic system for aortic transillumination.
- FIGS.1-3 show a
perfusion filter catheter 100 according to the present invention configured for retrograde deployment via a peripheral arterial access point. FIG. 1 is a cutaway perspective view of theperfusion filter catheter 100 deployed within the aorta of a patient via femoral artery access. FIG. 2 shows the distal end of thecatheter 100 with theembolic filter assembly 102 in a deployed state. FIG. 3 shows the distal end of the catheter with theembolic filter assembly 102′ in a collapsed state for insertion or withdrawal of the device from the patient. - Referring now to FIG. 1, the
perfusion filter catheter 100 includes an elongatedtubular catheter shaft 104 with aproximal end 108 anddistal end 110. Thecatheter shaft 104 is preferably extruded of a flexible thermoplastic material or a thermoplastic elastomer. Suitable materials for thecatheter shaft 104 include, but are not limited to, polyvinylchloride, polyurethane, polyethylene, polypropylene, polyamides (nylons), and alloys or copolymers thereof, as well as braided, coiled or counterwound wire or filament reinforced composites. Thetubular catheter shaft 104 may have a single lumen or multilumen construction. In the exemplary embodiment shown, thecatheter 100 has asingle perfusion lumen 106 extending from theproximal end 108 to thedistal end 110 of thecatheter shaft 104. Theperfusion lumen 106 is open at thedistal end 110 of thecatheter shaft 104. Thedistal end 110 of thecatheter shaft 104 may have a simple beveled or rounded distal edge, as shown, or it may include additional side ports or a flow diffuser to reduce jetting when oxygenated blood is infused through theperfusion lumen 106. Theproximal end 108 of the elongatedtubular catheter shaft 104 is adapted for connecting theperfusion lumen 106 to a cardiopulmonary bypass pump or other source of oxygenated blood using standard barb connectors or other connectors, such as a standard luer fitting (not shown). Preferably, thecatheter shaft 104 is made with thin walled construction to maximize the internal diameter and therefore the flow rate of theperfusion lumen 106 for a given outside diameter and length of thecatheter shaft 104. Thin walled construction also allows the outside diameter of thecatheter shaft 104 to be minimized in order to reduce the invasiveness of the procedure and to reduce trauma at the insertion site. Theperfusion lumen 106 should be configured to allow sufficient blood flow to preserve organ function without hemolysis or other damage to the blood. For standard cardiopulmonary support techniques, acatheter shaft 104 of 18-24 French size (6-8 mm outside diameter) is sufficient to deliver the requisite 3-4 liters of oxygenated blood to preserve organ function. For low flow cardiopulmonary support techniques, such as described in commonly owned, copending patent application Ser. No. 60/084,835, filed May 8, 1998 which is hereby incorporated by reference, the size of thecatheter shaft 104 can be reduced to 9-18 French size (3-6 mm outside diameter) for delivering 0.5-3 liters of oxygenated blood to preserve organ function. Thecatheter shaft 104 should have a length sufficient to reach from the arterial access point where it is inserted to the ascending aorta of the patient. For femoral artery deployment, thecatheter shaft 104 preferably has a length from approximately 80-120 cm. - A deployable
embolic filter assembly 102 is located just proximal to thedistal end 110 of thecatheter shaft 104. Theembolic filter assembly 102 includes afilter screen 112 made of a fine mesh material. In this exemplary embodiment and each of the other embodiments described below, the fine mesh material of thefilter screen 112 may be a woven or knitted fabric, such as Dacron polyester or nylon mesh, or other textile fabrics, or it may be a nonwoven fabric, such as a spun bonded polyolefin or expanded polytetrafluoroethylene or other nonwoven materials. The fine mesh material of thefilter screen 112 may be woven, knitted or otherwise formed from monofilament or multifilament fibers. The fine mesh material of thefilter screen 112 may also be a fine wire mesh or a combination of wire and textile fibers. Alternatively, the fine mesh material of thefilter screen 112 may be an open cell foam material. The fine mesh material of thefilter screen 112 must be nontoxic and hemocompatible, that is, non-thrombogenic and non-hemolytic. Preferably, the fine mesh material of thefilter screen 112 has a high percentage of open space, with a uniform pore size. The pore size of thefilter screen 112 can be chosen to capture macroemboli only or to capture macroemboli and microemboli. In most cases the pore size of thefilter screen 112 will preferably be in the range of 1-200 micrometers. For capturing macroemboli only, the pore size of thefilter screen 112 will preferably be in the range of 50-200 micrometers, more preferably in the range of 80-100 micrometers. For capturing macroemboli and microemboli, the pore size of thefilter screen 112 will preferably be in the range of 1-100 micrometers, more preferably in the range of 5-20 micrometers. In other applications, such as for treating thromboembolic disease, a larger pore size, e.g. up to 1000 micrometers (1 mm) or larger, would also be useful. In some embodiments, a combination of filter materials having different pore sizes may be used. - Alternatively or additionally the material of the filter screen in each embodiment of the filter catheter may be made of or coated with an adherent material or substance to capture or hold embolic debris which comes into contact with the filter screen within the embolic filter assembly. Suitable adherent materials include, but are not limited to, known biocompatible adhesives and bioadhesive materials or substances, which are hemocompatible and non-thrombogenic. Such materials are known to those having ordinary skill in the art and are described in, among other references, U.S. Pat. Nos. 4,768,523, 5,055,046, 5,066,709, 5,197,973, 5,225,196, 5,374,431, 5,578,310, 5,645,062, 5,648,167, 5,651,982, and 5,665,477. In one particularly preferred embodiment, only the upstream side of the elements of the filter screen are coated with the adherent material to positively capture the embolic debris which comes in contact with the upstream side of the filter screen after entering the filter assembly. Other bioactive substances, for example, heparin or thrombolytic agents, may be impregnated into or coated on the surface of the filter screen material or incorporated into an adhesive coating.
- The
embolic filter assembly 102 is movable between a collapsed state, as shown in FIG. 3, and an expanded or deployed state, as shown in FIGS. 1 and 2. Thefilter screen 112 may be attached directly to thecatheter shaft 104 and it may constitute the entireembolic filter assembly 102, particularly if thefilter screen 112 is made of a resilient or semirigid fabric that has enough body to be self-supporting in the deployed state. Generally, however, theembolic filter assembly 102 will also include afilter support structure 114, particularly if a highly flexible or flaccid material is used for thefilter screen 112. Thefilter support structure 114 attaches and supports thefilter screen 112 on thecatheter shaft 104. In the illustrative embodiment of FIGS. 1-3, thefilter support structure 114 is constructed with anouter hoop 116 and a plurality ofstruts 118 which extend approximately radially from a ring-shapedhub 126 that is mounted on thecatheter shaft 104. In this case fourstruts 118 are shown, however, two, three ormore struts 118 may be used. The opendistal end 122 of thefilter screen 112 is attached to theouter hoop 116 and theproximal end 120 of thefilter screen 112 is sealingly attached to thecatheter shaft 104. When theembolic filter assembly 102 is deployed, theouter hoop 116 of thefilter support structure 114 holds the opendistal end 122 of thefilter screen 112 against the inner wall of the aorta, as shown in FIG. 1. To accommodate most normal adult aortas, theouter hoop 116 of thefilter support structure 114 and thedistal end 122 of thefilter screen 112 have a diameter of approximately 2.5 to 4 cm, plus or minus 0.5 cm. Larger and smaller diameterfilter support structures 114 may be made to accommodate patients with distended or Marfan syndrome aortas or for pediatric patients. - The
embolic filter assembly 102 may be deployed by a passive means or by an active means. Passive means for deploying theembolic filter assembly 102 could include using the elastic memory of thefilter screen 112 and/or thefilter support structure 114 to deploy theembolic filter assembly 102, and/or using pressure from the blood flow in the aorta to deploy theembolic filter assembly 102. By contrast, active means for deploying theembolic filter assembly 102 could include one or more actuation members within thecatheter shaft 104 for mechanically actuating thefilter support structure 114 to deploy theembolic filter assembly 102 from theproximal end 108 of thecatheter 100. Shape memory materials may also be used as actuation members for deploying theembolic filter assembly 102. Alternatively, active means for deploying theembolic filter assembly 102 could include one or more lumens within thecatheter shaft 104 for hydraulically actuating thefilter support structure 114 to deploy theembolic filter assembly 102. Passive means may be used to augment the action of the active deployment means. As shown in FIG. 3, anouter tube 124 may be provided to cover theembolic filter assembly 102 when it is in the collapsed state in order to create a smooth outer surface for insertion and withdrawal of thecatheter 100 and to prevent premature deployment of theembolic filter assembly 102, particularly if passive deployment means are used. - The
perfusion filter catheter 100 is prepared for use by folding or compressing theembolic filter assembly 102 into a collapsed state within theouter tube 124, as shown in FIG. 3. Thedistal end 110 of thecatheter 100 is inserted into the aorta in a retrograde fashion. Preferably, this is done through a peripheral arterial access, such as the femoral artery or subclavian artery, using the Seldinger technique or an arterial cutdown. Alternatively, thecatheter 100 may be introduced directly through an incision into the descending aorta after the aorta has been surgically exposed. Theembolic filter assembly 102 is advanced up the descending aorta and across the aortic arch while in the collapsed state. The position of thecatheter 100 may be monitored using fluoroscopy or ultrasound, such as transesophageal echography (TEE). Appropriate markers, which may include radiopaque markers and/or sonoreflective markers, may be located on thedistal end 110 of thecatheter 100 and/or theembolic filter assembly 102 to enhance imaging and to show the position of thecatheter 100 and the deployment state of theembolic filter assembly 102. When thedistal end 110 of thecatheter 100 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, theouter tube 124 is withdrawn and theembolic filter assembly 102 is deployed, as shown in FIG. 3. Optionally, a distal portion of thecatheter shaft 104 may be precurved to match the curvature of the aortic arch to aid in placement and stabilization of thecatheter 100 and theembolic filter assembly 102 within the aorta. Once theembolic filter assembly 102 is deployed, oxygenated blood may be infused through theperfusion lumen 106 to augment cardiac output of the beating heart or to establish cardiopulmonary bypass so that the heart can be arrested. Any potential emboli are captured by thefilter screen 112 and prevented from entering the neurovasculature or other branches downstream. After use, theembolic filter assembly 102 is returned to the collapsed position and thecatheter 100 is withdrawn from the patient. - Preferably, the
embolic filter assembly 102 is configured so that, when it is in the deployed state, at least a majority of thefilter screen 112 is held away from the aortic walls so that flow through the pores of thefilter screen 112 is not occluded by contact with the aortic wall. In addition, this also assures that blood flow into the side branches of the aorta will not be obstructed by thefilter screen 112. In this way, each side branch of the aorta will receive the benefit of flow through the full surface area of thefilter screen 112 so that blood flow is not restricted by the area of the ostium of each side branch. In the illustrative embodiment of FIGS. 1-3, thefilter screen 112 has a roughly conical shape with an opendistal end 122. The conical shape holds the fine mesh material of thefilter screen 112 away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of thefilter screen 112. - Deployment of the
embolic filter assembly 102 can be accomplished passively or actively. FIGS. 4-11 show various methods of passively deploying theembolic filter assembly 102 and FIGS. 12-23 show various methods of actively deploying theembolic filter assembly 102. FIGS. 4-6 show one method of passively deploying theembolic filter assembly 102. In this exemplary embodiment, theouter hoop 116 and thestruts 118 of thefilter support structure 114 are made of an elastic or superelastic metal or polymer, for example a superelastic nickel/titanium alloy, which is easily deformed into the collapsed state and which expands passively from the collapsed state to the deployed state. To place theembolic filter assembly 102 in the collapsed position shown in FIG. 4, thestruts 118 are folded back in the proximal direction and theouter hoop 116 is folded against thecatheter shaft 104 along with the material of thefilter screen 112. Theouter tube 124 is placed over the foldedembolic filter assembly 102 to hold it in the collapsed position. Once theperfusion filter catheter 100 is in position within the patient's aorta, theouter tube 124 is pulled back, as shown in FIG. 5, to release the foldedembolic filter assembly 102. Theouter hoop 116 and struts 118 expand thefilter screen 112 to its deployed position, shown in FIG. 6, and hold the opendistal end 122 of thefilter screen 112 against the inner wall of the aorta, as shown in FIG. 1. After use, theembolic filter assembly 102 is returned to the collapsed position by advancing theouter tube 124 distally over thefilter screen 112 and thefilter support structure 114, then thecatheter 100 is withdrawn from the patient. - FIGS. 7, 7A,8 and 8A show another method of passively deploying an
embolic filter assembly 132 on aperfusion filter catheter 130. In this embodiment, the filter support structure includes a plurality ofstruts 136 which are hinged or flexibly attached at their inner, proximal ends to thecatheter shaft 134. Thestruts 136 may be made of either a metal or a polymer. Thedistal end 138 of thefilter screen 140 is attached to thestruts 136 along an outer, distal portion of thestruts 136. Theproximal end 146 of thefilter screen 140 is sealingly attached to thecatheter shaft 134. The portion of thefilter screen 140 attached to thestruts 136 forms askirt 142 along the distal edge of thefilter assembly 132. The remaining portion of thefilter screen 140 forms afilter pocket 144 along the proximal end of thefilter assembly 132. Theskirt 142 and thefilter pocket 144 may be made of the same filter material or they may be made of different filter materials having different porosities. Theskirt 142 of thefilter screen 140 may even be made of a nonporous material. - The
embolic filter assembly 132 is folded into the collapsed position shown in FIG. 7 by folding thestruts 136 in the distal direction so they lie against thecatheter shaft 134. FIG. 7A is a cutaway view of thecatheter 130 with theembolic filter assembly 132 in the collapsed position. The material of thefilter screen 140 is folded around or in between thestruts 136. Theouter tube 148 is placed over the foldedembolic filter assembly 132 to hold it in the collapsed position. Once theperfusion filter catheter 130 is in position within the patient's aorta, theouter tube 148 is pulled back, as shown in FIG. 8, to release the foldedembolic filter assembly 132. Blood flow within the aorta catches theskirt 142 of thefilter screen 140 and forces theembolic filter assembly 132 to open into the deployed position shown in FIG. 8. FIG. 8A is a cutaway view of thecatheter 130 with theembolic filter assembly 132 in the deployed position. Optionally, thestruts 136 may be resiliently biased toward the deployed position to assist in passive deployment of theembolic filter assembly 132. As theembolic filter assembly 132 is passively opened by the blood flow, theskirt 142 of thefilter screen 140 naturally and atraumatically seals against the aortic wall. The passive deployment of theskirt 142 also naturally compensates for patient-to-patient variations in aortic luminal diameter. Thefilter pocket 144 of theembolic filter assembly 132 is held away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of thefilter screen 140. - FIGS.9-11 show another method of passively deploying an
embolic filter assembly 152 on aperfusion filter catheter 150. In this embodiment, thefilter screen 154 is self-expanding and self-supporting, so no separate filter support structure is needed. Preferably, theembolic filter assembly 152 includes resilient wires orfilaments 156 that are interwoven with the fibers of thefilter screen 154. Alternatively, the resilient wires orfilaments 156 may be attached to the interior or exterior surface of thefilter screen 154 fabric. The resilient wires orfilaments 156 may be made of either a polymer or a metal, such as an elastic or superelastic alloy. In one preferred embodiment, the resilient wires orfilaments 156, and preferably the fibers of thefilter screen 154 as well, are woven at an angle to the longitudinal axis of theembolic filter assembly 152, so that theembolic filter assembly 152 can expand and contract in diameter by changing the angle of the wires orfilaments 156. Generally, as theembolic filter assembly 152 expands in diameter, the angle between the wires orfilaments 156 and the longitudinal axis of theembolic filter assembly 152 increases and theembolic filter assembly 152 may also foreshorten. The resilient wires orfilaments 156 urge theembolic filter assembly 152 to expand to the deployed position. Theproximal end 158 of thefilter screen 154 is sealingly attached to thecatheter shaft 162. - The
perfusion filter catheter 150 is shown in FIG. 9 with theembolic filter assembly 152 compressed into the collapsed position. Theembolic filter assembly 152 compresses in diameter smoothly without folding as the resilient wires orfilaments 156 and the fibers of thefilter screen 154 decrease their angle with respect to the longitudinal axis of theembolic filter assembly 152. Anouter tube 164 holds theembolic filter assembly 152 in the collapsed position. Once theperfusion filter catheter 150 is in position within the patient's aorta, theouter tube 164 is pulled back, which allows theembolic filter assembly 152 to expand, as shown in FIG. 10. As theembolic filter assembly 152 expands, the angle between the wires orfilaments 156 and the longitudinal axis of theembolic filter assembly 152 increases and theembolic filter assembly 152 foreshortens slightly. FIG. 11 shows theembolic filter assembly 152 fully expanded in the deployed position. The resilient wires orfilaments 156 are preformed so that, when deployed, thefilter screen 154 has a roughly conical shape with an opendistal end 160. The conical shape holds thefilter screen 154 away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of thefilter screen 154. Thedistal end 160 of theembolic filter assembly 152 seals against the aortic wall. The self-expanding aspect of theembolic filter assembly 152 naturally compensates for patient-to-patient variations in aortic luminal diameter. - In alternate embodiments, the resilient wires or
filaments 156 may be preformed to other geometries so that thefilter screen 154 of theembolic filter assembly 152 assumes a different configuration when deployed, including each of the other configurations discussed within this patent specification. - FIGS.12-14 show one method of actively deploying an
embolic filter assembly 168 on aperfusion filter catheter 166. In this exemplary embodiment, thefilter support structure 170 includes a collapsibleouter hoop 172 and a plurality ofactuation wires 174. Thedistal end 176 of thefilter screen 180 is attached to theouter hoop 172 and theproximal end 182 of thefilter screen 180 is sealingly attached to thecatheter shaft 184. Theactuation wires 174 are slidably received withinactuation wire lumens 186 located in the outer wall of thecatheter shaft 184. Theactuation wires 174 exit theactuation wire lumens 186 throughside ports 188 located near the distal end of thecatheter shaft 184. Theactuation wires 174 and theouter hoop 172 are each made of a resilient polymer or a metal, such as stainless steel, nickel/titanium alloy or the like. - The
perfusion filter catheter 166 is shown in FIG. 12 with theembolic filter assembly 168 compressed into the collapsed position. Theactuation wires 174 are withdrawn into theactuation wire lumens 186 through theside ports 188 and theouter hoop 172 is folded or collapsed against thecatheter shaft 184. The material of thefilter screen 180 is folded or collapsed around thecatheter shaft 184. Anouter tube 190 covers theembolic filter assembly 168 in the collapsed position to facilitate insertion of thecatheter 166. Once theperfusion filter catheter 150 is in position within the patient's aorta, theouter tube 190 is pulled back to expose theembolic filter assembly 152. Then, theactuation wires 174 are advanced distally to expand theouter hoop 172 and thefilter screen 180, as shown in FIG. 13. FIG. 14 shows theembolic filter assembly 168 fully expanded in the deployed position. In this exemplary embodiment, thefilter screen 180 is configured as a frustum of a cone with an opendistal end 176. Theouter hoop 172 at thedistal end 176 of thefilter screen 180 seals against the aortic wall. - FIGS.15-17 show another method of actively deploying an
embolic filter assembly 202 on aperfusion filter catheter 200. In this embodiment, thefilter support structure 204 includes anouter hoop 206 and a plurality ofstruts 208, which are all interconnected hollow tubular members. Preferably, theouter hoop 206 and thestruts 208 are made of a flexible polymeric material. Thefilter support structure 204 is connected to aninflation lumen 210, which parallels theperfusion lumen 218 within thecatheter shaft 212. At its proximal end, theinflation lumen 210 branches off from thecatheter shaft 212 to aside arm 214 with a luer fitting 216 for connecting to a syringe or other inflation device. By way of example, this embodiment of theembolic filter assembly 202 is shown with a trumpet-shapedfilter screen 220. Thefilter screen 220 includes askirt portion 222 extending distally from a proximal,filter pocket 224. Theskirt portion 222 is in the shape of a frustum of a cone with an open distal end, which is attached to theouter hoop 206. Thefilter pocket 224 is roughly cylindrical in shape with a closed proximal end, which is sealingly attached to thecatheter shaft 212. Theskirt 222 and thefilter pocket 224 may be made of the same filter material or they may be made of different filter materials having different porosities. Theskirt 222 of thefilter screen 220 may even be made of a nonporous material. - The
perfusion filter catheter 200 is shown in FIG. 17 with theembolic filter assembly 202 folded into a collapsed position. Theouter hoop 206 and thestruts 208 of thefilter support structure 204 are deflated and the material of thefilter screen 220 is folded or collapsed around thecatheter shaft 212. Anouter tube 226 covers theembolic filter assembly 202 in the collapsed position to facilitate insertion of thecatheter 200. Optionally, theouter tube 226 may have a slit or a weakened longitudinal tear line along its length to facilitate removal of theouter tube 226 over theside arm 214 at the proximal end of thecatheter 200. Once theperfusion filter catheter 200 is in position within the patient's aorta, theouter tube 226 is pulled back to expose theembolic filter assembly 202. Then, theembolic filter assembly 202 is deployed by inflating theouter hoop 206 and thestruts 208 with fluid injected through theinflation lumen 210 to actively expand thefilter support structure 204, as shown in FIG. 16. When theembolic filter assembly 202 is deployed, theouter hoop 206 of thefilter support structure 204 seals against the inner wall of the aorta, as shown in FIG. 15. Preferably, at least the outer wall of theouter hoop 206 is somewhat compliant when inflated in order to compensate for patient-to-patient variations in aortic luminal diameter. - FIGS.18-20 show another method of actively deploying an
embolic filter assembly 232 on aperfusion filter catheter 230. In this embodiment, the filter support structure 234 includes anouter hoop 236 and a plurality ofstruts 238, which are connected to aninner catheter shaft 240. Theouter hoop 236 and thestruts 238 may be made of a resilient polymer or metal, for example a superelastic nickel/titanium alloy. Thedistal end 242 of thefilter screen 244 is attached to theouter hoop 236. Theproximal end 246 of thefilter screen 244 is sealingly attached to anouter catheter shaft 250. Theinner catheter shaft 240 is slidably and rotatably received within theouter catheter shaft 250. Preferably, thefilter screen 244 has one or more spiral grooves orflutes 248 that wind helically around thefilter screen 244. - The
embolic filter assembly 232 is folded into the collapsed position shown in FIG. 20 by extending and rotating theinner catheter shaft 240 in a first direction with respect to theouter catheter shaft 250. This collapses the filter support structure 234 back against theinner catheter shaft 240 and furls thefilter screen 244 around theinner catheter shaft 240. The spiral flutes 248 in thefilter screen 244 help it to collapse smoothly around theinner catheter shaft 240. Anouter tube 252 covers theembolic filter assembly 232 in the collapsed position to facilitate insertion of thecatheter 230. Once theperfusion filter catheter 230 is in position within the patient's aorta, theouter tube 252 is pulled back to expose theembolic filter assembly 232. Then, theembolic filter assembly 232 is deployed by rotating theinner catheter shaft 240 in the opposite direction with respect to theouter catheter shaft 250 and allowing it to retract slightly, as shown in FIG. 19. The filter support structure 234 and thefilter screen 244 will expand within the aorta and thedistal end 242 of thefilter screen 244 will seal against the aortic wall, as shown in FIG. 18. When it is in the deployed position, the spiral flutes 248 of theembolic filter assembly 232 hold most of thefilter screen 244 away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of thefilter screen 244. After use, theembolic filter assembly 232 is returned to the collapsed position as described above and thecatheter 230 is withdrawn from the patient. - The coaxial arrangement of the
inner catheter shaft 240 and theouter catheter shaft 250 in this embodiment of theperfusion filter catheter 230 creates an annular space that can optionally be used as alumen 258 to aspirate potential emboli that are captured by thefilter screen 244. To facilitate this, aside arm 254 with a luer fitting and a slidinghemostasis valve 256 may be added to the proximal end of theouter catheter shaft 250, as shown in FIG. 18. - FIGS.21-23 show another method of actively deploying an
embolic filter assembly 262 on aperfusion filter catheter 260. In this embodiment, the filter support structure 234 includes anouter hoop 266 and a plurality ofstruts 268, which are connected to aninner catheter shaft 270. Theouter hoop 266 and thestruts 268 may be made of a resilient polymer or metal, for example a superelastic nickel/titanium alloy. Thedistal end 272 of thefilter screen 274 is attached to theouter hoop 266. Theproximal end 276 of thefilter screen 274 is sealingly attached to anouter catheter shaft 280. Theinner catheter shaft 270 is slidably received within theouter catheter shaft 280. Preferably, thefilter screen 274 has a series ofcircumferential pleats 278 that give thefilter screen 274 an accordion appearance. - The
embolic filter assembly 262 is folded into the collapsed position shown in FIG. 23 by extending theinner catheter shaft 270 distally with respect to theouter catheter shaft 280. This collapses the filter support structure 264 back against theinner catheter shaft 270 and collapses thecircumferential pleats 248 of thefilter screen 274 against theinner catheter shaft 270. Anouter tube 282 covers theembolic filter assembly 262 in the collapsed position to facilitate insertion of thecatheter 260. Once theperfusion filter catheter 260 is in position within the patient's aorta, theouter tube 282 is pulled back to expose theembolic filter assembly 262. Then, theembolic filter assembly 262 is deployed by retracting theinner catheter shaft 270 proximally with respect to theouter catheter shaft 280, as shown in FIG. 22. The filter support structure 264 and thefilter screen 274 will expand within the aorta and thedistal end 272 of thefilter screen 274 will seal against the aortic wall, as shown in FIG. 21. When it is in the deployed position, thecircumferential pleats 278 of theembolic filter assembly 262 hold the majority of thefilter screen 274 away from the aortic walls and away from the ostia of the side branches so that blood can flow freely through the pores of thefilter screen 274. After use, theembolic filter assembly 262 is returned to the collapsed position as described above and thecatheter 260 is withdrawn from the patient. - As with the previous embodiment, the coaxial arrangement of the
inner catheter shaft 270 and theouter catheter shaft 280 in this embodiment of theperfusion filter catheter 260 creates an annular space that can optionally be used as alumen 288 to aspirate potential emboli that are captured by thefilter screen 274. To facilitate this, aside arm 284 with a luer fitting and a slidinghemostasis valve 286 may be added to the proximal end of theouter catheter shaft 280, as shown in FIG. 21. - Active deployment of the embolic filter assembly can also be accomplished with any of the preceding embodiments by using shape memory materials, such as a nickel/titanium alloy, to construct the filter support structure and/or the actuation members. The transition temperature of the shape memory material should be chosen to be close to normal body temperature so that extreme temperature variations will not be necessary for deployment. The shape memory material of the filter support structure should be annealed in the deployed position to confer a shape memory in this configuration. Then, the embolic filter assembly should be cooled below the transition temperature of the shape memory material, so that the filter support structure is malleable and can be shaped into a collapsed position. Depending on the transition temperature, this can be done at room temperature or in iced saline solution. If desired, an outer tube can be placed over the embolic filter assembly to facilitate catheter insertion and to avoid premature deployment. Once the perfusion filter catheter is in position within the patient's aorta, the outer tube is pulled back to expose the embolic filter assembly and the filter support structure is heated above the transition temperature to deploy the embolic filter assembly. Depending on the transition temperature of the shape memory material, the filter support structure can be passively heated by body heat (accounting, of course, for decreased body temperature during hypothermic cardiopulmonary support methods) or it can be self-heated by applying an electrical current through the filter support structure. When heated, the filter support structure expands to its annealed configuration within the aorta. After use, the embolic filter assembly is returned to the collapsed position by advancing the outer tube distally over the filter screen and the filter support structure, then the catheter is withdrawn from the patient.
- The foregoing examples of the perfusion filter catheter of the present invention showed retrograde deployment of the device within the aorta via femoral artery access. Each of the described embodiments of the perfusion filter catheter can also be adapted for retrograde deployment via subclavian artery access or for antegrade or retrograde deployment via direct aortic puncture.
- FIG. 24 shows a
perfusion filter catheter 290 which is adapted for retrograde deployment via subclavian artery access. In this exemplary embodiment, theperfusion filter catheter 290 is depicted with a trumpet-style, passively-deployedembolic filter assembly 292. Because it is intended for subclavian artery access, theperfusion filter catheter 290 has atubular catheter shaft 294 with a length of approximately 60-90 cm. Because of the shorter length, as compared to the femoral version of the catheter, the outside diameter of thecatheter shaft 294 can be reduced to 12-18 French size (4-6 mm outside diameter) for delivering the 3-4 liters of oxygenated blood needed to preserve organ function. The reduced diameter of thecatheter shaft 294 is especially advantageous for subclavian artery delivery of thecatheter 290. To further reduce the size of the catheter system for subclavian or femoral artery delivery, theouter tube 296 may be adapted for use as an introducer sheath by the addition of anoptional hemostasis valve 298 at the proximal end of theouter tube 296. This eliminates the need for a separate introducer sheath for introducing thecatheter 290 into the circulatory system. - In use, the
perfusion filter catheter 290 is introduced into the subclavian artery with theembolic filter assembly 292 in a collapsed state within theouter tube 296, using the Seldinger technique or an arterial cutdown. Theembolic filter assembly 292 is advanced across the aortic arch while in the collapsed state. The position of thecatheter 292 may be monitored using fluoroscopy or ultrasound, such as transesophageal echography (TEE). Radiopaque markers and/or sonoreflective markers, may be located on thecatheter 290 and/or theembolic filter assembly 292 to enhance imaging and to show the position of thecatheter 290 and the deployment state of theembolic filter assembly 292. When the distal end of thecatheter 290 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, theouter tube 296 is withdrawn and theembolic filter assembly 292 is either actively or passively deployed, as shown in FIG. 24. Once theembolic filter assembly 292 is deployed, oxygenated blood may be infused into the aorta through thetubular catheter shaft 294. Any potential emboli are captured by theembolic filter assembly 292 and prevented from entering the neurovasculature or other branches downstream. After use, theembolic filter assembly 292 is returned to the collapsed position and thecatheter 290 is withdrawn from the patient. - Retrograde deployment of the
perfusion filter catheter 290 via direct aortic puncture is quite similar to introduction via subclavian artery access, except that thecatheter 290 is introduced directly into the descending aorta after it has been surgically exposed, for example during open-chest or minimally invasive cardiac surgery. Because of the direct aortic insertion, the length and the diameter of thecatheter shaft 294 may be further reduced. - FIGS.25-27 show a
perfusion filter catheter 300 which is adapted for antegrade deployment via direct aortic puncture. In this exemplary embodiment, theperfusion filter catheter 300 is depicted with a hybrid-styleembolic filter assembly 302, which is a compromise between the conical filter screen and the trumpet-style filter screen previously described. Because thecatheter 300 is introduced directly into the ascending aorta, thecatheter shaft 304 can be reduced to a length of approximately 20-60 cm and an outside diameter of approximately 12-18 French size (4-6 mm outside diameter) for delivering the 3-4 liters of oxygenated blood needed to preserve organ function during cardiopulmonary bypass. An important modification that must be made to thecatheter 300 for antegrade deployment is that the perfusion port orports 306 which connect to theperfusion lumen 308 must exit thecatheter shaft 304 proximal to thefilter screen 310 so that fluid flow will come from the upstream side of theembolic filter assembly 302. Thecatheter shaft 304 need not extend all the way to the distal end of thefilter screen 310. Thefilter screen 310 may be entirely supported by thefilter support structure 312, particularly if theembolic filter assembly 302 is to be passively deployed. Alternatively, a small diameterfilter support member 314 may extend from thecatheter shaft 304 to the distal end of thefilter screen 310. If theembolic filter assembly 302 is intended to be actively deployed, thefilter support member 314 may be slidably and/or rotatably received within thecatheter shaft 304. Either of these configurations allows theembolic filter assembly 302 to be folded or compressed to a size as small as the diameter of thecatheter shaft 304 to facilitate insertion of thecatheter 300. Optionally, anouter tube 316 may be placed over the foldedembolic filter assembly 302 to hold it in the collapsed position. - In use, the ascending aorta of the patient is surgically exposed, using open-chest or minimally invasive surgical techniques. A
purse string suture 318 is placed in the ascending aorta and an aortotomy incision is made through the aortic wall. Thecatheter 300, with theembolic filter assembly 302 in the collapsed position within theouter tube 316, is inserted through the aortotomy and advanced antegrade into the aortic arch. When the proximal end of theembolic filter assembly 302 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, theouter tube 316 is withdrawn and theembolic filter assembly 302 is either actively or passively deployed, as shown in FIG. 25. Once theembolic filter assembly 302 is deployed, oxygenated blood may be infused into the aorta through thetubular catheter shaft 304. Any potential emboli are captured by theembolic filter assembly 302 and prevented from entering the neurovasculature or other branches downstream. After use, theembolic filter assembly 302 is returned to the collapsed position, thecatheter 300 is withdrawn from the patient, and thepurse string suture 318 is tightened to close the aortotomy. - In general, each of the passive and active deployment methods described above may be used interchangeably or together in combinations with each of the embodiments of the perfusion filter catheter and each of catheter insertion methods which are described above and below. Likewise, many of the features of the embodiments described may be used in various combinations with one another to create new embodiments, which are considered to be a part of this disclosure, as it would be too cumbersome to describe all of the numerous possible combinations and subcombinations of the disclosed features.
- Following are a number of alternate embodiments of the perfusion filter catheter of the present invention illustrating additional features and variations in the configuration of the invention. In general, each of the described embodiments may be passively or actively deployed by the methods described above. Each embodiment of the perfusion filter catheter described can also be adapted for retrograde deployment via peripheral arterial access, such as femoral or subclavian artery access, or for antegrade or retrograde deployment via direct aortic puncture.
- FIGS. 28 and 29 show a
perfusion filter catheter 320 having anembolic filter assembly 322 with a gradedporosity filter screen 324. Thefilter screen 324 is attached to afilter support structure 326 mounted on acatheter shaft 328 for antegrade or retrograde deployment. Thefilter screen 324 may be made in each of the configurations disclosed herein or any other convenient shape. By way of example, thefilter screen 324 in this embodiment is depicted as being in the shape of a frustum of a cone. Thefilter screen 324 has anupstream end 330 and adownstream end 332. Theupstream end 330 of thefilter screen 324 has a finer filter mesh than thedownstream end 332. Depending on the capabilities of the fabrication process used, the pore size of thefilter screen 324 may make a gradual transition from theupstream end 330 to thedownstream end 332 or there may be two or more discrete zones of varying pore size. In one preferred embodiment, the filter mesh on theupstream end 330 has a pore size of approximately 5-50 micrometers for capturing microemboli and macroemboli and the filter mesh on thedownstream end 332 has a pore size of approximately 50-100 micrometers for capturing macroemboli only. The pore size of thefilter screen 324 has been greatly exaggerated in FIG. 28 for clarity of illustration. - In use, the
perfuision filter catheter 320 is introduced into the aorta with theembolic filter assembly 322 in a collapsed state within anouter tube 334, using one of the methods described above. Theembolic filter assembly 322 is advanced across the aortic arch while in the collapsed state. When theupstream end 336 of thecatheter 320 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, theouter tube 334 is withdrawn and theembolic filter assembly 322 is either actively or passively deployed, as shown in FIG. 29. Preferably, theembolic filter assembly 292 is dimensioned so that when it is deployed, theupstream end 330 of thefilter screen 324 is positioned in the vicinity of the ostia for the brachiocephalic artery and the left common carotid artery and thedownstream end 332 of thefilter screen 324 is positioned downstream of this position, preferably in the descending aorta. This configuration assures that all of the perfusate which is destined for the neurovasculature must pass through the finer,upstream end 330 of thefilter screen 324 to remove all microemboli and macroemboli. Whereas, the perfusate which is destined for the viscera and the lower limbs, which are more tolerant of small emboli, need only pass through thedownstream end 332 of thefilter screen 324, so as to remove at least the macroemboli. - FIG. 30 shows a
perfusion filter catheter 340 having a longitudinally flutedembolic filter assembly 342. Theembolic filter assembly 342 has afilter screen 344 that is attached at its opendistal end 352 to afilter support structure 346 mounted on acatheter shaft 348 for antegrade or retrograde deployment. Thefilter screen 344 has a plurality of longitudinally oriented folds or flutes 350. FIG. 30A is a cutaway section of theembolic filter assembly 342 cut alongline 30A in FIG. 30 in order to better show thelongitudinal flutes 350. Thelongitudinal flutes 350 provide additional surface area to thefilter screen 344 to reduce pressure drop from blood flow across theembolic filter assembly 342. Thelongitudinal flutes 350 also serve to hold a majority of thefilter screen 344 away from the aortic wall and away from the ostia of the arch vessels. The longitudinally flutedembolic filter assembly 342 can be adapted for passive or active deployment by any of the methods described above. - FIG. 31 shows a
perfusion filter catheter 360 having a longitudinally ribbedembolic filter assembly 362. Theembolic filter assembly 362 has afilter screen 364 that is attached at its opendistal end 372 to afilter support structure 366 mounted on acatheter shaft 368 for antegrade or retrograde deployment. Thefilter screen 364 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen. Theembolic filter assembly 362 has a plurality of longitudinally orientedribs 370 positioned around the exterior of thefilter screen 364. FIG. 31A is a cutaway section of theembolic filter assembly 362 cut alongline 31A in FIG. 31 in order to better show the longitudinally orientedribs 370. Thelongitudinal ribs 370 serve as standoff members to center thefilter screen 364 within the aorta so as hold a majority of thefilter screen 364 away from the aortic wall and away from the ostia of the arch vessels. The longitudinally ribbedembolic filter assembly 362 can be adapted for passive or active deployment by any of the methods described above. - FIG. 32 shows a
perfusion filter catheter 380 having anembolic filter assembly 382 that is surrounded by acage 394 ofstandoff members 396. Theembolic filter assembly 382 has afilter screen 384 that is attached at its opendistal end 392 to a filter support structure 386 mounted on acatheter shaft 388 for antegrade or retrograde deployment. Thefilter screen 384 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen. Theembolic filter assembly 382 further includes a plurality ofstandoff members 396 that form acage 394 surrounding thefilter screen 384. Thestandoff members 396 may be made of a resilient polymer or metal, such as an elastic or superelastic alloy, or a shape-memory material. The geometry of thestandoff members 396 is quite variable. By way of example, FIG. 32 depicts thestandoff members 396 as a plurality of longitudinally oriented wires which, together, form a roughlycylindrical cage 394. Other possible configurations include circumferential members, diagonal members, and combinations thereof. Thestandoff members 396 of thecage 394 serve to center thefilter screen 384 within the aorta so as hold a majority of thefilter screen 384 away from the aortic wall and away from the ostia of the arch vessels. Theembolic filter assembly 382 and thestandoff members 396 of thecage 394 can be adapted for passive or active deployment by any of the methods described above. - FIG. 33 shows a
perfusion filter catheter 400 having anembolic filter assembly 402 that is 10 surrounded by acage 414 of coiledwire standoff members 416. Theembolic filter assembly 402 has afilter screen 404 that is attached at its opendistal end 412 to afilter support structure 406 mounted on acatheter shaft 408 for antegrade or retrograde deployment. Thefilter screen 404 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen. Theembolic filter assembly 402 further includes a plurality of loosely coiledwire standoff members 416 which form acage 414 surrounding thefilter screen 404. Thecoiled standoff members 416 may be made of a resilient polymer or metal, such as an elastic or superelastic alloy, or a shape-memory material. Thecoiled standoff members 416 of thecage 414 serve to center thefilter screen 404 within the aorta so as hold a majority of thefilter screen 404 away from the aortic wall and away from the ostia of the arch vessels. Theembolic filter assembly 402 and thestandoff members 416 of thecage 414 can be adapted for passive or active deployment by any of the methods described above. - FIG. 34 shows a
perfusion filter catheter 420 having anembolic filter assembly 422 that is surrounded by acage 434 ofcoarse netting 436. Theembolic filter assembly 422 has afilter screen 424 that is attached at its open distal end 432 to a filter support structure 426 mounted on acatheter shaft 428 for antegrade or retrograde deployment. Thefilter screen 424 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen. Theembolic filter assembly 422 further includes acoarse netting 436, which forms a roughlycylindrical cage 434 surrounding thefilter screen 424. The netting 436 may be made of a resilient polymer or metal, such as an elastic or superelastic alloy, or a shape-memory material. The netting 436 of thecage 434 serves to center thefilter screen 424 within the aorta so as hold a majority of thefilter screen 424 away from the aortic wall and away from the ostia of the arch vessels. Theembolic filter assembly 422 and thecoarse netting 436 of thecage 434 can be adapted for passive or active deployment by any of the methods described above. - FIG. 35 shows a cutaway view of a
perfusion filter catheter 440 having anembolic filter assembly 442 that is surrounded by afender 454 made from a porous foam or afibrous network 456. Theembolic filter assembly 442 has afilter screen 444 that is attached at its open distal end 452 to afilter support structure 446 mounted on acatheter shaft 448 for antegrade or retrograde deployment. Thefilter screen 444 may be configured as a conical, trumpet, longitudinally fluted or other style of filter screen. Theembolic filter assembly 442 further includes a roughlycylindrical fender 454 made from a highly porous foam or afibrous network 456, which surrounds thefilter screen 444. Thefender 454 may be made of a highly porous open cell polymer foam or a network of polymeric fibers. Thefender 454 serves to center thefilter screen 444 within the aorta so as hold a majority of thefilter screen 444 away from the aortic wall and away from the ostia of the arch vessels. Theembolic filter assembly 442 and thefender 454 can be adapted for passive or active deployment or a combination thereof. - FIGS. 36 and 37 show an alternate embodiment of a
perfusion filter catheter 460 with a passively deployedembolic filter assembly 462. Theembolic filter assembly 462 has afilter screen 464 that is attached at its opendistal end 474 to afilter support structure 466 mounted on acatheter shaft 468 for antegrade or retrograde deployment. The proximal end 476 of thefilter screen 464 is sealingly attached to thecatheter shaft 468. Thefilter screen 464 may be configured as a conical, trumpet or other style of filter screen. Thefilter support structure 466 has anouter hoop 470 which is attached by aperpendicular leg 472 to thecatheter shaft 468. Preferably, theouter hoop 470 is made of a resilient polymer or metal, such as an elastic or superelastic alloy, or possibly a shape-memory material. Thefilter support structure 466, in this embodiment, has no struts. Optionally, the distal end 478 of thecatheter shaft 468 may be curved toward the center of theouter hoop 470 to help center theperfusion port 480 located at the distal end of thecatheter shaft 468 within the aorta when thecatheter 460 is deployed. Also, theperfusion port 480 may optionally include additional side ports or a flow diffuser, as shown, to reduce jetting when oxygenated blood is infused through theperfusion lumen 482. - The
perfusion filter catheter 460 is prepared for use by bending theouter hoop 470 in the proximal direction or wrapping it around thecatheter shaft 468, then folding or wrapping the material of thefilter screen 464 around thecatheter shaft 468. Anouter tube 484 is placed over theembolic filter assembly 462 to hold it in the collapsed position, as shown in FIG. 37. Thecatheter 460 is introduced and theembolic filter assembly 462 is advanced across the aortic arch while in the collapsed state. When thedistal end 474 of theembolic filter assembly 462 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, theouter tube 484 is withdrawn and the resilientouter hoop 470 expands to deploy theembolic filter assembly 462, as shown in FIG. 36. Theouter hoop 470 and thedistal end 474 of thefilter screen 464 will seal against the aortic wall. After use, theembolic filter assembly 462 is returned to the collapsed position by advancing theouter tube 484 distally over thefilter screen 464 and thefilter support structure 466, then thecatheter 460 is withdrawn from the patient. - FIGS.38-41 show an alternate embodiment of a
perfusion filter catheter 490 with an actively deployedembolic filter assembly 492. Theembolic filter assembly 492 has afilter screen 494 with a sewntubular channel 496 which extends circumferentially around the opendistal end 498 of thefilter screen 494. Thedistal end 498 of thefilter screen 494 is attached on one side to thecatheter shaft 504, and theproximal end 506 of thefilter screen 494 is sealingly attached to thecatheter shaft 504. Thefilter screen 494 may be configured as a conical, trumpet or other style of filter screen. The filter support structure in this embodiment consists of a preshaped,superelastic actuation wire 500, which, when theembolic filter assembly 492 is in the collapsed state, resides in asecond lumen 502 within thecatheter shaft 504. Preferably, theactuation wire 500 has a bead orsmall loop 508 at its distal end to create a blunt, non-piercing tip. Thesecond lumen 502 of thecatheter shaft 504 communicates with thetubular channel 496 at thedistal end 498 of thefilter screen 494. When theactuation wire 500 is extended, it forms a hoop as it passes through thetubular channel 496 of thefilter screen 494. - Optionally, the
distal end 510 of thecatheter shaft 504 may be curved toward the center of theembolic filter assembly 492 to help center theperfusion port 510 located at the distal end of thecatheter shaft 504 within the aorta when thecatheter 490 is deployed. Also, theperfusion port 510 may optionally include additional side ports or a flow diffuser, as shown, to reduce jetting when oxygenated blood is infused through theperfusion lumen 512 during cardiopulmonary bypass. - The
perfusion filter catheter 490 is prepared for use by withdrawing theactuation wire 500 into thesecond lumen 502, then folding or wrapping the flexible material of thefilter screen 494 around thecatheter shaft 504. Optionally, anouter tube 514 may be placed over theembolic filter assembly 492 to hold it in the collapsed position, as shown in FIG. 38. Thecatheter 490 is introduced and theembolic filter assembly 492 is advanced across the aortic arch while in the collapsed state. When thedistal end 498 of theembolic filter assembly 492 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, theouter tube 514 is withdrawn, which allows thefilter screen 494 to unwrap from thecatheter shaft 504, as shown in FIG. 39. - Then, the preshaped,
superelastic actuation wire 500 is advanced distally so that it begins to form a hoop as it passes through thetubular channel 496 at thedistal end 498 of thefilter screen 494, as shown in FIG. 40. Theactuation wire 500 is further advanced until it forms a complete hoop, as shown in FIG. 41, thereby sealing thedistal end 498 of thefilter screen 494 against the aortic wall. After use, theembolic filter assembly 492 is returned to the collapsed position as described above, then thecatheter 490 is withdrawn from the patient. - FIGS. 42 and 43 show another alternate embodiment of a
perfusion filter catheter 520 with an actively deployedembolic filter assembly 522. Theembolic filter assembly 522 has a filter screen 524 with a sewntubular channel 526 which extends circumferentially around the opendistal end 528 of the filter screen 524. Thedistal end 528 of the filter screen 524 is attached on one side to thecatheter shaft 534, and theproximal end 536 of the filter screen 524 is sealingly attached to thecatheter shaft 534. The filter screen 524 may be configured as a conical, trumpet or other style of filter screen. The filter support structure in this embodiment consists of a preshaped, elastic orsuperelastic wire loop 530. Thewire loop 530 passes through thetubular channel 526 at thedistal end 528 of the filter screen 524. When theembolic filter assembly 522 is in the collapsed position, thewire loop 530 is withdrawn into asecond lumen 532 within thecatheter shaft 534, as shown in FIG. 42. In the collapsed position, thewire loop 530 acts as a purse string to close the filter screen 524 tightly around thecatheter shaft 534. When thewire loop 530 is advanced distally, it forms a hoop that holds thedistal end 528 of the filter screen 524 open, as shown in FIG. 43. - Optionally, the
distal end 540 of thecatheter shaft 534 may be curved toward the center of theembolic filter assembly 522 to help center theperfusion port 542 located at the distal end of thecatheter shaft 534 within the aorta when thecatheter 520 is deployed. Also, theperfusion port 540 may optionally include additional side ports or a flow diffuser, as shown, to reduce jetting when oxygenated blood is infused through the perfusion lumen 544 during cardiopulmonary bypass. - The
perfusion filter catheter 520 is prepared for use by withdrawing thewire loop 530 into thesecond lumen 532, then folding or wrapping the flexible material of the filter screen 524 around thecatheter shaft 534. Optionally, anouter tube 538 may be placed over theembolic filter assembly 522 to hold it in the collapsed position. Thecatheter 520 is introduced and theembolic filter assembly 522 is advanced across the aortic arch while in the collapsed state. When thedistal end 528 of theembolic filter assembly 522 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, theouter tube 538 is withdrawn, and the preshaped,superelastic wire loop 530 is advanced distally so that it forms a hoop that holds thedistal end 528 of the filter screen 524 open and seals against the aortic wall. The inherent adjustability of thewire loop 530 used to deploy theembolic filter assembly 522 naturally compensates for patient-to-patient variations in aortic luminal diameter. After use, theembolic filter assembly 522 is returned to the collapsed position by withdrawing thewire loop 530 into thesecond lumen 532. This closes the filter screen 524 like a purse string to capture any potential emboli that are in theembolic filter assembly 522. Then, thecatheter 520 is withdrawn from the patient. - FIGS. 44 and 45 show another alternate embodiment of a
perfusion filter catheter 550 with an actively deployedembolic filter assembly 552. Theembolic filter assembly 552 has a filter screen 554 with an opendistal end 558 that is attached to atoroidal balloon 560. Thetoroidal balloon 560 is attached on one side to thecatheter shaft 564 and it is fluidly connected to aninflation lumen 562 within thecatheter shaft 564. Theproximal end 566 of the filter screen 554 is sealingly attached to thecatheter shaft 564. The filter screen 554 may be configured as a conical, trumpet or other style of filter screen. Optionally, thedistal end 570 of thecatheter shaft 564 may be curved toward the center of theembolic filter assembly 552 to help center theperfusion port 572 located at the distal end of thecatheter shaft 564 within the aorta when thecatheter 550 is deployed. Also, theperfusion port 570 may optionally include additional side ports or a flow diffuser, as shown, to reduce jetting when oxygenated blood is infused through theperfusion lumen 574 during cardiopulmonary bypass. - The
perfusion filter catheter 550 is prepared for use by deflating thetoroidal balloon 560, then folding or wrapping the deflatedtoroidal balloon 560 and the filter screen 554 around thecatheter shaft 564. Optionally, anouter tube 564 may be placed over theembolic filter assembly 552 to hold it in the collapsed position, as shown in FIG. 44. Thecatheter 550 is introduced and theembolic filter assembly 552 is advanced across the aortic arch while in the collapsed state. When thedistal end 558 of theembolic filter assembly 552 is positioned in the ascending aorta between the aortic valve and the brachiocephalic artery, theouter tube 564 is pulled back to expose theembolic filter assembly 552. Then, theembolic filter assembly 202 is deployed by inflating thetoroidal balloon 560 with fluid injected through theinflation lumen 562, as shown in FIG. 45. When theembolic filter assembly 552 is deployed, thetoroidal balloon 560 seals against the inner wall of the aorta. Preferably, at least the outer wall of thetoroidal balloon 560 is somewhat compliant when inflated in order to compensate for patient-to-patient variations in aortic luminal diameter. After use, thetoroidal balloon 560 is deflated and thecatheter 550 is withdrawn from the patient. - Ideally, it is preferable that the embolic filter assembly of the perfusion filter catheter be deployed continuously throughout the entire period of cardiopulmonary bypass or extracorporeal perfusion. It is most critical, however, that the embolic filter assembly be deployed during periods when the potential for embolization is the highest, such as during manipulations of the heart and the aorta, during clamping and unclamping of the aorta and during the initial period after the heart is restarted following cardioplegic arrest. It has been previously stated that, for continuous deployment of a filter device in the aortic lumen, it is desirable for the filter mesh to have a surface area of 3-10 in2. The shallow, cone-shaped aortic filter devices illustrated in the known prior art only manage to provide surface areas at the lower end of this desired range in the largest of human aortas (approximately 3.0-3.9 in2 in aortas of 3.5-4.0 cm diameter estimated based on the drawings and descriptions in the prior art disclosures) and in no cases are there embodiments disclosed which could provide surface areas in the middle and upper end of this range or that could even meet the minimum limit of this desired range in more typically sized aortas in the range of 2.5-3.5 cm diameter. Consequently, it is the opinion of the present inventors that the prior art does not provide an adequate solution to the technical problem that it illuminates.
- The solution to this dilemma is to provide a filter assembly that has a greater ratio of filter surface area to the cross-sectional area of the aortic lumen. (The cross-sectional area of the aortic lumen being approximately equal to the area of the open upstream end of the embolic filter assembly at its deployed diameter within the aorta.) Preferably, the embolic filter assembly should provide a ratio of the filter surface area to the cross-sectional area of the aortic lumen of greater than approximately 2, more preferably greater than 3, more preferably greater than 4, more preferably greater than 5 and most preferably greater than 6. With these ratios of the filter surface area to the cross-sectional area of the aortic lumen, it is possible to achieve a filter mesh surface area of 3-10 in2 or greater in all typical adult human aortas ranging from 2.0 to 4.0 cm in diameter. Furthermore, given the embolic filter assembly structures that have been disclosed herein, it is envisioned that ratios of the filter surface area to the cross-sectional area of the aortic lumen of 8, 10, 12 and even greater are readily achievable. Higher ratios such as these are desirable as they allow a very fine filter mesh to be utilized to effectively capture both macroemboli and microemboli without compromising the aortic blood flow. Along with this, it is preferable to utilize an embolic filter assembly structure or other means that maximizes the effective surface area of the filter mesh by holding at least a majority of the filter mesh away from the aortic wall or any other structures that might potentially obstruct flow through the filter mesh.
- To further illustrate this point, the following are given as examples of embolic filter assemblies exhibiting the desired range of ratios of the filter surface area to the cross-sectional area of the aortic lumen. These examples are merely illustrative of some of the possible embodiments of the embolic filter assembly and should not be interpreted as limiting in any way to the scope of the present invention. Turning first to FIGS.1-3, there is illustrated an embolic filter assembly that is approximately conical in shape. In order to achieve a ratio of the filter surface area to the cross-sectional area of the aortic lumen of greater than approximately 2, a conical filter assembly must have a filter length L of greater than the aortic diameter D. To achieve a ratio of the filter surface area to the cross-sectional area of the aortic lumen of greater than approximately 4, a conical filter assembly must have a filter length L of greater than twice the aortic diameter D. To achieve a ratio of the filter surface area to the cross-sectional area of the aortic lumen of greater than approximately 6, a conical filter assembly must have a filter length L of greater than three times the aortic diameter D. With these ratios of the filter surface area to the cross-sectional area of the aortic lumen, it is possible to achieve a filter mesh surface area of 3-10 in2 or greater in all typical adult human aortas ranging from 2.0 to 4.0 cm in diameter. Greater length to diameter ratios will provide more improved ratios of the filter surface area to the cross-sectional area of the aortic lumen.
- Turning next to FIGS.7-8, 15-17 and 25-27, there are illustrated embolic filter assemblies having an approximately trumpet-shaped geometry that includes an approximately conical upstream section connected to an approximately cylindrical extension with a closed downstream end. This geometry provides an improvement in the ratio of the filter surface area to the cross-sectional area of the aortic lumen of approximately 15 to 50 percent compared with the simple conical geometry. Thus, even greater ratios of the filter surface area to the cross-sectional area of the aortic lumen are readily achieved using this trumpet-shaped geometry. Further improvements of the ratio of the filter surface area to the cross-sectional area of the aortic lumen can be realized with the convoluted embolic filter assemblies illustrated in FIGS. 18-20, 20-23 and 30. With these convoluted geometries, ratios of the filter surface area to the cross-sectional area of the aortic lumen of 2-12 or even greater can be achieved.
- Each of the embodiments of the invention described herein may be used for administration of standard cardiopulmonary bypass and cardioplegic arrest by combining the aortic filter catheter with a standard aortic crossclamp and a standard arterial perfusion cannula inserted into the ascending aorta between the crossclamp and the embolic filter assembly. Where the aortic filter catheter includes an integral perfusion lumen, the CPB system can be simplified by the eliminating the separate arterial perfusion cannula. The CPB system can be further simplified by incorporating an aortic occlusion device into the aortic filter catheter and eliminating the aortic crossclamp. Such a system would allow percutaneous transluminal administration of cardiopulmonary bypass and cardioplegic arrest with protection from undesirable embolic events.
- FIGS.46-50 show the operation of an embodiment of a
perfusion filter catheter 600 that combines anembolic filter assembly 602 with a toroidal balloonaortic occlusion device 604. Theembolic filter assembly 602 and the toroidal balloonaortic occlusion device 604 are mounted on anelongated catheter shaft 606 that may be adapted for peripheral introduction via the femoral artery or subclavian artery or for central insertion directly into the ascending aorta. The toroidal balloonaortic occlusion device 604 is connected to an inflation lumen within theelongated catheter shaft 606. A cardioplegia lumen, which may also serve as a guidewire lumen, connects to acardioplegia port 608 at the distal end of thecatheter shaft 606. A perfusion lumen connects to one or moreperfusion ports 610 located on thecatheter shaft 606 downstream from the toroidal balloonaortic occlusion device 604, but upstream of theembolic filter assembly 602. - FIG. 46 shows the
perfusion filter catheter 600 in the collapsed or undeployed state with theembolic filter assembly 602 and the toroidal balloonaortic occlusion device 604 collapsed or folded about theelongated catheter shaft 606. Theperfuision filter catheter 600 is inserted in the collapsed state and advanced into the patient's ascending aorta until theembolic filter assembly 602 is positioned between the coronary ostia and the brachiocephalic artery. The toroidal balloonaortic occlusion device 604 is then inflated to expand and deploy theembolic filter assembly 602, as shown in FIG. 47. Theembolic filter assembly 602 may assume a simple conical shape or, more preferably, one of the surface area increasing geometries described above. In addition, theembolic filter assembly 602 may include a structure or other means to hold the filter material apart from the aortic wall to maximize the effective filter area. With theembolic filter assembly 602 deployed, cardiopulmonary bypass with embolic protection can be started through theperfusion ports 610. - When it is desired to initiate cardioplegic arrest, the toroidal balloon
aortic occlusion device 604 is further inflated until it expands inward to occlude the aortic lumen, as shown in FIG. 48. A cardioplegic agent is infused through thecardioplegia port 608 and into the coronary arteries to arrest the heart. Oxygenated blood continues to be infused through theperfusion ports 610. After completion of the surgical procedure, the toroidal balloonaortic occlusion device 604 is partially deflated, leaving theembolic filter assembly 602 deployed, as shown in FIG. 49. Oxygenated blood enters the coronary arteries to restart the heart beating. If anyembolic materials 612 are dislodged during manipulation of the heart or when the heart resumes beating, they will be captured by theembolic filter assembly 602. Once the patient is weaned off of bypass, the toroidal balloonaortic occlusion device 604 is deflated to collapse theembolic filter assembly 602, as shown in FIG. 50. Any potential emboli are trapped within theembolic filter assembly 602 and can be removed along with thecatheter 600. - FIG. 51 shows an embodiment of a
perfusion filter catheter 620 that combines anembolic filter assembly 622 with an inflatable balloonaortic occlusion device 624. Theembolic filter assembly 622 may be any one of the actively or passively deployed embolic filter assemblies described herein. Preferably, the inflatable balloonaortic occlusion device 624 is an 5 elastomeric balloon of sufficient inflated diameter to occlude the ascending aorta and is mounted on theelongated catheter shaft 626 upstream of theembolic filter assembly 622. Alternatively, the inflatable balloonaortic occlusion device 624 may be positioned to occlude the inlet end of theembolic filter assembly 622 to minimize the area of contact between theperfusion filter catheter 620 and the aortic wall. The inflatable balloonaortic occlusion device 624 is connected to an inflation lumen within theelongated catheter shaft 626. A cardioplegia lumen, which may also serve as a guidewire lumen, connects to acardioplegia port 628 at the distal end of thecatheter shaft 626. A perfusion lumen connects to one or moreperfusion ports 630 located on thecatheter shaft 626 downstream from the inflatable balloonaortic occlusion device 624, but upstream of theembolic filter assembly 622. The operation of theperfusion filter catheter 620 of FIG. 51 is quite similar to that described for the embodiment of FIGS. 46-50. - FIG. 52 shows an embodiment of a perfusion filter catheter640 that combines an
embolic filter assembly 642 with a selectively deployable external catheterflow control valve 644. Theembolic filter assembly 642 may be any one of the actively or passively deployed embolic filter assemblies described herein. The selectively deployable external catheterflow control valve 644 is mounted on theelongated catheter shaft 646 upstream of theembolic filter assembly 642. Alternatively, the selectively deployable external catheterflow control valve 644 may be positioned to occlude the inlet end of theembolic filter assembly 642 to minimize the area of contact between the perfusion filter catheter 640 and the aortic wall. Selectively deployable external catheter flow control valves suitable for this application are described in commonly owned, copending U.S. patent applications Ser. Nos. 08/665,635, 08/664,361 and 08/664,360, filed Jun. 17, 1996, which are hereby incorporated by reference in their entirety. Theelongated catheter shaft 646 may include one or more deployment lumens as needed for actuating the external catheterflow control valve 644. A cardioplegia lumen, which may also serve as a guidewire lumen, connects to acardioplegia port 648 at the distal end of thecatheter shaft 646. A perfusion lumen connects to one or moreperfusion ports 650 located on thecatheter shaft 646 downstream from the external catheterflow control valve 644, but upstream of theembolic filter assembly 622. The operation of the perfusion filter catheter 640 of FIG. 52 is quite similar to that described for the embodiment of FIGS. 46-50. - FIG. 53 shows an additional feature of the present invention that may be used in combination with many of the features and embodiments previously described. FIG. 53 shows an embodiment of a
perfusion filter catheter 660 with anembolic filter assembly 662 having areas of different filter porosity. Theembolic filter assembly 662 is mounted on anelongated catheter shaft 666 that may be adapted for peripheral introduction via the femoral artery or subclavian artery or for central insertion directly into the ascending aorta. Theembolic filter assembly 662 may resemble any one of the actively or passively deployed embolic filter assemblies described herein. Preferably, theembolic filter assembly 662 assumes one of the surface area increasing geometries described above, such as a trumpet-styleembolic filter assembly 662 as shown. Theembolic filter assembly 662 is divided along a longitudinal dividing line into areas of different filter porosity. In a preferred embodiment, theembolic filter assembly 662 has anupper portion 664 of finer porosity facing toward the aortic arch vessels and alower portion 668 of courser porosity facing away from the aortic arch vessels. Preferably, theelongated catheter shaft 666 will have a preformed curve to help orient theupper portion 664 and thelower portion 668 of theembolic filter assembly 662 in the proper position once deployed. The filter mesh of theupper portion 664 may be selected to exclude both macroemboli and microemboli, and the filter mesh of thelower portion 668 may be selected to exclude macroemboli only. Alternatively, theupper portion 664 may be impermeable so as to act like a shunt to direct potential emboli downstream away from the aortic arch vessels. - Another feature that may be combined with the features and embodiments of the present invention is an aortic transillumination system for locating and monitoring the position of the catheter, the filter and the optional occlusion devices without fluoroscopy by transillumination of the aortic wall. Aortic transillumination systems using optical fibers and/or light emitting diodes or lasers suitable for this application are described in commonly owned, copending U.S. patent application Ser. No. 60/088,652, filed Jun. 9, 1998, which is hereby incorporated by reference in its entirety. By way of example, FIG. 54 shows an embodiment of a
perfusion filter catheter 670 with a fiberoptic system for aortic transillumination. A firstoptical fiber 684 is positioned near a distal end of theperfusion filter catheter 670, upstream of theembolic filter assembly 672, so that it will emit a first laterally directed beam of light. A secondoptical fiber 672 is positioned on the outer rim of thefilter support structure 674 so that it will emit a second laterally directed beam of light. Anoptical coupling 682 at the proximal end of theperfusion filter catheter 670 connects theoptical fibers light source 680 by way of anoptical cable 678. The light beams emitted by theoptical fibers perfusion filter catheter 670 and theembolic filter assembly 672. Similarly, in embodiments of the perfusion filter catheter utilizing an aortic occlusion device, one or more optical fibers or other light emitting devices may be positioned on the aortic occlusion device to locate and monitor its position and state of deployment. - Likewise, the features and embodiments of the present invention may also be combined with a bumper location device for facilitating catheter insertion and positioning by providing tactile feedback when the catheter device contacts the aortic valve. Bumper location devices suitable for this application are described in commonly owned, copending U.S. patent application Ser. Nos. 60/060,158, filed Sep. 26, 1997, and No. 60/073,681, filed Feb. 4, 1998, which are hereby incorporated by reference in their entirety.
- While the present invention has been described herein with respect to the exemplary embodiments and the best mode for practicing the invention, it will be apparent to one of ordinary skill in the art that many modifications, improvements and subcombinations of the various embodiments, adaptations and variations can be made to the invention without departing from the spirit and scope thereof.
Claims (43)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/108,245 US20020161394A1 (en) | 1997-09-26 | 2002-03-26 | Aortic filter catheter |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6011797P | 1997-09-26 | 1997-09-26 | |
US09/158,405 US6361545B1 (en) | 1997-09-26 | 1998-09-22 | Perfusion filter catheter |
US10/108,245 US20020161394A1 (en) | 1997-09-26 | 2002-03-26 | Aortic filter catheter |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/158,405 Division US6361545B1 (en) | 1997-09-26 | 1998-09-22 | Perfusion filter catheter |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020161394A1 true US20020161394A1 (en) | 2002-10-31 |
Family
ID=22027475
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/158,405 Expired - Lifetime US6361545B1 (en) | 1997-09-26 | 1998-09-22 | Perfusion filter catheter |
US10/108,245 Abandoned US20020161394A1 (en) | 1997-09-26 | 2002-03-26 | Aortic filter catheter |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/158,405 Expired - Lifetime US6361545B1 (en) | 1997-09-26 | 1998-09-22 | Perfusion filter catheter |
Country Status (5)
Country | Link |
---|---|
US (2) | US6361545B1 (en) |
EP (1) | EP1017333A2 (en) |
AU (1) | AU749573B2 (en) |
CA (1) | CA2304463A1 (en) |
WO (1) | WO1999016382A2 (en) |
Cited By (276)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030050685A1 (en) * | 1999-08-09 | 2003-03-13 | Nikolic Serjan D. | Method for improving cardiac function |
US20050015109A1 (en) * | 2003-07-16 | 2005-01-20 | Samuel Lichtenstein | Methods and devices for altering blood flow through the left ventricle |
EP1527740A1 (en) * | 2003-10-29 | 2005-05-04 | Medtronic Vascular, Inc. | Distal protection device for filtering and occlusion |
US20050119688A1 (en) * | 2003-10-06 | 2005-06-02 | Bjarne Bergheim | Method and assembly for distal embolic protection |
US20050143810A1 (en) * | 2003-10-24 | 2005-06-30 | Martin Dauner | Cardiovascular implant, method and device for its production, and its provision for surgery |
US20050240200A1 (en) * | 2004-04-23 | 2005-10-27 | Bjarne Bergheim | Method and system for cardiac valve delivery |
US20060020285A1 (en) * | 2004-07-22 | 2006-01-26 | Volker Niermann | Method for filtering blood in a vessel with helical elements |
US20060020286A1 (en) * | 2004-07-22 | 2006-01-26 | Volker Niermann | Device for filtering blood in a vessel with helical elements |
US20060036310A1 (en) * | 2004-08-13 | 2006-02-16 | Scimed Life Systems, Inc. | Method to simultaneously load and cover self expanding stents |
US20060241735A1 (en) * | 2005-04-26 | 2006-10-26 | Cardiac Pacemakers, Inc. | Self-deploying vascular occlusion device |
US20060253023A1 (en) * | 2005-04-20 | 2006-11-09 | Scimed Life Systems, Inc. | Neurovascular intervention device |
US7220271B2 (en) | 2003-01-30 | 2007-05-22 | Ev3 Inc. | Embolic filters having multiple layers and controlled pore size |
US20070135834A1 (en) * | 2003-01-30 | 2007-06-14 | Ev3 Inc. | Embolic filters with controlled pore size |
US20080065145A1 (en) * | 2006-09-11 | 2008-03-13 | Carpenter Judith T | Embolic protection device and method of use |
US20080275485A1 (en) * | 2006-04-03 | 2008-11-06 | Possis Medical, Inc. | Guidewire with collapsible filter system and method of use |
US20090248060A1 (en) * | 2008-03-19 | 2009-10-01 | Schneider M Bret | Electrostatic vascular filters |
US7618433B2 (en) * | 1999-02-24 | 2009-11-17 | Boston Scientific Scimed, Inc. | Intravascular filter and method |
US7621870B2 (en) | 2002-03-12 | 2009-11-24 | Ev3 Inc. | Everted filter device |
US20090326669A1 (en) * | 2006-08-04 | 2009-12-31 | Roman Preuss | Insertion of vibration-damping elements in prosthetic systems for the manipulation and damping of natural frequencies |
US20100030321A1 (en) * | 2008-07-29 | 2010-02-04 | Aga Medical Corporation | Medical device including corrugated braid and associated method |
US7674222B2 (en) | 1999-08-09 | 2010-03-09 | Cardiokinetix, Inc. | Cardiac device and methods of use thereof |
US7682390B2 (en) | 2001-07-31 | 2010-03-23 | Medtronic, Inc. | Assembly for setting a valve prosthesis in a corporeal duct |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
US7740655B2 (en) | 2006-04-06 | 2010-06-22 | Medtronic Vascular, Inc. | Reinforced surgical conduit for implantation of a stented valve therein |
US7749249B2 (en) | 2006-02-21 | 2010-07-06 | Kardium Inc. | Method and device for closing holes in tissue |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US20100179585A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Embolic deflection device |
US20100179647A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure |
US20100179583A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of deploying and retrieving an embolic diversion device |
US7758606B2 (en) | 2000-06-30 | 2010-07-20 | Medtronic, Inc. | Intravascular filter with debris entrapment mechanism |
US7762943B2 (en) * | 2004-03-03 | 2010-07-27 | Cardiokinetix, Inc. | Inflatable ventricular partitioning device |
US7766934B2 (en) | 2005-07-12 | 2010-08-03 | Cook Incorporated | Embolic protection device with an integral basket and bag |
US7771452B2 (en) | 2005-07-12 | 2010-08-10 | Cook Incorporated | Embolic protection device with a filter bag that disengages from a basket |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US7780726B2 (en) | 2001-07-04 | 2010-08-24 | Medtronic, Inc. | Assembly for placing a prosthetic valve in a duct in the body |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7837610B2 (en) | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
US7850708B2 (en) | 2005-06-20 | 2010-12-14 | Cook Incorporated | Embolic protection device having a reticulated body with staggered struts |
US7862500B2 (en) | 2002-08-01 | 2011-01-04 | Cardiokinetix, Inc. | Multiple partitioning devices for heart treatment |
US7871436B2 (en) | 2007-02-16 | 2011-01-18 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
US7887477B2 (en) | 1999-08-09 | 2011-02-15 | Cardiokinetix, Inc. | Method of improving cardiac function using a porous membrane |
US7892281B2 (en) | 1999-11-17 | 2011-02-22 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US7897086B2 (en) | 2004-08-05 | 2011-03-01 | Cardiokinetix, Inc. | Method of making a laminar ventricular partitioning device |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US20110130657A1 (en) * | 2009-12-02 | 2011-06-02 | Chomas James E | Protection Device and Method Against Embolization Agent Reflux |
US7955351B2 (en) | 2005-02-18 | 2011-06-07 | Tyco Healthcare Group Lp | Rapid exchange catheters and embolic protection devices |
WO2011068924A1 (en) * | 2009-12-02 | 2011-06-09 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US7959672B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical | Replacement valve and anchor |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7972378B2 (en) | 2008-01-24 | 2011-07-05 | Medtronic, Inc. | Stents for prosthetic heart valves |
US7988724B2 (en) | 2003-12-23 | 2011-08-02 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8048153B2 (en) | 2003-12-23 | 2011-11-01 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US8052749B2 (en) | 2003-12-23 | 2011-11-08 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8052750B2 (en) | 2006-09-19 | 2011-11-08 | Medtronic Ventor Technologies Ltd | Valve prosthesis fixation techniques using sandwiching |
US20110288529A1 (en) * | 2010-05-19 | 2011-11-24 | Fulton Richard E | Augmented delivery catheter and method |
US8070801B2 (en) | 2001-06-29 | 2011-12-06 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8075615B2 (en) | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US8109962B2 (en) | 2005-06-20 | 2012-02-07 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US8109996B2 (en) | 2004-03-03 | 2012-02-07 | Sorin Biomedica Cardio, S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US20120046740A1 (en) * | 2004-11-05 | 2012-02-23 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US20120046683A1 (en) * | 2008-10-31 | 2012-02-23 | Scott Wilson | Devices and methods for temporarily opening a blood vessel |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8152831B2 (en) | 2005-11-17 | 2012-04-10 | Cook Medical Technologies Llc | Foam embolic protection device |
US8157853B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US20120095500A1 (en) * | 2010-10-14 | 2012-04-19 | Heuser Richard R | Concentric wire embolism protection device |
US8182508B2 (en) | 2005-10-04 | 2012-05-22 | Cook Medical Technologies Llc | Embolic protection device |
US8187298B2 (en) | 2005-08-04 | 2012-05-29 | Cook Medical Technologies Llc | Embolic protection device having inflatable frame |
US8192478B2 (en) | 1999-08-09 | 2012-06-05 | Cardiokinetix, Inc. | System for improving cardiac function |
US8216269B2 (en) | 2005-11-02 | 2012-07-10 | Cook Medical Technologies Llc | Embolic protection device having reduced profile |
WO2012094195A1 (en) * | 2011-01-07 | 2012-07-12 | Merhi William M | Angiography catheter |
US8221446B2 (en) | 2005-03-15 | 2012-07-17 | Cook Medical Technologies | Embolic protection device |
US8231670B2 (en) | 2003-12-23 | 2012-07-31 | Sadra Medical, Inc. | Repositionable heart valve and method |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US8246671B2 (en) | 1999-08-09 | 2012-08-21 | Cardiokinetix, Inc. | Retrievable cardiac devices |
US8246678B2 (en) | 2003-12-23 | 2012-08-21 | Sadra Medicl, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8252052B2 (en) | 2003-12-23 | 2012-08-28 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8252018B2 (en) | 2007-09-14 | 2012-08-28 | Cook Medical Technologies Llc | Helical embolic protection device |
US8252017B2 (en) | 2005-10-18 | 2012-08-28 | Cook Medical Technologies Llc | Invertible filter for embolic protection |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8377114B2 (en) | 1999-08-09 | 2013-02-19 | Cardiokinetix, Inc. | Sealing and filling ventricular partitioning devices to improve cardiac function |
US8377092B2 (en) | 2005-09-16 | 2013-02-19 | Cook Medical Technologies Llc | Embolic protection device |
US8388644B2 (en) | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
US8398537B2 (en) | 2005-06-10 | 2013-03-19 | Cardiokinetix, Inc. | Peripheral seal for a ventricular partitioning device |
US8419748B2 (en) | 2007-09-14 | 2013-04-16 | Cook Medical Technologies Llc | Helical thrombus removal device |
US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
CN103079497A (en) * | 2010-06-30 | 2013-05-01 | 玛芬股份有限公司 | Percutaneous, ultrasound-guided introduction of medical devices |
US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
US8506620B2 (en) | 2005-09-26 | 2013-08-13 | Medtronic, Inc. | Prosthetic cardiac and venous valves |
US8512397B2 (en) | 2009-04-27 | 2013-08-20 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit |
US8529430B2 (en) | 2002-08-01 | 2013-09-10 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
US8539662B2 (en) | 2005-02-10 | 2013-09-24 | Sorin Group Italia S.R.L. | Cardiac-valve prosthesis |
US8545418B2 (en) | 2004-08-25 | 2013-10-01 | Richard R. Heuser | Systems and methods for ablation of occlusions within blood vessels |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8591570B2 (en) | 2004-09-07 | 2013-11-26 | Medtronic, Inc. | Prosthetic heart valve for replacing previously implanted heart valve |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US8613765B2 (en) | 2008-02-28 | 2013-12-24 | Medtronic, Inc. | Prosthetic heart valve systems |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US8628566B2 (en) | 2008-01-24 | 2014-01-14 | Medtronic, Inc. | Stents for prosthetic heart valves |
US8632562B2 (en) | 2005-10-03 | 2014-01-21 | Cook Medical Technologies Llc | Embolic protection device |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US8685084B2 (en) | 2011-12-29 | 2014-04-01 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit and assembly method |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US8728155B2 (en) | 2011-03-21 | 2014-05-20 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus and method for the treatment of valve dysfunction |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US8747459B2 (en) | 2006-12-06 | 2014-06-10 | Medtronic Corevalve Llc | System and method for transapical delivery of an annulus anchored self-expanding valve |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8784478B2 (en) | 2006-10-16 | 2014-07-22 | Medtronic Corevalve, Inc. | Transapical delivery system with ventruculo-arterial overlfow bypass |
US8790242B2 (en) | 2009-10-26 | 2014-07-29 | Cardiokinetix, Inc. | Ventricular volume reduction |
US20140214072A1 (en) * | 2013-01-29 | 2014-07-31 | St. Jude Medical, Cardiology Division, Inc. | Aortic great vessel protection |
US8795315B2 (en) | 2004-10-06 | 2014-08-05 | Cook Medical Technologies Llc | Emboli capturing device having a coil and method for capturing emboli |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US20140257362A1 (en) * | 2013-03-07 | 2014-09-11 | St. Jude Medical, Cardiology Division, Inc. | Filtering and removing particulates from bloodstream |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8858619B2 (en) | 2002-04-23 | 2014-10-14 | Medtronic, Inc. | System and method for implanting a replacement valve |
US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US8876796B2 (en) | 2010-12-30 | 2014-11-04 | Claret Medical, Inc. | Method of accessing the left common carotid artery |
US8940002B2 (en) | 2010-09-30 | 2015-01-27 | Kardium Inc. | Tissue anchor system |
US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8945169B2 (en) | 2005-03-15 | 2015-02-03 | Cook Medical Technologies Llc | Embolic protection device |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US8951280B2 (en) | 2000-11-09 | 2015-02-10 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US8974489B2 (en) | 2009-07-27 | 2015-03-10 | Claret Medical, Inc. | Dual endovascular filter and methods of use |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
US8998976B2 (en) | 2011-07-12 | 2015-04-07 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
US8998981B2 (en) | 2008-09-15 | 2015-04-07 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US9011521B2 (en) | 2003-12-23 | 2015-04-21 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9011478B2 (en) | 2003-01-30 | 2015-04-21 | Covidien Lp | Embolic filters with a distal loop or no loop |
US9050066B2 (en) | 2010-06-07 | 2015-06-09 | Kardium Inc. | Closing openings in anatomical tissue |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US9078660B2 (en) | 2000-08-09 | 2015-07-14 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
US9078781B2 (en) | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
US9089422B2 (en) | 2008-01-24 | 2015-07-28 | Medtronic, Inc. | Markers for prosthetic heart valves |
US9089341B2 (en) | 2012-02-28 | 2015-07-28 | Surefire Medical, Inc. | Renal nerve neuromodulation device |
US9089668B2 (en) | 2011-09-28 | 2015-07-28 | Surefire Medical, Inc. | Flow directional infusion device |
US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US9138307B2 (en) | 2007-09-14 | 2015-09-22 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
US9161836B2 (en) | 2011-02-14 | 2015-10-20 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US20150297250A1 (en) * | 2014-04-16 | 2015-10-22 | Covidien Lp | Systems and methods for catheter advancement |
US20150305850A1 (en) * | 2012-12-21 | 2015-10-29 | The Regents Of The University Of California | In Vivo Positionable Filtration Devices and Methods Related Thereto |
US9204964B2 (en) | 2009-10-01 | 2015-12-08 | Kardium Inc. | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US9237886B2 (en) | 2007-04-20 | 2016-01-19 | Medtronic, Inc. | Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof |
US9248017B2 (en) | 2010-05-21 | 2016-02-02 | Sorin Group Italia S.R.L. | Support device for valve prostheses and corresponding kit |
US9277993B2 (en) | 2011-12-20 | 2016-03-08 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
US9289289B2 (en) | 2011-02-14 | 2016-03-22 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US20160100928A1 (en) * | 2013-05-14 | 2016-04-14 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US9326843B2 (en) | 2009-01-16 | 2016-05-03 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US9332992B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Method for making a laminar ventricular partitioning device |
US9332993B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9415225B2 (en) | 2005-04-25 | 2016-08-16 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US9439757B2 (en) | 2014-12-09 | 2016-09-13 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US9480548B2 (en) | 2006-09-11 | 2016-11-01 | Edwards Lifesciences Ag | Embolic protection device and method of use |
CN106102654A (en) * | 2014-01-10 | 2016-11-09 | 企斯动哈特有限公司 | Dissect independent deflector |
US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
US9539088B2 (en) | 2001-09-07 | 2017-01-10 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US9566144B2 (en) | 2015-04-22 | 2017-02-14 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
WO2017062036A1 (en) * | 2015-10-09 | 2017-04-13 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US9629718B2 (en) | 2013-05-03 | 2017-04-25 | Medtronic, Inc. | Valve delivery tool |
US9636205B2 (en) | 2009-01-16 | 2017-05-02 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US9694121B2 (en) | 1999-08-09 | 2017-07-04 | Cardiokinetix, Inc. | Systems and methods for improving cardiac function |
US9744038B2 (en) | 2008-05-13 | 2017-08-29 | Kardium Inc. | Medical device for constricting tissue or a bodily orifice, for example a mitral valve |
US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US9775704B2 (en) | 2004-04-23 | 2017-10-03 | Medtronic3F Therapeutics, Inc. | Implantable valve prosthesis |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US20170325938A1 (en) | 2016-05-16 | 2017-11-16 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US9889031B1 (en) | 2014-03-25 | 2018-02-13 | Surefire Medical, Inc. | Method of gastric artery embolization |
US9888994B2 (en) | 2012-05-15 | 2018-02-13 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US20180049726A1 (en) * | 2015-02-02 | 2018-02-22 | Centre National De La Recherche Scientifique | Microdevice for the In Vivo Capture of Circulating Cellular Biomarkers |
US9901434B2 (en) | 2007-02-27 | 2018-02-27 | Cook Medical Technologies Llc | Embolic protection device including a Z-stent waist band |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
US9907639B2 (en) | 2006-09-19 | 2018-03-06 | Cook Medical Technologies Llc | Apparatus and methods for in situ embolic protection |
US9918833B2 (en) | 2010-09-01 | 2018-03-20 | Medtronic Vascular Galway | Prosthetic valve support structure |
US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
EP3323360A1 (en) * | 2016-11-21 | 2018-05-23 | Cook Medical Technologies LLC | Implantable medical device with atraumatic tip |
WO2018102651A1 (en) * | 2016-12-01 | 2018-06-07 | Mayo Foundation For Medical Education And Research | Percutaneously-deployable intravascular embolic protection devices and methods |
US10064696B2 (en) | 2000-08-09 | 2018-09-04 | Edwards Lifesciences Corporation | Devices and methods for delivering an endocardial device |
WO2018136724A3 (en) * | 2017-01-20 | 2018-09-13 | W. L. Gore & Associates, Inc. | Embolic filter system |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
WO2018187413A1 (en) * | 2017-04-05 | 2018-10-11 | Boston Scientific Scimed, Inc. | Emboli-capturing centering device |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10143552B2 (en) | 2015-05-14 | 2018-12-04 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10201417B2 (en) | 2015-02-03 | 2019-02-12 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US10201418B2 (en) | 2010-09-10 | 2019-02-12 | Symetis, SA | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
US10258465B2 (en) | 2003-12-23 | 2019-04-16 | Boston Scientific Scimed Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US10278805B2 (en) | 2000-08-18 | 2019-05-07 | Atritech, Inc. | Expandable implant devices for filtering blood flow from atrial appendages |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10299922B2 (en) | 2005-12-22 | 2019-05-28 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US10307147B2 (en) | 1999-08-09 | 2019-06-04 | Edwards Lifesciences Corporation | System for improving cardiac function by sealing a partitioning membrane within a ventricle |
US10335277B2 (en) | 2015-07-02 | 2019-07-02 | Boston Scientific Scimed Inc. | Adjustable nosecone |
US10335577B2 (en) | 2010-05-19 | 2019-07-02 | Nfinium Vascular Technologies, Llc | Augmented delivery catheter and method |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
US10368990B2 (en) | 2017-01-23 | 2019-08-06 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10449043B2 (en) | 2015-01-16 | 2019-10-22 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
CN110392556A (en) * | 2017-03-13 | 2019-10-29 | 东丽株式会社 | Filter means |
US10470881B2 (en) | 2015-05-14 | 2019-11-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10485976B2 (en) | 1998-04-30 | 2019-11-26 | Medtronic, Inc. | Intracardiovascular access (ICVA™) system |
US10555809B2 (en) | 2012-06-19 | 2020-02-11 | Boston Scientific Scimed, Inc. | Replacement heart valve |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US10588636B2 (en) * | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
EP3632374A1 (en) | 2018-10-04 | 2020-04-08 | Universitätsspital Basel | Protective device for open heart aortic valve replacement surgery and kit comprising the same |
US20200163685A1 (en) * | 2017-03-27 | 2020-05-28 | Transverse Medical, Inc. | Filter apparatuses and methods |
US10743977B2 (en) | 2009-01-16 | 2020-08-18 | Boston Scientific Scimed, Inc. | Intravascular blood filter |
US10751183B2 (en) | 2014-09-28 | 2020-08-25 | Edwards Lifesciences Corporation | Apparatuses for treating cardiac dysfunction |
US10779940B2 (en) | 2015-09-03 | 2020-09-22 | Boston Scientific Scimed, Inc. | Medical device handle |
US10780250B1 (en) | 2016-09-19 | 2020-09-22 | Surefire Medical, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US10828154B2 (en) | 2017-06-08 | 2020-11-10 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
US10849746B2 (en) | 2015-05-14 | 2020-12-01 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
WO2020242545A1 (en) | 2017-12-28 | 2020-12-03 | Groh Mark | Embolic protection catheter and related devices and methods |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US10898330B2 (en) | 2017-03-28 | 2021-01-26 | Edwards Lifesciences Corporation | Positioning, deploying, and retrieving implantable devices |
US10898325B2 (en) | 2017-08-01 | 2021-01-26 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
US10939996B2 (en) | 2017-08-16 | 2021-03-09 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11071844B2 (en) | 2018-03-07 | 2021-07-27 | Innovative Cardiovascular Solutions, Llc | Embolic protection device |
US11090460B2 (en) | 2015-03-31 | 2021-08-17 | Surefire Medical, Inc. | Method for infusing an immunotherapy agent to a solid tumor for treatment |
US11147668B2 (en) | 2018-02-07 | 2021-10-19 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
US11154390B2 (en) | 2017-12-19 | 2021-10-26 | Claret Medical, Inc. | Systems for protection of the cerebral vasculature during a cardiac procedure |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11191630B2 (en) | 2017-10-27 | 2021-12-07 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11191641B2 (en) | 2018-01-19 | 2021-12-07 | Boston Scientific Scimed, Inc. | Inductance mode deployment sensors for transcatheter valve system |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11229517B2 (en) | 2018-05-15 | 2022-01-25 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11241312B2 (en) | 2018-12-10 | 2022-02-08 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
US11246625B2 (en) | 2018-01-19 | 2022-02-15 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
EP3964168A1 (en) * | 2013-05-10 | 2022-03-09 | Medtronic, Inc. | System for deploying a device to a distal location across a diseased vessel |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US11285002B2 (en) | 2003-12-23 | 2022-03-29 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US11304801B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
WO2022087136A1 (en) * | 2020-10-20 | 2022-04-28 | Legacy Ventures LLC | Clot retrieval system |
US11331187B2 (en) | 2016-06-17 | 2022-05-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
US11337790B2 (en) | 2017-02-22 | 2022-05-24 | Boston Scientific Scimed, Inc. | Systems and methods for protecting the cerebral vasculature |
US11338117B2 (en) | 2018-10-08 | 2022-05-24 | Trisalus Life Sciences, Inc. | Implantable dual pathway therapeutic agent delivery port |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11351023B2 (en) | 2018-08-21 | 2022-06-07 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11389168B2 (en) | 2016-09-01 | 2022-07-19 | Microvention, Inc. | Temporary aortic occlusion device |
US11389169B2 (en) | 2016-09-01 | 2022-07-19 | Microvention, Inc. | Temporary aortic occlusion device |
US11400263B1 (en) | 2016-09-19 | 2022-08-02 | Trisalus Life Sciences, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
US11439491B2 (en) | 2018-04-26 | 2022-09-13 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11439732B2 (en) | 2018-02-26 | 2022-09-13 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
CN115670738A (en) * | 2022-12-28 | 2023-02-03 | 北京华脉泰科医疗器械股份有限公司 | Thrombolytic catheter filter and thrombolytic filter combination kit |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US11607301B2 (en) | 2009-01-16 | 2023-03-21 | Boston Scientific Scimed, Inc. | Intravascular blood filters and methods of use |
US11771544B2 (en) | 2011-05-05 | 2023-10-03 | Symetis Sa | Method and apparatus for compressing/loading stent-valves |
US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
US11931252B2 (en) | 2019-07-15 | 2024-03-19 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus and method for the treatment of valve dysfunction |
Families Citing this family (403)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5636641A (en) | 1994-07-25 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | High strength member for intracorporeal use |
US6736843B1 (en) | 1994-07-25 | 2004-05-18 | Advanced Cardiovascular Systems, Inc. | Cylindrically-shaped balloon-expandable stent |
US6270477B1 (en) * | 1996-05-20 | 2001-08-07 | Percusurge, Inc. | Catheter for emboli containment |
US5662671A (en) | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US6183411B1 (en) * | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6050936A (en) * | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
AU6688398A (en) | 1997-03-06 | 1998-09-22 | Percusurge, Inc. | Intravascular aspiration system |
US6152946A (en) * | 1998-03-05 | 2000-11-28 | Scimed Life Systems, Inc. | Distal protection device and method |
US6258120B1 (en) | 1997-12-23 | 2001-07-10 | Embol-X, Inc. | Implantable cerebral protection device and methods of use |
ATE382309T1 (en) * | 1997-11-07 | 2008-01-15 | Salviac Ltd | EMBOLIC PROTECTION DEVICE |
US7491216B2 (en) * | 1997-11-07 | 2009-02-17 | Salviac Limited | Filter element with retractable guidewire tip |
US9498604B2 (en) | 1997-11-12 | 2016-11-22 | Genesis Technologies Llc | Medical device and method |
US20100030256A1 (en) | 1997-11-12 | 2010-02-04 | Genesis Technologies Llc | Medical Devices and Methods |
US20040260333A1 (en) * | 1997-11-12 | 2004-12-23 | Dubrul William R. | Medical device and method |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
EP1054634A4 (en) * | 1998-02-10 | 2006-03-29 | Artemis Medical Inc | Entrapping apparatus and method for use |
US6602265B2 (en) * | 1998-02-10 | 2003-08-05 | Artemis Medical, Inc. | Tissue separation medical device and method |
US6450989B2 (en) * | 1998-04-27 | 2002-09-17 | Artemis Medical, Inc. | Dilating and support apparatus with disease inhibitors and methods for use |
US6260552B1 (en) * | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US7128073B1 (en) * | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US6896690B1 (en) | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
AU3844399A (en) * | 1999-05-07 | 2000-11-21 | Salviac Limited | Support frame for embolic protection device |
AU4606400A (en) * | 1999-05-07 | 2000-11-21 | Salviac Limited | Improved filter element for embolic protection device |
US6964672B2 (en) * | 1999-05-07 | 2005-11-15 | Salviac Limited | Support frame for an embolic protection device |
WO2000067666A1 (en) * | 1999-05-07 | 2000-11-16 | Salviac Limited | Improved filter element for embolic protection device |
US6918921B2 (en) * | 1999-05-07 | 2005-07-19 | Salviac Limited | Support frame for an embolic protection device |
US7037320B2 (en) * | 2001-12-21 | 2006-05-02 | Salviac Limited | Support frame for an embolic protection device |
US20020058911A1 (en) | 1999-05-07 | 2002-05-16 | Paul Gilson | Support frame for an embolic protection device |
US20030150821A1 (en) | 1999-07-16 | 2003-08-14 | Bates Mark C. | Emboli filtration system and methods of use |
CA2379414C (en) | 1999-07-30 | 2010-09-14 | Incept Llc | Vascular filter having articulation region and methods of use in the ascending aorta |
CA2378715C (en) * | 1999-07-30 | 2011-09-06 | Incept Llc | Vascular device for emboli, thrombus and foreign body removal and methods of use |
US7320697B2 (en) * | 1999-07-30 | 2008-01-22 | Boston Scientific Scimed, Inc. | One piece loop and coil |
US8328829B2 (en) | 1999-08-19 | 2012-12-11 | Covidien Lp | High capacity debulking catheter with razor edge cutting window |
US6299622B1 (en) | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
US7708749B2 (en) | 2000-12-20 | 2010-05-04 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
IL131863A0 (en) * | 1999-09-10 | 2001-03-19 | Bruckheimer Elchanan | Intravascular device and method using it |
DE29916162U1 (en) * | 1999-09-14 | 2000-01-13 | Cormedics Gmbh | Vascular filter system |
US6994092B2 (en) * | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
EP1237487A4 (en) * | 1999-12-06 | 2010-11-03 | Simcha Milo | Ultrasonic medical device |
US6443971B1 (en) | 1999-12-21 | 2002-09-03 | Advanced Cardiovascular Systems, Inc. | System for, and method of, blocking the passage of emboli through a vessel |
GB9930654D0 (en) * | 1999-12-23 | 2000-02-16 | Halpin Richard M B | Device for controlling extra-vascular haemorrhage |
US6660021B1 (en) | 1999-12-23 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Intravascular device and system |
US6575997B1 (en) | 1999-12-23 | 2003-06-10 | Endovascular Technologies, Inc. | Embolic basket |
US6402771B1 (en) | 1999-12-23 | 2002-06-11 | Guidant Endovascular Solutions | Snare |
US6540722B1 (en) * | 1999-12-30 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US6695813B1 (en) | 1999-12-30 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US7918820B2 (en) | 1999-12-30 | 2011-04-05 | Advanced Cardiovascular Systems, Inc. | Device for, and method of, blocking emboli in vessels such as blood arteries |
US6511503B1 (en) | 1999-12-30 | 2003-01-28 | Advanced Cardiovascular Systems, Inc. | Catheter apparatus for treating occluded vessels and filtering embolic debris and method of use |
US6443926B1 (en) * | 2000-02-01 | 2002-09-03 | Harold D. Kletschka | Embolic protection device having expandable trap |
US6540767B1 (en) * | 2000-02-08 | 2003-04-01 | Scimed Life Systems, Inc. | Recoilable thrombosis filtering device and method |
US6629953B1 (en) | 2000-02-18 | 2003-10-07 | Fox Hollow Technologies, Inc. | Methods and devices for removing material from a vascular site |
GB2369575A (en) * | 2000-04-20 | 2002-06-05 | Salviac Ltd | An embolic protection system |
US6334864B1 (en) * | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
US6602271B2 (en) | 2000-05-24 | 2003-08-05 | Medtronic Ave, Inc. | Collapsible blood filter with optimal braid geometry |
US6645221B1 (en) * | 2000-05-30 | 2003-11-11 | Zuli, Holdings Ltd. | Active arterial embolization filter |
US6964670B1 (en) | 2000-07-13 | 2005-11-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection guide wire |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6616684B1 (en) * | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
DE10049865B8 (en) * | 2000-10-09 | 2008-10-30 | Universitätsklinikum Freiburg | Device for removing an aortic valve on the human heart by means of a minimally invasive surgical procedure |
US6881217B2 (en) * | 2000-10-13 | 2005-04-19 | Henry M. Israel | Stent assembly |
US6506203B1 (en) | 2000-12-19 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Low profile sheathless embolic protection system |
AU2002231074A1 (en) * | 2000-12-20 | 2002-07-01 | Fox Hollow Technologies, Inc. | Debulking catheter |
US20020128680A1 (en) * | 2001-01-25 | 2002-09-12 | Pavlovic Jennifer L. | Distal protection device with electrospun polymer fiber matrix |
US6840950B2 (en) * | 2001-02-20 | 2005-01-11 | Scimed Life Systems, Inc. | Low profile emboli capture device |
US6635070B2 (en) * | 2001-05-21 | 2003-10-21 | Bacchus Vascular, Inc. | Apparatus and methods for capturing particulate material within blood vessels |
US6599307B1 (en) * | 2001-06-29 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Filter device for embolic protection systems |
US7338510B2 (en) | 2001-06-29 | 2008-03-04 | Advanced Cardiovascular Systems, Inc. | Variable thickness embolic filtering devices and method of manufacturing the same |
US6951570B2 (en) * | 2001-07-02 | 2005-10-04 | Rubicon Medical, Inc. | Methods, systems, and devices for deploying a filter from a filter device |
US6878153B2 (en) * | 2001-07-02 | 2005-04-12 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection and removing embolic material |
US6962598B2 (en) * | 2001-07-02 | 2005-11-08 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection |
AU2012209037B2 (en) * | 2001-08-22 | 2013-12-12 | W. L. Gore & Associates, Inc. | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
US6929634B2 (en) * | 2001-08-22 | 2005-08-16 | Gore Enterprise Holdings, Inc. | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
US7063714B2 (en) * | 2001-08-22 | 2006-06-20 | Gore Enterprise Holdings, Inc. | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
US6902540B2 (en) * | 2001-08-22 | 2005-06-07 | Gerald Dorros | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
US20030040762A1 (en) * | 2001-08-22 | 2003-02-27 | Gerald Dorros | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
EP2305342A3 (en) * | 2001-08-22 | 2013-04-03 | Gore Enterprise Holdings, Inc. | Apparatus and methods for treating strokes and controlling cerebral flow characteristics |
US6638294B1 (en) | 2001-08-30 | 2003-10-28 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
US6592606B2 (en) | 2001-08-31 | 2003-07-15 | Advanced Cardiovascular Systems, Inc. | Hinged short cage for an embolic protection device |
WO2003022131A2 (en) * | 2001-09-07 | 2003-03-20 | Mardil, Inc. | Method and apparatus for external heart stabilization |
SE523902C2 (en) * | 2001-09-07 | 2004-06-01 | Jan Otto Solem | Apparatus for closing a puncture in a body vessel |
US6863683B2 (en) | 2001-09-19 | 2005-03-08 | Abbott Laboratoris Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
US6616682B2 (en) * | 2001-09-19 | 2003-09-09 | Jomed Gmbh | Methods and apparatus for distal protection during a medical procedure |
US6802851B2 (en) * | 2001-09-20 | 2004-10-12 | Gordia Neurovascular, Inc. | Stent aneurysm embolization method using collapsible member and embolic coils |
US6811560B2 (en) * | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
US8262689B2 (en) | 2001-09-28 | 2012-09-11 | Advanced Cardiovascular Systems, Inc. | Embolic filtering devices |
EP1430839B1 (en) * | 2001-09-28 | 2009-06-10 | Kanji Inoue | Free thrombus capturing tool |
US20030083692A1 (en) * | 2001-10-29 | 2003-05-01 | Scimed Life Systems, Inc. | Distal protection device and method of use thereof |
US20040111108A1 (en) | 2001-11-09 | 2004-06-10 | Farnan Robert C. | Balloon catheter with non-deployable stent |
CA2464053A1 (en) | 2001-11-09 | 2003-05-22 | Novoste Corporation | Baloon catheter with non-deployable stent |
US6890340B2 (en) * | 2001-11-29 | 2005-05-10 | Medtronic Vascular, Inc. | Apparatus for temporary intraluminal protection |
EP1461112B1 (en) * | 2001-12-05 | 2012-11-21 | Sagax Inc. | Endovascular device for entrapment of particulate matter and method for use |
US7241304B2 (en) * | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
US7322958B2 (en) * | 2001-12-27 | 2008-01-29 | Wholey Mark H | Apparatus for thromboembolic protection |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7144408B2 (en) * | 2002-03-05 | 2006-12-05 | Salviac Limited | Embolic protection system |
US7063707B2 (en) * | 2002-03-06 | 2006-06-20 | Scimed Life Systems, Inc. | Medical retrieval device |
US20030176886A1 (en) * | 2002-03-12 | 2003-09-18 | Wholey Mark H. | Vascular catheter with expanded distal tip for receiving a thromboembolic protection device and method of use |
AU2003262373A1 (en) * | 2002-04-19 | 2003-11-03 | Salviac Limited | A medical device |
WO2003088869A2 (en) * | 2002-04-19 | 2003-10-30 | Salviac Limited | A medical device |
US8070769B2 (en) * | 2002-05-06 | 2011-12-06 | Boston Scientific Scimed, Inc. | Inverted embolic protection filter |
US7585309B2 (en) * | 2002-05-16 | 2009-09-08 | Boston Scientific Scimed, Inc. | Aortic filter |
DE10233085B4 (en) | 2002-07-19 | 2014-02-20 | Dendron Gmbh | Stent with guide wire |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US7303575B2 (en) * | 2002-08-01 | 2007-12-04 | Lumen Biomedical, Inc. | Embolism protection devices |
US8114114B2 (en) * | 2002-08-27 | 2012-02-14 | Emboline, Inc. | Embolic protection device |
AU2003268379A1 (en) * | 2002-09-03 | 2004-03-29 | John R. Fagan | Arterial embolic filter deployed from catheter |
US7331973B2 (en) | 2002-09-30 | 2008-02-19 | Avdanced Cardiovascular Systems, Inc. | Guide wire with embolic filtering attachment |
US7252675B2 (en) | 2002-09-30 | 2007-08-07 | Advanced Cardiovascular, Inc. | Embolic filtering devices |
US20040093012A1 (en) | 2002-10-17 | 2004-05-13 | Cully Edward H. | Embolic filter frame having looped support strut elements |
US20040088000A1 (en) | 2002-10-31 | 2004-05-06 | Muller Paul F. | Single-wire expandable cages for embolic filtering devices |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
AU2003294293A1 (en) * | 2002-11-13 | 2004-06-03 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US20040138694A1 (en) * | 2003-01-15 | 2004-07-15 | Scimed Life Systems, Inc. | Intravascular filtering membrane and method of making an embolic protection filter device |
US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US7163549B2 (en) * | 2003-02-11 | 2007-01-16 | Boston Scientific Scimed Inc. | Filter membrane manufacturing method |
US7137991B2 (en) * | 2003-02-24 | 2006-11-21 | Scimed Life Systems, Inc. | Multi-wire embolic protection filtering device |
US8591540B2 (en) | 2003-02-27 | 2013-11-26 | Abbott Cardiovascular Systems Inc. | Embolic filtering devices |
US7250041B2 (en) * | 2003-03-12 | 2007-07-31 | Abbott Cardiovascular Systems Inc. | Retrograde pressure regulated infusion |
US20050015048A1 (en) * | 2003-03-12 | 2005-01-20 | Chiu Jessica G. | Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof |
WO2004082532A1 (en) * | 2003-03-17 | 2004-09-30 | Ev3 Sunnyvale, Inc. | Thin film composite lamination |
US20040199201A1 (en) * | 2003-04-02 | 2004-10-07 | Scimed Life Systems, Inc. | Embolectomy devices |
US8246640B2 (en) | 2003-04-22 | 2012-08-21 | Tyco Healthcare Group Lp | Methods and devices for cutting tissue at a vascular location |
US7331976B2 (en) * | 2003-04-29 | 2008-02-19 | Rex Medical, L.P. | Distal protection device |
US20040220612A1 (en) * | 2003-04-30 | 2004-11-04 | Swainston Kyle W | Slidable capture catheter |
US6969396B2 (en) * | 2003-05-07 | 2005-11-29 | Scimed Life Systems, Inc. | Filter membrane with increased surface area |
WO2004100772A2 (en) * | 2003-05-12 | 2004-11-25 | University Of Florida | Devices and methods for disruption and removal of luninal occlusions |
US7537600B2 (en) * | 2003-06-12 | 2009-05-26 | Boston Scientific Scimed, Inc. | Valved embolic protection filter |
US7699865B2 (en) * | 2003-09-12 | 2010-04-20 | Rubicon Medical, Inc. | Actuating constraining mechanism |
US8535344B2 (en) * | 2003-09-12 | 2013-09-17 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection and removing embolic material |
JP3660931B2 (en) * | 2003-09-22 | 2005-06-15 | 新 石丸 | Thrombus embolus capture device |
WO2005042081A1 (en) * | 2003-10-28 | 2005-05-12 | Peacock James C Iii | Embolic filter device and related systems and methods |
US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
US7892251B1 (en) | 2003-11-12 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Component for delivering and locking a medical device to a guide wire |
WO2005058197A1 (en) * | 2003-12-16 | 2005-06-30 | Wholey Mark H | Vascular catheter with an expandable section and a distal tip for delivering a thromboembolic protection device and method of use |
US20050137691A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical | Two piece heart valve and anchor |
US20050137686A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US20050159770A1 (en) * | 2004-01-21 | 2005-07-21 | Diqur Medical Systems, Llc | Funnel catheter device and method of operation thereof |
US20050177185A1 (en) * | 2004-02-05 | 2005-08-11 | Scimed Life Systems, Inc. | Counterwound coil for embolic protection sheath |
US8092483B2 (en) * | 2004-03-06 | 2012-01-10 | Medtronic, Inc. | Steerable device having a corewire within a tube and combination with a functional medical component |
US7988705B2 (en) * | 2004-03-06 | 2011-08-02 | Lumen Biomedical, Inc. | Steerable device having a corewire within a tube and combination with a functional medical component |
US7678129B1 (en) | 2004-03-19 | 2010-03-16 | Advanced Cardiovascular Systems, Inc. | Locking component for an embolic filter assembly |
WO2005094283A2 (en) | 2004-03-25 | 2005-10-13 | Hauser David L | Vascular filter device |
US8409237B2 (en) * | 2004-05-27 | 2013-04-02 | Medtronic, Inc. | Emboli filter export system |
EP1765451B1 (en) * | 2004-06-14 | 2021-11-17 | Edwards Lifesciences Corporation | Devices for arterio-venous fistula creation |
US7976516B2 (en) * | 2004-06-25 | 2011-07-12 | Lumen Biomedical, Inc. | Medical device having mechanically interlocked segments |
US20060047286A1 (en) * | 2004-08-31 | 2006-03-02 | Stephen West | Clot retrieval device |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US20060047301A1 (en) * | 2004-09-02 | 2006-03-02 | Ogle Matthew F | Emboli removal system with oxygenated flow |
US9655633B2 (en) | 2004-09-10 | 2017-05-23 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20060058837A1 (en) * | 2004-09-10 | 2006-03-16 | Arani Bose | System and method for treating ischemic stroke |
US7927346B2 (en) * | 2004-09-10 | 2011-04-19 | Stryker Corporation | Diversion device to increase cerebral blood flow |
US8366735B2 (en) | 2004-09-10 | 2013-02-05 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20060100658A1 (en) * | 2004-11-09 | 2006-05-11 | Hiroyuki Obana | Interventional guiding sheath system and method of use |
US20060241677A1 (en) | 2005-01-03 | 2006-10-26 | Eric Johnson | Methods for maintaining a filtering device within a lumen |
US20060173490A1 (en) * | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US20060190024A1 (en) * | 2005-02-24 | 2006-08-24 | Bei Nianjiong | Recovery catheter apparatus and method |
US9259305B2 (en) | 2005-03-31 | 2016-02-16 | Abbott Cardiovascular Systems Inc. | Guide wire locking mechanism for rapid exchange and other catheter systems |
US20060229658A1 (en) * | 2005-04-07 | 2006-10-12 | Stivland Timothy M | Embolic protection filter with reduced landing zone |
US8475487B2 (en) * | 2005-04-07 | 2013-07-02 | Medrad, Inc. | Cross stream thrombectomy catheter with flexible and expandable cage |
US20060247672A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for pericardial access |
US20060253148A1 (en) * | 2005-05-04 | 2006-11-09 | Leone James E | Apparatus and method of using an occluder for embolic protection |
US10076641B2 (en) | 2005-05-11 | 2018-09-18 | The Spectranetics Corporation | Methods and systems for delivering substances into luminal walls |
US20060287668A1 (en) * | 2005-06-16 | 2006-12-21 | Fawzi Natalie V | Apparatus and methods for intravascular embolic protection |
US20080172066A9 (en) * | 2005-07-29 | 2008-07-17 | Galdonik Jason A | Embolectomy procedures with a device comprising a polymer and devices with polymer matrices and supports |
US7938820B2 (en) * | 2005-08-18 | 2011-05-10 | Lumen Biomedical, Inc. | Thrombectomy catheter |
US8021351B2 (en) * | 2005-08-18 | 2011-09-20 | Medtronic Vascular, Inc. | Tracking aspiration catheter |
US7972359B2 (en) | 2005-09-16 | 2011-07-05 | Atritech, Inc. | Intracardiac cage and method of delivering same |
US20080188928A1 (en) * | 2005-09-16 | 2008-08-07 | Amr Salahieh | Medical device delivery sheath |
US20070100372A1 (en) * | 2005-11-02 | 2007-05-03 | Cook Incorporated | Embolic protection device having a filter |
US8007488B2 (en) * | 2005-11-10 | 2011-08-30 | Phase One Medical Llc | Catheter device |
US9192755B2 (en) | 2005-11-10 | 2015-11-24 | Phase One Medical, Llc | Catheter device |
JP2009515598A (en) * | 2005-11-10 | 2009-04-16 | フェイズ ワン メディカル リミテッド ライアビリティ カンパニー | Catheter device |
US20070112371A1 (en) * | 2005-11-14 | 2007-05-17 | Medtronic Vascular, Inc. | Embolic protection filter having compact collapsed dimensions and method of making same |
US20070135826A1 (en) | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
US9107733B2 (en) * | 2006-01-13 | 2015-08-18 | W. L. Gore & Associates, Inc. | Removable blood conduit filter |
US20070185524A1 (en) * | 2006-02-03 | 2007-08-09 | Pedro Diaz | Rapid exchange emboli capture guidewire system and methods of use |
US9119651B2 (en) * | 2006-02-13 | 2015-09-01 | Retro Vascular, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US20070197962A1 (en) * | 2006-02-22 | 2007-08-23 | Masuo Morikawa | Catheter for removing foreign substance in blood vessel |
US20070198050A1 (en) * | 2006-02-22 | 2007-08-23 | Phase One Medica, Llc | Medical implant device |
US20070219577A1 (en) * | 2006-03-20 | 2007-09-20 | Boston Scientific Scimed, Inc. | Sprayed in delivery sheath tubes |
US20070265655A1 (en) * | 2006-05-09 | 2007-11-15 | Boston Scientific Scimed, Inc. | Embolic protection filter with enhanced stability within a vessel |
US20070276419A1 (en) | 2006-05-26 | 2007-11-29 | Fox Hollow Technologies, Inc. | Methods and devices for rotating an active element and an energy emitter on a catheter |
JP4925728B2 (en) * | 2006-05-30 | 2012-05-09 | ニプロ株式会社 | Device for capturing scattered foreign matter |
JP4925729B2 (en) * | 2006-05-30 | 2012-05-09 | ニプロ株式会社 | Percutaneous thrombectomy device |
US8333000B2 (en) | 2006-06-19 | 2012-12-18 | Advanced Cardiovascular Systems, Inc. | Methods for improving stent retention on a balloon catheter |
US7828854B2 (en) * | 2006-10-31 | 2010-11-09 | Ethicon, Inc. | Implantable repair device |
EP2088961A4 (en) * | 2006-11-21 | 2014-04-16 | Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct | Branch stent graft for aortic aneurysm repair |
WO2008066881A1 (en) | 2006-11-29 | 2008-06-05 | Amir Belson | Embolic protection device |
US20080221552A1 (en) * | 2007-03-09 | 2008-09-11 | Abbott Cardiovascular Systems Inc. | Agent delivery perfusion catheter |
US20080243170A1 (en) * | 2007-03-30 | 2008-10-02 | Boston Scientific Scimed, Inc. | Embolic capturing devices and methods |
US7780630B2 (en) * | 2007-03-30 | 2010-08-24 | Boston Scientific Scimed, Inc. | Perfusion device |
US7686783B2 (en) * | 2007-03-30 | 2010-03-30 | Boston Scientific Scimed, Inc. | Perfusion and embolic protection |
US8216209B2 (en) | 2007-05-31 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US7867273B2 (en) | 2007-06-27 | 2011-01-11 | Abbott Laboratories | Endoprostheses for peripheral arteries and other body vessels |
US10376685B2 (en) | 2007-08-31 | 2019-08-13 | Mermaid Medical Vascular Aps | Thrombus detection device and method |
US8613753B2 (en) * | 2007-08-31 | 2013-12-24 | BiO2 Medical, Inc. | Multi-lumen central access vena cava filter apparatus and method of using same |
US9687333B2 (en) * | 2007-08-31 | 2017-06-27 | BiO2 Medical, Inc. | Reduced profile central venous access catheter with vena cava filter and method |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
WO2009053855A2 (en) * | 2007-10-27 | 2009-04-30 | Salviac Limited | Embolic filter device and method of manufacturing the same |
DE102007056946A1 (en) * | 2007-11-27 | 2009-05-28 | Gunnar Pah | Device for filtering blood |
US20090187211A1 (en) | 2007-12-21 | 2009-07-23 | Abbott Laboratories | Vena cava filter having hourglass shape |
WO2009086205A2 (en) * | 2007-12-21 | 2009-07-09 | Abbott Laboratories | Body lumen filter |
ES2647310T3 (en) | 2008-02-22 | 2017-12-20 | Covidien Lp | Device for flow restoration |
US8784440B2 (en) | 2008-02-25 | 2014-07-22 | Covidien Lp | Methods and devices for cutting tissue |
US8070694B2 (en) | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
US9402707B2 (en) | 2008-07-22 | 2016-08-02 | Neuravi Limited | Clot capture systems and associated methods |
DE202009019019U1 (en) * | 2008-09-04 | 2015-07-27 | Swat Medical Ab | Foldable temporary embolic protection device with elongated blood permeable unit |
DK2326379T3 (en) * | 2008-09-17 | 2013-09-08 | Joanneum Res Forschungsgmbh | Filament-based catheter |
US8852225B2 (en) * | 2008-09-25 | 2014-10-07 | Medtronic, Inc. | Emboli guarding device |
WO2010039862A1 (en) * | 2008-09-30 | 2010-04-08 | Rox Medical, Inc. | Methods for screening and treating patients with compromised cardiopulmonary function |
CA2739665C (en) | 2008-10-13 | 2018-01-02 | Tyco Healthcare Group Lp | Devices and methods for manipulating a catheter shaft |
EP2196174B1 (en) | 2008-12-12 | 2014-02-26 | Abbott Laboratories Vascular Enterprises Limited | Process for loading a stent onto a stent delivery system |
US20100152711A1 (en) * | 2008-12-15 | 2010-06-17 | Boston Scientific Scimed, Inc. | Offset coupling region |
US8444669B2 (en) | 2008-12-15 | 2013-05-21 | Boston Scientific Scimed, Inc. | Embolic filter delivery system and method |
EP3586793B1 (en) | 2009-01-09 | 2021-06-02 | Embrella Cardiovascular, Inc. | Embolic deflection device |
US20100185179A1 (en) * | 2009-01-21 | 2010-07-22 | Abbott Cardiovascular Systems Inc. | Needled cannula with filter device |
EP2391303A4 (en) * | 2009-01-29 | 2020-09-09 | Boston Scientific Scimed, Inc. | Illuminated intravascular blood filter |
US20100204672A1 (en) * | 2009-02-12 | 2010-08-12 | Penumra, Inc. | System and method for treating ischemic stroke |
US20100228280A1 (en) * | 2009-03-09 | 2010-09-09 | Adam Groothuis | Methods and devices for treatment of lumenal systems |
EP2241284B1 (en) | 2009-04-15 | 2012-09-19 | National University of Ireland, Galway | Intravasculature devices and balloons for use therewith |
US9636204B2 (en) | 2009-04-16 | 2017-05-02 | Cvdevices, Llc | Deflection devices, systems and methods for the prevention of stroke |
WO2010121192A1 (en) | 2009-04-16 | 2010-10-21 | Cvdevices, Llc | Devices, systems, and methods for the prevention of stroke |
US9681967B2 (en) | 2009-04-16 | 2017-06-20 | Cvdevices, Llc | Linked deflection devices, systems and methods for the prevention of stroke |
RU2509537C2 (en) | 2009-04-29 | 2014-03-20 | ТАЙКО ХЕЛСКЕА ГРУП эЛПи | Methods and devices for tissue cutting and cleansing |
US8192452B2 (en) | 2009-05-14 | 2012-06-05 | Tyco Healthcare Group Lp | Easily cleaned atherectomy catheters and methods of use |
US9510855B2 (en) * | 2009-06-15 | 2016-12-06 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
US20110022074A1 (en) * | 2009-07-22 | 2011-01-27 | Alex Powell | Permanent arterial emboli dissolution filter to prevent embolic occlusion of a blood vessel |
US10092427B2 (en) | 2009-11-04 | 2018-10-09 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
US9649211B2 (en) | 2009-11-04 | 2017-05-16 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
EP2913013B1 (en) | 2009-12-02 | 2016-11-09 | Covidien LP | Methods and devices for cutting tissue |
EP2509519B1 (en) | 2009-12-11 | 2019-08-07 | Covidien LP | Material removal device having improved material capture efficiency |
CN102821704A (en) * | 2010-02-05 | 2012-12-12 | 斯瑞克运营有限公司 | Multimode occlusion and stenosis treatment apparatus and method of use |
US9199066B2 (en) | 2010-03-12 | 2015-12-01 | Quattro Vascular Pte Ltd. | Device and method for compartmental vessel treatment |
AU2011233575A1 (en) * | 2010-04-01 | 2012-10-25 | Xenolith Medical Ltd. | Expandable devices and methods of use |
EP2558005B1 (en) | 2010-04-13 | 2022-03-30 | MIVI Neuroscience, Inc | Embolectomy devices for treatment of acute ischemic stroke condition |
EP2380604A1 (en) | 2010-04-19 | 2011-10-26 | InnoRa Gmbh | Improved coating formulations for scoring or cutting balloon catheters |
CA2800920C (en) | 2010-06-14 | 2015-04-14 | Covidien Lp | Material removal device |
US9561094B2 (en) | 2010-07-23 | 2017-02-07 | Nfinium Vascular Technologies, Llc | Devices and methods for treating venous diseases |
US10130470B2 (en) | 2010-08-17 | 2018-11-20 | St. Jude Medical, Llc | Sleeve for facilitating movement of a transfemoral catheter |
US9439795B2 (en) | 2010-09-17 | 2016-09-13 | St. Jude Medical, Cardiology Division, Inc. | Retainers for transcatheter heart valve delivery systems |
US8632559B2 (en) | 2010-09-21 | 2014-01-21 | Angioscore, Inc. | Method and system for treating valve stenosis |
US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
WO2012052982A1 (en) | 2010-10-22 | 2012-04-26 | Neuravi Limited | Clot engagement and removal system |
AU2011319797B2 (en) | 2010-10-28 | 2015-04-09 | Covidien Lp | Material removal device and method of use |
CA2817213C (en) | 2010-11-11 | 2016-06-14 | Covidien Lp | Flexible debulking catheters with imaging and methods of use and manufacture |
US10123865B2 (en) | 2010-12-16 | 2018-11-13 | BiO2 Medical, Inc. | Vascular filter assembly having low profile sheath |
RU2462197C1 (en) * | 2011-02-11 | 2012-09-27 | Общество с ограниченной ответственностью "АСТОР" | Method of active prophylaxis of acute cerebral circulation disorders of embologenic nature and filtering stent-graft for its realisation according to belyaev ov |
WO2012120490A2 (en) | 2011-03-09 | 2012-09-13 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
US11259824B2 (en) | 2011-03-09 | 2022-03-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
EP2522307B1 (en) * | 2011-05-08 | 2020-09-30 | ITSO Medical AB | Device for delivery of medical devices to a cardiac valve |
EP2736450A1 (en) | 2011-07-28 | 2014-06-04 | St. Jude Medical, Inc. | Expandable radiopaque marker for transcatheter aortic valve implantation |
EP4101399A1 (en) | 2011-08-05 | 2022-12-14 | Route 92 Medical, Inc. | System for treatment of acute ischemic stroke |
EP2750862B1 (en) | 2011-09-01 | 2016-07-06 | Covidien LP | Catheter with helical drive shaft and methods of manufacture |
EP2762083B1 (en) * | 2011-09-27 | 2017-01-18 | Kanji Inoue | Device for capturing debris in blood vessel |
US20130096606A1 (en) * | 2011-10-17 | 2013-04-18 | William C. Bruchman | Embolic protection devices and related systems and methods |
JP5951955B2 (en) * | 2011-10-17 | 2016-07-13 | 株式会社東海メディカルプロダクツ | Filter device for embolization substance capture |
US9744023B2 (en) | 2011-10-25 | 2017-08-29 | Boston Scientific Scimed, Inc. | Embolic debris deflector |
US8968354B2 (en) | 2011-10-26 | 2015-03-03 | Boston Scientific Scimed, Inc. | Extended protection embolic filter |
US20130116654A1 (en) * | 2011-11-08 | 2013-05-09 | Edwards Lifesciences Llc | Aortic Occlusion Catheter |
US20140303667A1 (en) * | 2011-12-02 | 2014-10-09 | Inceptus Medical, Llc | Embolic protection device and methods of use |
RU2014129392A (en) | 2012-01-06 | 2016-02-27 | Эмболайн, Инк. | Embedded anti-embolic protection |
US10426501B2 (en) | 2012-01-13 | 2019-10-01 | Crux Biomedical, Inc. | Retrieval snare device and method |
KR20140114856A (en) | 2012-02-01 | 2014-09-29 | 콰트로 배스큘러 피티이 리미티드 | Device for compartmental dilatation of blood vessels |
US9179936B2 (en) | 2012-02-08 | 2015-11-10 | Quattro Vascular Pte Ltd. | Constraining structure with non-linear axial struts |
US9216033B2 (en) | 2012-02-08 | 2015-12-22 | Quattro Vascular Pte Ltd. | System and method for treating biological vessels |
WO2013119332A2 (en) | 2012-02-09 | 2013-08-15 | Stout Medical Group, L.P. | Embolic device and methods of use |
US10213288B2 (en) | 2012-03-06 | 2019-02-26 | Crux Biomedical, Inc. | Distal protection filter |
US8735702B1 (en) * | 2012-03-21 | 2014-05-27 | Deborah R. Miles | Portable dissipating medium used for removal of vibrational interference in a bowed string of a violin family instrument |
WO2013142201A1 (en) * | 2012-03-21 | 2013-09-26 | Nexeon Medsystems, Inc. | Apparatus and methods for filtering emboli during percutaneous aortic valve replacement and repair procedures with filtration system coupled in-situ to distal end of sheath |
CN104334118B (en) * | 2012-04-06 | 2016-12-28 | Pi-R-方形有限公司 | Percutaneous thromboembolism protection sleeve pipe |
US8882828B2 (en) * | 2012-04-27 | 2014-11-11 | Medtronic Vascular, Inc. | Ring on a closed web stent-graft for use in tip capture |
AU2013259912A1 (en) * | 2012-05-08 | 2015-01-15 | The Curators Of The University Of Missouri | Embolic protection system |
US20130338690A1 (en) * | 2012-06-15 | 2013-12-19 | Gadal Consulting, LLC | Device and method for removing unwanted material in a vascular conduit |
US9480561B2 (en) * | 2012-06-26 | 2016-11-01 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for aortic protection and TAVI planar alignment |
US9918837B2 (en) | 2012-06-29 | 2018-03-20 | St. Jude Medical, Cardiology Division, Inc. | System to assist in the release of a collapsible stent from a delivery device |
US20140031857A1 (en) * | 2012-07-25 | 2014-01-30 | Boston Scientific Scimed, Inc. | Embolic protection filter for transcatheter aortic valve replacement and uses thereof |
US20140172006A1 (en) * | 2012-08-24 | 2014-06-19 | Synecor Llc | System for facilitating transcatheter aortic valve procedures using femoral access |
US9579157B2 (en) | 2012-09-13 | 2017-02-28 | Covidien Lp | Cleaning device for medical instrument and method of use |
CN104755124B (en) | 2012-11-01 | 2019-04-12 | 玛芬股份有限公司 | For determining the tool of sheath pipe transfer |
US9943329B2 (en) | 2012-11-08 | 2018-04-17 | Covidien Lp | Tissue-removing catheter with rotatable cutter |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US8784434B2 (en) | 2012-11-20 | 2014-07-22 | Inceptus Medical, Inc. | Methods and apparatus for treating embolism |
US10307240B2 (en) | 2012-12-11 | 2019-06-04 | Alan Zajarias | Methods and apparatus for capturing embolic debris during endovascular procedures |
US20140214069A1 (en) * | 2013-01-30 | 2014-07-31 | Edwards Lifesciences Corporation | Inflatable Embolic Deflector |
US9888993B2 (en) | 2013-03-01 | 2018-02-13 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection device |
US9968433B2 (en) * | 2013-03-01 | 2018-05-15 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection pass through tube |
US10973618B2 (en) | 2013-03-01 | 2021-04-13 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection device |
US10076404B2 (en) * | 2013-03-12 | 2018-09-18 | Boston Scientific Limited | Catheter system with balloon-operated filter sheath and fluid flow maintenance |
US9642635B2 (en) | 2013-03-13 | 2017-05-09 | Neuravi Limited | Clot removal device |
US9433429B2 (en) | 2013-03-14 | 2016-09-06 | Neuravi Limited | Clot retrieval devices |
WO2014140092A2 (en) | 2013-03-14 | 2014-09-18 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
CN105208950A (en) | 2013-03-14 | 2015-12-30 | 尼尔拉维有限公司 | A clot retrieval device for removing occlusive clot from a blood vessel |
US10143545B2 (en) | 2013-03-15 | 2018-12-04 | W. L. Gore & Associates, Inc. | Vascular filtration device |
CN105658174B (en) | 2013-07-17 | 2018-01-12 | 湖区制造公司 | High flow capacity embolic |
RU2571343C2 (en) * | 2013-08-22 | 2015-12-20 | Юрий Германович Андреев | Inflow or outflow occlusion device |
KR20150026766A (en) * | 2013-08-29 | 2015-03-11 | 김준홍 | Guard catheter for guarding the RVOT wire, guard method in Mitral cerclage coronary sinus annuloplasty |
CN105611903B (en) * | 2013-08-30 | 2017-11-21 | 雪松-西奈医学中心 | For taking out the apparatus and method of mechanical heart valve leaflets through conduit |
US10398550B2 (en) | 2013-09-12 | 2019-09-03 | St. Jude Medical, Cardiology Division, Inc. | Atraumatic interface in an implant delivery device |
US10076399B2 (en) | 2013-09-13 | 2018-09-18 | Covidien Lp | Endovascular device engagement |
US10117668B2 (en) | 2013-10-08 | 2018-11-06 | The Spectranetics Corporation | Balloon catheter with non-deployable stent having improved stability |
EP2859864A1 (en) | 2013-10-14 | 2015-04-15 | Protembis GmbH | Medical device for embolic protection |
GB2523291B (en) * | 2013-10-16 | 2016-02-24 | Cook Medical Technologies Llc | Vascular occluder with crossing frame elements |
US10350098B2 (en) | 2013-12-20 | 2019-07-16 | Volcano Corporation | Devices and methods for controlled endoluminal filter deployment |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US10226268B2 (en) * | 2014-01-03 | 2019-03-12 | Legacy Ventures LLC | Clot retrieval system |
US10285720B2 (en) | 2014-03-11 | 2019-05-14 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US9820761B2 (en) | 2014-03-21 | 2017-11-21 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
US11278388B2 (en) | 2014-05-21 | 2022-03-22 | Swat Medical Ab | Embolic protection device and method |
US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
CN106604696A (en) | 2014-05-28 | 2017-04-26 | 斯瑞克欧洲控股有限责任公司 | Vaso-occlusive devices and methods of use |
WO2015184450A1 (en) * | 2014-05-30 | 2015-12-03 | Cardiac Valve Solutions Llc | Temporary valve and filter on guide catheter |
JP2017516584A (en) | 2014-06-04 | 2017-06-22 | エンフィニアム バスキュラー テクノロジーズ, エルエルシー | Low radial force vascular device and method of occlusion |
US10792056B2 (en) * | 2014-06-13 | 2020-10-06 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
EP3154452A1 (en) | 2014-06-13 | 2017-04-19 | Neuravi Limited | Devices for removal of acute blockages from blood vessels |
WO2015200532A1 (en) * | 2014-06-24 | 2015-12-30 | Edwards Lifesciences Corporation | Peripheral antegrade perfusion and occlusion device |
WO2015200702A1 (en) | 2014-06-27 | 2015-12-30 | Covidien Lp | Cleaning device for catheter and catheter including the same |
US10265086B2 (en) | 2014-06-30 | 2019-04-23 | Neuravi Limited | System for removing a clot from a blood vessel |
EP2987463A1 (en) * | 2014-08-21 | 2016-02-24 | Noureddine Frid | 3d filter for prevention of stroke |
EP3705087B1 (en) | 2014-09-14 | 2023-12-27 | Emboline, Inc. | Introducer sheath with embolic protection |
US20160089172A1 (en) * | 2014-09-30 | 2016-03-31 | Boston Scientific Scimed, Inc. | Devices and methods for applying suction |
US9987117B2 (en) * | 2014-11-06 | 2018-06-05 | Furqan Tejani | Thromboembolic protection device |
US10232148B2 (en) | 2014-11-17 | 2019-03-19 | TriReme Medical, LLC | Balloon catheter system and method of using same |
CN106999196B (en) | 2014-11-26 | 2020-07-28 | 尼尔拉维有限公司 | Thrombus retrieval device for removing obstructive thrombus from blood vessel |
US11253278B2 (en) | 2014-11-26 | 2022-02-22 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US10617435B2 (en) | 2014-11-26 | 2020-04-14 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11065019B1 (en) | 2015-02-04 | 2021-07-20 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US10426497B2 (en) | 2015-07-24 | 2019-10-01 | Route 92 Medical, Inc. | Anchoring delivery system and methods |
DE202016009165U1 (en) | 2015-02-04 | 2023-04-26 | Route 92 Medical, Inc. | Rapid Aspiration Thrombectomy System |
US10314667B2 (en) | 2015-03-25 | 2019-06-11 | Covidien Lp | Cleaning device for cleaning medical instrument |
US9592111B2 (en) | 2015-04-30 | 2017-03-14 | Mark Groh | Valve replacement devices |
US10159490B2 (en) | 2015-05-08 | 2018-12-25 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
KR102139168B1 (en) * | 2015-05-15 | 2020-07-29 | 텔리플렉스 메디컬 인코포레이티드 | Tethered filter assemblies and methods for use thereof |
US10292721B2 (en) | 2015-07-20 | 2019-05-21 | Covidien Lp | Tissue-removing catheter including movable distal tip |
EP3344184A4 (en) | 2015-09-01 | 2019-05-15 | Mivi Neuroscience, Inc. | Thrombectomy devices and treatment of acute ischemic stroke with thrombus engagement |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US10314664B2 (en) | 2015-10-07 | 2019-06-11 | Covidien Lp | Tissue-removing catheter and tissue-removing element with depth stop |
AU2016341439B2 (en) | 2015-10-23 | 2021-07-08 | Inari Medical, Inc. | Intravascular treatment of vascular occlusion and associated devices, systems, and methods |
US10716915B2 (en) | 2015-11-23 | 2020-07-21 | Mivi Neuroscience, Inc. | Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems |
US10617509B2 (en) | 2015-12-29 | 2020-04-14 | Emboline, Inc. | Multi-access intraprocedural embolic protection device |
WO2017197065A1 (en) | 2016-05-13 | 2017-11-16 | St. Jude Medical, Cardiology Division, Inc. | Systems for device implantation |
WO2017200866A1 (en) * | 2016-05-17 | 2017-11-23 | The Cleveland Clinic Foundation | Apparatus for blocking bloodflow through a dissected aorta |
US11304698B2 (en) | 2016-07-25 | 2022-04-19 | Virender K. Sharma | Cardiac shunt device and delivery system |
CN114587469A (en) * | 2016-07-25 | 2022-06-07 | 维兰德.K.沙马 | Magnetic anastomosis device and delivery system |
MX2019001899A (en) | 2016-08-17 | 2019-09-18 | Neuravi Ltd | A clot retrieval system for removing occlusive clot from a blood vessel. |
CA3035706A1 (en) | 2016-09-06 | 2018-03-15 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
US11877752B2 (en) | 2016-09-07 | 2024-01-23 | Daniel Ezra Walzman | Filterless aspiration, irrigating, macerating, rotating microcatheter and method of use |
US11439492B2 (en) * | 2016-09-07 | 2022-09-13 | Daniel Ezra Walzman | Lasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use |
EP3522798A4 (en) | 2016-10-06 | 2020-05-13 | Mivi Neuroscience, Inc. | Hydraulic displacement and removal of thrombus clots, and catheters for performing hydraulic displacement |
US9994980B2 (en) | 2016-10-14 | 2018-06-12 | Inceptus Medical, Llc | Braiding machine and methods of use |
WO2018080590A1 (en) | 2016-10-24 | 2018-05-03 | Inari Medical | Devices and methods for treating vascular occlusion |
US11197750B2 (en) | 2016-11-29 | 2021-12-14 | Lake Region Manufacturing, Inc. | Embolic protection device |
WO2018132387A1 (en) | 2017-01-10 | 2018-07-19 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
EP3585305A1 (en) * | 2017-02-23 | 2020-01-01 | Boston Scientific Scimed, Inc. | Medical drain device |
WO2018156962A1 (en) | 2017-02-24 | 2018-08-30 | Inceptus Medical LLC | Vascular occlusion devices and methods |
EP3614933A1 (en) | 2017-04-27 | 2020-03-04 | Boston Scientific Scimed, Inc. | Occlusive medical device with fabric retention barb |
US10478535B2 (en) | 2017-05-24 | 2019-11-19 | Mivi Neuroscience, Inc. | Suction catheter systems for applying effective aspiration in remote vessels, especially cerebral arteries |
US11234723B2 (en) | 2017-12-20 | 2022-02-01 | Mivi Neuroscience, Inc. | Suction catheter systems for applying effective aspiration in remote vessels, especially cerebral arteries |
US11000682B2 (en) | 2017-09-06 | 2021-05-11 | Inari Medical, Inc. | Hemostasis valves and methods of use |
US11885051B2 (en) | 2017-10-14 | 2024-01-30 | Inceptus Medical, Llc | Braiding machine and methods of use |
DE102018100199A1 (en) * | 2018-01-05 | 2019-07-11 | Vm Holding Gmbh | cardiac catheterization |
US11154314B2 (en) | 2018-01-26 | 2021-10-26 | Inari Medical, Inc. | Single insertion delivery system for treating embolism and associated systems and methods |
CN112423703A (en) * | 2018-03-27 | 2021-02-26 | 马杜罗探索有限责任公司 | Auxiliary instrument for providing neuroprotection during interventional procedure |
AU2019269606A1 (en) | 2018-05-17 | 2020-12-03 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11382632B2 (en) * | 2018-06-27 | 2022-07-12 | Boston Scientific Scimed, Inc. | Vascular occlusion device |
EP3836855A4 (en) | 2018-08-13 | 2022-08-10 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
EP3840670B1 (en) | 2018-08-21 | 2023-11-15 | Boston Scientific Scimed, Inc. | Projecting member with barb for cardiovascular devices |
US10842498B2 (en) | 2018-09-13 | 2020-11-24 | Neuravi Limited | Systems and methods of restoring perfusion to a vessel |
US11406416B2 (en) | 2018-10-02 | 2022-08-09 | Neuravi Limited | Joint assembly for vasculature obstruction capture device |
EP3880134A4 (en) * | 2018-11-15 | 2022-07-06 | Baleen Medical LLC | Methods, systems, and devices for embolic protection |
US20200222172A1 (en) * | 2019-01-11 | 2020-07-16 | Varun Shetty | Method and system for reducing pulmonary flow |
US11304792B2 (en) | 2019-02-13 | 2022-04-19 | Emboline, Inc. | Catheter with integrated embolic protection device |
JP2020142074A (en) | 2019-03-04 | 2020-09-10 | ニューラヴィ・リミテッド | Actuated clot retrieval catheter |
WO2020180866A1 (en) * | 2019-03-04 | 2020-09-10 | Boston Scientific Scimed, Inc. | Systems and methods for protecting the cerebral vasculature |
EP3934591A4 (en) * | 2019-03-08 | 2022-11-23 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
EP3718505A1 (en) | 2019-04-05 | 2020-10-07 | Aorticlab Sarl | Transcatheter anti embolic filter for arterial and venous vessels |
US11077285B2 (en) | 2019-06-15 | 2021-08-03 | Maduro Discovery, Llc | Catheter construction |
US11707351B2 (en) | 2019-08-19 | 2023-07-25 | Encompass Technologies, Inc. | Embolic protection and access system |
US11540838B2 (en) | 2019-08-30 | 2023-01-03 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with sealing disk |
EP3791815A1 (en) | 2019-09-11 | 2021-03-17 | Neuravi Limited | Expandable mouth catheter |
EP4044938A4 (en) | 2019-10-16 | 2023-11-15 | Inari Medical, Inc. | Systems, devices, and methods for treating vascular occlusions |
US11712231B2 (en) | 2019-10-29 | 2023-08-01 | Neuravi Limited | Proximal locking assembly design for dual stent mechanical thrombectomy device |
US11839725B2 (en) | 2019-11-27 | 2023-12-12 | Neuravi Limited | Clot retrieval device with outer sheath and inner catheter |
US11779364B2 (en) | 2019-11-27 | 2023-10-10 | Neuravi Limited | Actuated expandable mouth thrombectomy catheter |
US11517340B2 (en) | 2019-12-03 | 2022-12-06 | Neuravi Limited | Stentriever devices for removing an occlusive clot from a vessel and methods thereof |
US11617865B2 (en) | 2020-01-24 | 2023-04-04 | Mivi Neuroscience, Inc. | Suction catheter systems with designs allowing rapid clearing of clots |
US11633198B2 (en) | 2020-03-05 | 2023-04-25 | Neuravi Limited | Catheter proximal joint |
EP4125634A1 (en) | 2020-03-24 | 2023-02-08 | Boston Scientific Scimed Inc. | Medical system for treating a left atrial appendage |
US11883043B2 (en) | 2020-03-31 | 2024-01-30 | DePuy Synthes Products, Inc. | Catheter funnel extension |
US11759217B2 (en) | 2020-04-07 | 2023-09-19 | Neuravi Limited | Catheter tubular support |
US11871946B2 (en) | 2020-04-17 | 2024-01-16 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11717308B2 (en) | 2020-04-17 | 2023-08-08 | Neuravi Limited | Clot retrieval device for removing heterogeneous clots from a blood vessel |
US11730501B2 (en) | 2020-04-17 | 2023-08-22 | Neuravi Limited | Floating clot retrieval device for removing clots from a blood vessel |
US11737771B2 (en) | 2020-06-18 | 2023-08-29 | Neuravi Limited | Dual channel thrombectomy device |
US11395669B2 (en) | 2020-06-23 | 2022-07-26 | Neuravi Limited | Clot retrieval device with flexible collapsible frame |
US11439418B2 (en) | 2020-06-23 | 2022-09-13 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11864781B2 (en) | 2020-09-23 | 2024-01-09 | Neuravi Limited | Rotating frame thrombectomy device |
US11872354B2 (en) | 2021-02-24 | 2024-01-16 | Neuravi Limited | Flexible catheter shaft frame with seam |
EP4112004A1 (en) * | 2021-07-01 | 2023-01-04 | Medtronic Inc. | An embolic filter |
CN114271990B (en) * | 2021-12-27 | 2022-10-14 | 上海傲流医疗科技有限公司 | Thrombus filtering and removing net |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5102415A (en) * | 1989-09-06 | 1992-04-07 | Guenther Rolf W | Apparatus for removing blood clots from arteries and veins |
US5769816A (en) * | 1995-11-07 | 1998-06-23 | Embol-X, Inc. | Cannula with associated filter |
US5814064A (en) * | 1997-03-06 | 1998-09-29 | Scimed Life Systems, Inc. | Distal protection device |
US6090097A (en) * | 1996-05-14 | 2000-07-18 | Embol-X, Inc. | Aortic occluder with associated filter and methods of use during cardiac surgery |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3996938A (en) | 1975-07-10 | 1976-12-14 | Clark Iii William T | Expanding mesh catheter |
US4494531A (en) | 1982-12-06 | 1985-01-22 | Cook, Incorporated | Expandable blood clot filter |
FR2567405B1 (en) * | 1984-07-12 | 1988-08-12 | Lefebvre Jean Marie | MEDICAL FILTER |
NL8502382A (en) | 1985-08-30 | 1987-03-16 | Martinus Jacobus Antonius Joha | CATHETER SUITABLE FOR MULTIPLE PURPOSES. |
US4650466A (en) | 1985-11-01 | 1987-03-17 | Angiobrade Partners | Angioplasty device |
US4710192A (en) * | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US4723549A (en) | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
US4793348A (en) | 1986-11-15 | 1988-12-27 | Palmaz Julio C | Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation |
US4817600A (en) | 1987-05-22 | 1989-04-04 | Medi-Tech, Inc. | Implantable filter |
US4873978A (en) | 1987-12-04 | 1989-10-17 | Robert Ginsburg | Device and method for emboli retrieval |
US5152777A (en) | 1989-01-25 | 1992-10-06 | Uresil Corporation | Device and method for providing protection from emboli and preventing occulsion of blood vessels |
US4969891A (en) | 1989-03-06 | 1990-11-13 | Gewertz Bruce L | Removable vascular filter |
US5059205A (en) | 1989-09-07 | 1991-10-22 | Boston Scientific Corporation | Percutaneous anti-migration vena cava filter |
US5135516A (en) * | 1989-12-15 | 1992-08-04 | Boston Scientific Corporation | Lubricious antithrombogenic catheters, guidewires and coatings |
FR2660189B1 (en) | 1990-03-28 | 1992-07-31 | Lefebvre Jean Marie | DEVICE INTENDED TO BE IMPLANTED IN A VESSEL WITH SIDE LEGS WITH ANTAGONIST TEETH. |
US5221261A (en) | 1990-04-12 | 1993-06-22 | Schneider (Usa) Inc. | Radially expandable fixation member |
US5275612A (en) | 1990-05-10 | 1994-01-04 | Symbiosis Corporation | Insulating ferrule for disposable laparoscopic surgical instrument |
US5108419A (en) | 1990-08-16 | 1992-04-28 | Evi Corporation | Endovascular filter and method for use thereof |
US5053008A (en) * | 1990-11-21 | 1991-10-01 | Sandeep Bajaj | Intracardiac catheter |
US5370647A (en) * | 1991-01-23 | 1994-12-06 | Surgical Innovations, Inc. | Tissue and organ extractor |
US5415630A (en) | 1991-07-17 | 1995-05-16 | Gory; Pierre | Method for removably implanting a blood filter in a vein of the human body |
FR2689388B1 (en) | 1992-04-07 | 1999-07-16 | Celsa Lg | PERFECTIONALLY RESORBABLE BLOOD FILTER. |
US5324304A (en) | 1992-06-18 | 1994-06-28 | William Cook Europe A/S | Introduction catheter set for a collapsible self-expandable implant |
US5452732A (en) | 1994-04-26 | 1995-09-26 | Bircoll; Mel | Method of dissecting along connective tissue lines |
DE69536046D1 (en) * | 1994-07-08 | 2010-04-01 | Ev3 Inc | System for performing an intravascular procedure |
US6013093A (en) * | 1995-11-28 | 2000-01-11 | Boston Scientific Corporation | Blood clot filtering |
US5549626A (en) | 1994-12-23 | 1996-08-27 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Vena caval filter |
DE19509464C1 (en) * | 1995-03-20 | 1996-06-27 | Horst J Dr Med Jaeger | Implant for artery or vein, with anchor piece fixed to wall of vessel |
US5695519A (en) * | 1995-11-30 | 1997-12-09 | American Biomed, Inc. | Percutaneous filter for carotid angioplasty |
US5935139A (en) * | 1996-05-03 | 1999-08-10 | Boston Scientific Corporation | System for immobilizing or manipulating an object in a tract |
US5662671A (en) | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US5876367A (en) | 1996-12-05 | 1999-03-02 | Embol-X, Inc. | Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries |
US5846260A (en) | 1997-05-08 | 1998-12-08 | Embol-X, Inc. | Cannula with a modular filter for filtering embolic material |
-
1998
- 1998-09-22 US US09/158,405 patent/US6361545B1/en not_active Expired - Lifetime
- 1998-09-23 CA CA002304463A patent/CA2304463A1/en not_active Abandoned
- 1998-09-23 AU AU93214/98A patent/AU749573B2/en not_active Ceased
- 1998-09-23 WO PCT/US1998/019777 patent/WO1999016382A2/en not_active Application Discontinuation
- 1998-09-23 EP EP98946132A patent/EP1017333A2/en not_active Withdrawn
-
2002
- 2002-03-26 US US10/108,245 patent/US20020161394A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5102415A (en) * | 1989-09-06 | 1992-04-07 | Guenther Rolf W | Apparatus for removing blood clots from arteries and veins |
US5769816A (en) * | 1995-11-07 | 1998-06-23 | Embol-X, Inc. | Cannula with associated filter |
US6090097A (en) * | 1996-05-14 | 2000-07-18 | Embol-X, Inc. | Aortic occluder with associated filter and methods of use during cardiac surgery |
US6592546B1 (en) * | 1996-05-14 | 2003-07-15 | Edwards Lifesciences Corp. | Aortic occluder with associated filter and methods of use during cardiac surgery |
US5814064A (en) * | 1997-03-06 | 1998-09-29 | Scimed Life Systems, Inc. | Distal protection device |
Cited By (568)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10485976B2 (en) | 1998-04-30 | 2019-11-26 | Medtronic, Inc. | Intracardiovascular access (ICVA™) system |
US9119706B2 (en) | 1999-02-24 | 2015-09-01 | Boston Scientific Scimed Inc. | Intravascular filter and method |
US7618433B2 (en) * | 1999-02-24 | 2009-11-17 | Boston Scientific Scimed, Inc. | Intravascular filter and method |
US8657873B2 (en) | 1999-08-09 | 2014-02-25 | Cardiokinetix, Inc. | System for improving cardiac function |
US8377114B2 (en) | 1999-08-09 | 2013-02-19 | Cardiokinetix, Inc. | Sealing and filling ventricular partitioning devices to improve cardiac function |
US8388672B2 (en) | 1999-08-09 | 2013-03-05 | Cardiokinetix, Inc. | System for improving cardiac function by sealing a partitioning membrane within a ventricle |
US7887477B2 (en) | 1999-08-09 | 2011-02-15 | Cardiokinetix, Inc. | Method of improving cardiac function using a porous membrane |
US8257428B2 (en) | 1999-08-09 | 2012-09-04 | Cardiokinetix, Inc. | System for improving cardiac function |
US8500790B2 (en) | 1999-08-09 | 2013-08-06 | Cardiokinetix, Inc. | Retrievable cardiac devices |
US8747454B2 (en) | 1999-08-09 | 2014-06-10 | Cardiokinetix, Inc. | System for improving cardiac function |
US9694121B2 (en) | 1999-08-09 | 2017-07-04 | Cardiokinetix, Inc. | Systems and methods for improving cardiac function |
US20030050685A1 (en) * | 1999-08-09 | 2003-03-13 | Nikolic Serjan D. | Method for improving cardiac function |
US8246671B2 (en) | 1999-08-09 | 2012-08-21 | Cardiokinetix, Inc. | Retrievable cardiac devices |
US10307253B2 (en) | 1999-08-09 | 2019-06-04 | Edwards Lifesciences Corporation | System for improving cardiac function by sealing a partitioning membrane within a ventricle |
US7279007B2 (en) | 1999-08-09 | 2007-10-09 | Cardioklnetix, Inc. | Method for improving cardiac function |
US7303526B2 (en) | 1999-08-09 | 2007-12-04 | Cardiokinetix, Inc. | Device for improving cardiac function |
US10307147B2 (en) | 1999-08-09 | 2019-06-04 | Edwards Lifesciences Corporation | System for improving cardiac function by sealing a partitioning membrane within a ventricle |
US7674222B2 (en) | 1999-08-09 | 2010-03-09 | Cardiokinetix, Inc. | Cardiac device and methods of use thereof |
US9017394B2 (en) | 1999-08-09 | 2015-04-28 | Cardiokinetix, Inc. | Retrievable cardiac devices |
US9872767B2 (en) | 1999-08-09 | 2018-01-23 | Edwards Lifesciences Corporation | Retrievable cardiac devices |
US8192478B2 (en) | 1999-08-09 | 2012-06-05 | Cardiokinetix, Inc. | System for improving cardiac function |
US8672827B2 (en) | 1999-08-09 | 2014-03-18 | Cardiokinetix, Inc. | Cardiac device and methods of use thereof |
US8500795B2 (en) | 1999-08-09 | 2013-08-06 | Cardiokinetix, Inc. | Retrievable devices for improving cardiac function |
US8986329B2 (en) | 1999-11-17 | 2015-03-24 | Medtronic Corevalve Llc | Methods for transluminal delivery of prosthetic valves |
US8801779B2 (en) | 1999-11-17 | 2014-08-12 | Medtronic Corevalve, Llc | Prosthetic valve for transluminal delivery |
US7892281B2 (en) | 1999-11-17 | 2011-02-22 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US9060856B2 (en) | 1999-11-17 | 2015-06-23 | Medtronic Corevalve Llc | Transcatheter heart valves |
US8998979B2 (en) | 1999-11-17 | 2015-04-07 | Medtronic Corevalve Llc | Transcatheter heart valves |
US9066799B2 (en) | 1999-11-17 | 2015-06-30 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US10219901B2 (en) | 1999-11-17 | 2019-03-05 | Medtronic CV Luxembourg S.a.r.l. | Prosthetic valve for transluminal delivery |
US8721708B2 (en) | 1999-11-17 | 2014-05-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8603159B2 (en) | 1999-11-17 | 2013-12-10 | Medtronic Corevalve, Llc | Prosthetic valve for transluminal delivery |
US8876896B2 (en) | 1999-11-17 | 2014-11-04 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US9962258B2 (en) | 1999-11-17 | 2018-05-08 | Medtronic CV Luxembourg S.a.r.l. | Transcatheter heart valves |
US10335280B2 (en) | 2000-01-19 | 2019-07-02 | Medtronic, Inc. | Method for ablating target tissue of a patient |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US9949831B2 (en) | 2000-01-19 | 2018-04-24 | Medtronics, Inc. | Image-guided heart valve placement |
US7758606B2 (en) | 2000-06-30 | 2010-07-20 | Medtronic, Inc. | Intravascular filter with debris entrapment mechanism |
US8777980B2 (en) | 2000-06-30 | 2014-07-15 | Medtronic, Inc. | Intravascular filter with debris entrapment mechanism |
US8092487B2 (en) | 2000-06-30 | 2012-01-10 | Medtronic, Inc. | Intravascular filter with debris entrapment mechanism |
US9078660B2 (en) | 2000-08-09 | 2015-07-14 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
US10064696B2 (en) | 2000-08-09 | 2018-09-04 | Edwards Lifesciences Corporation | Devices and methods for delivering an endocardial device |
US10278805B2 (en) | 2000-08-18 | 2019-05-07 | Atritech, Inc. | Expandable implant devices for filtering blood flow from atrial appendages |
US8951280B2 (en) | 2000-11-09 | 2015-02-10 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US8070801B2 (en) | 2001-06-29 | 2011-12-06 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8956402B2 (en) | 2001-06-29 | 2015-02-17 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US8002826B2 (en) | 2001-07-04 | 2011-08-23 | Medtronic Corevalve Llc | Assembly for placing a prosthetic valve in a duct in the body |
US8628570B2 (en) | 2001-07-04 | 2014-01-14 | Medtronic Corevalve Llc | Assembly for placing a prosthetic valve in a duct in the body |
US9149357B2 (en) | 2001-07-04 | 2015-10-06 | Medtronic CV Luxembourg S.a.r.l. | Heart valve assemblies |
US7780726B2 (en) | 2001-07-04 | 2010-08-24 | Medtronic, Inc. | Assembly for placing a prosthetic valve in a duct in the body |
US7682390B2 (en) | 2001-07-31 | 2010-03-23 | Medtronic, Inc. | Assembly for setting a valve prosthesis in a corporeal duct |
US9539088B2 (en) | 2001-09-07 | 2017-01-10 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US10342657B2 (en) | 2001-09-07 | 2019-07-09 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US20100042136A1 (en) * | 2002-03-12 | 2010-02-18 | Ev3 Inc. | Everted filter device |
US8956384B2 (en) | 2002-03-12 | 2015-02-17 | Covidien Lp | Everted filter device |
US9468514B2 (en) | 2002-03-12 | 2016-10-18 | Covidien Lp | Everted filter device |
US8092486B2 (en) | 2002-03-12 | 2012-01-10 | Tyco Healthcare Group Lp | Everted filter device |
US7621870B2 (en) | 2002-03-12 | 2009-11-24 | Ev3 Inc. | Everted filter device |
US8858619B2 (en) | 2002-04-23 | 2014-10-14 | Medtronic, Inc. | System and method for implanting a replacement valve |
US8529430B2 (en) | 2002-08-01 | 2013-09-10 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
US7862500B2 (en) | 2002-08-01 | 2011-01-04 | Cardiokinetix, Inc. | Multiple partitioning devices for heart treatment |
US8827892B2 (en) | 2002-08-01 | 2014-09-09 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
US9592123B2 (en) | 2002-08-01 | 2017-03-14 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
US7323001B2 (en) | 2003-01-30 | 2008-01-29 | Ev3 Inc. | Embolic filters with controlled pore size |
US7220271B2 (en) | 2003-01-30 | 2007-05-22 | Ev3 Inc. | Embolic filters having multiple layers and controlled pore size |
US8137376B2 (en) | 2003-01-30 | 2012-03-20 | Tyco Healthcare Group Lp | Embolic filters having multiple layers and controlled pore size |
US9603692B2 (en) | 2003-01-30 | 2017-03-28 | Covidien Lp | Embolic filters with controlled pore size |
US9011478B2 (en) | 2003-01-30 | 2015-04-21 | Covidien Lp | Embolic filters with a distal loop or no loop |
US20070135834A1 (en) * | 2003-01-30 | 2007-06-14 | Ev3 Inc. | Embolic filters with controlled pore size |
US8409242B2 (en) | 2003-01-30 | 2013-04-02 | Covidien Lp | Embolic filters with controlled pore size |
US20070083076A1 (en) * | 2003-07-16 | 2007-04-12 | Samuel Lichtenstein | Methods and devices for altering blood flow through the left ventricle |
US7513867B2 (en) | 2003-07-16 | 2009-04-07 | Kardium, Inc. | Methods and devices for altering blood flow through the left ventricle |
US20050015109A1 (en) * | 2003-07-16 | 2005-01-20 | Samuel Lichtenstein | Methods and devices for altering blood flow through the left ventricle |
US20050119688A1 (en) * | 2003-10-06 | 2005-06-02 | Bjarne Bergheim | Method and assembly for distal embolic protection |
US9144485B2 (en) | 2003-10-06 | 2015-09-29 | Medtronic 3F Therapeutics, Inc. | Method and assembly for distal embolic protection |
US8430902B2 (en) | 2003-10-06 | 2013-04-30 | Medtronic 3F Therapeutics, Inc. | Method and assembly for distal embolic protection |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US20100036474A1 (en) * | 2003-10-06 | 2010-02-11 | 3F Therapeutics, Inc. | Method and assembly for distal embolic protection |
US7604650B2 (en) * | 2003-10-06 | 2009-10-20 | 3F Therapeutics, Inc. | Method and assembly for distal embolic protection |
US20050143810A1 (en) * | 2003-10-24 | 2005-06-30 | Martin Dauner | Cardiovascular implant, method and device for its production, and its provision for surgery |
EP1527740A1 (en) * | 2003-10-29 | 2005-05-04 | Medtronic Vascular, Inc. | Distal protection device for filtering and occlusion |
US8894703B2 (en) | 2003-12-23 | 2014-11-25 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US7988724B2 (en) | 2003-12-23 | 2011-08-02 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US9956075B2 (en) | 2003-12-23 | 2018-05-01 | Boston Scientific Scimed Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US10206774B2 (en) | 2003-12-23 | 2019-02-19 | Boston Scientific Scimed Inc. | Low profile heart valve and delivery system |
US9872768B2 (en) | 2003-12-23 | 2018-01-23 | Boston Scientific Scimed, Inc. | Medical devices and delivery systems for delivering medical devices |
US10478289B2 (en) | 2003-12-23 | 2019-11-19 | Boston Scientific Scimed, Inc. | Replacement valve and anchor |
US9011521B2 (en) | 2003-12-23 | 2015-04-21 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8840662B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve and method |
US11696825B2 (en) | 2003-12-23 | 2023-07-11 | Boston Scientific Scimed, Inc. | Replacement valve and anchor |
US9861476B2 (en) | 2003-12-23 | 2018-01-09 | Boston Scientific Scimed Inc. | Leaflet engagement elements and methods for use thereof |
US10258465B2 (en) | 2003-12-23 | 2019-04-16 | Boston Scientific Scimed Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8231670B2 (en) | 2003-12-23 | 2012-07-31 | Sadra Medical, Inc. | Repositionable heart valve and method |
US11185408B2 (en) | 2003-12-23 | 2021-11-30 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US10925724B2 (en) | 2003-12-23 | 2021-02-23 | Boston Scientific Scimed, Inc. | Replacement valve and anchor |
US8246678B2 (en) | 2003-12-23 | 2012-08-21 | Sadra Medicl, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US10772724B2 (en) | 2003-12-23 | 2020-09-15 | Boston Scientific Scimed, Inc. | Medical devices and delivery systems for delivering medical devices |
US8252052B2 (en) | 2003-12-23 | 2012-08-28 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8858620B2 (en) | 2003-12-23 | 2014-10-14 | Sadra Medical Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8052749B2 (en) | 2003-12-23 | 2011-11-08 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8048153B2 (en) | 2003-12-23 | 2011-11-01 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US9585749B2 (en) | 2003-12-23 | 2017-03-07 | Boston Scientific Scimed, Inc. | Replacement heart valve assembly |
US9585750B2 (en) | 2003-12-23 | 2017-03-07 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US10716663B2 (en) | 2003-12-23 | 2020-07-21 | Boston Scientific Scimed, Inc. | Methods and apparatus for performing valvuloplasty |
US11285002B2 (en) | 2003-12-23 | 2022-03-29 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US9532872B2 (en) | 2003-12-23 | 2017-01-03 | Boston Scientific Scimed, Inc. | Systems and methods for delivering a medical implant |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US10314695B2 (en) | 2003-12-23 | 2019-06-11 | Boston Scientific Scimed Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7959672B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical | Replacement valve and anchor |
US10335273B2 (en) | 2003-12-23 | 2019-07-02 | Boston Scientific Scimed Inc. | Leaflet engagement elements and methods for use thereof |
US8623078B2 (en) | 2003-12-23 | 2014-01-07 | Sadra Medical, Inc. | Replacement valve and anchor |
US8623076B2 (en) | 2003-12-23 | 2014-01-07 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US8951299B2 (en) | 2003-12-23 | 2015-02-10 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US9393113B2 (en) | 2003-12-23 | 2016-07-19 | Boston Scientific Scimed Inc. | Retrievable heart valve anchor and method |
US9387076B2 (en) | 2003-12-23 | 2016-07-12 | Boston Scientific Scimed Inc. | Medical devices and delivery systems for delivering medical devices |
US9358106B2 (en) | 2003-12-23 | 2016-06-07 | Boston Scientific Scimed Inc. | Methods and apparatus for performing valvuloplasty |
US10357359B2 (en) | 2003-12-23 | 2019-07-23 | Boston Scientific Scimed Inc | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9358110B2 (en) | 2003-12-23 | 2016-06-07 | Boston Scientific Scimed, Inc. | Medical devices and delivery systems for delivering medical devices |
US9277991B2 (en) | 2003-12-23 | 2016-03-08 | Boston Scientific Scimed, Inc. | Low profile heart valve and delivery system |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US10413412B2 (en) | 2003-12-23 | 2019-09-17 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US9320599B2 (en) | 2003-12-23 | 2016-04-26 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US9308085B2 (en) | 2003-12-23 | 2016-04-12 | Boston Scientific Scimed, Inc. | Repositionable heart valve and method |
US10413409B2 (en) | 2003-12-23 | 2019-09-17 | Boston Scientific Scimed, Inc. | Systems and methods for delivering a medical implant |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US10426608B2 (en) | 2003-12-23 | 2019-10-01 | Boston Scientific Scimed, Inc. | Repositionable heart valve |
US9867695B2 (en) | 2004-03-03 | 2018-01-16 | Sorin Group Italia S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US8535373B2 (en) | 2004-03-03 | 2013-09-17 | Sorin Group Italia S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US7976455B2 (en) | 2004-03-03 | 2011-07-12 | Cardiokinetix, Inc. | Inflatable ventricular partitioning device |
US8109996B2 (en) | 2004-03-03 | 2012-02-07 | Sorin Biomedica Cardio, S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US7762943B2 (en) * | 2004-03-03 | 2010-07-27 | Cardiokinetix, Inc. | Inflatable ventricular partitioning device |
US20050240200A1 (en) * | 2004-04-23 | 2005-10-27 | Bjarne Bergheim | Method and system for cardiac valve delivery |
US9775704B2 (en) | 2004-04-23 | 2017-10-03 | Medtronic3F Therapeutics, Inc. | Implantable valve prosthesis |
US10219899B2 (en) | 2004-04-23 | 2019-03-05 | Medtronic 3F Therapeutics, Inc. | Cardiac valve replacement systems |
US11484405B2 (en) | 2004-06-16 | 2022-11-01 | Boston Scientific Scimed, Inc. | Everting heart valve |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US9744035B2 (en) | 2004-06-16 | 2017-08-29 | Boston Scientific Scimed, Inc. | Everting heart valve |
US8992608B2 (en) | 2004-06-16 | 2015-03-31 | Sadra Medical, Inc. | Everting heart valve |
US8668733B2 (en) | 2004-06-16 | 2014-03-11 | Sadra Medical, Inc. | Everting heart valve |
US20060020285A1 (en) * | 2004-07-22 | 2006-01-26 | Volker Niermann | Method for filtering blood in a vessel with helical elements |
US20060020286A1 (en) * | 2004-07-22 | 2006-01-26 | Volker Niermann | Device for filtering blood in a vessel with helical elements |
AU2005203022B2 (en) * | 2004-07-22 | 2012-03-01 | Cardinal Health 529, Llc | Method for filtering blood in a vessel with helical elements |
US9332993B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
US7897086B2 (en) | 2004-08-05 | 2011-03-01 | Cardiokinetix, Inc. | Method of making a laminar ventricular partitioning device |
US9332992B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Method for making a laminar ventricular partitioning device |
US7765670B2 (en) * | 2004-08-13 | 2010-08-03 | Boston Scientific Scimed, Inc. | Method to simultaneously load and cover self expanding stents |
US20060036310A1 (en) * | 2004-08-13 | 2006-02-16 | Scimed Life Systems, Inc. | Method to simultaneously load and cover self expanding stents |
US8545418B2 (en) | 2004-08-25 | 2013-10-01 | Richard R. Heuser | Systems and methods for ablation of occlusions within blood vessels |
US8591570B2 (en) | 2004-09-07 | 2013-11-26 | Medtronic, Inc. | Prosthetic heart valve for replacing previously implanted heart valve |
US8795315B2 (en) | 2004-10-06 | 2014-08-05 | Cook Medical Technologies Llc | Emboli capturing device having a coil and method for capturing emboli |
US8617236B2 (en) * | 2004-11-05 | 2013-12-31 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US20120046740A1 (en) * | 2004-11-05 | 2012-02-23 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US10531952B2 (en) | 2004-11-05 | 2020-01-14 | Boston Scientific Scimed, Inc. | Medical devices and delivery systems for delivering medical devices |
US8328868B2 (en) | 2004-11-05 | 2012-12-11 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US9498329B2 (en) | 2004-11-19 | 2016-11-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US9486313B2 (en) | 2005-02-10 | 2016-11-08 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US8540768B2 (en) | 2005-02-10 | 2013-09-24 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US9895223B2 (en) | 2005-02-10 | 2018-02-20 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US8539662B2 (en) | 2005-02-10 | 2013-09-24 | Sorin Group Italia S.R.L. | Cardiac-valve prosthesis |
US8920492B2 (en) | 2005-02-10 | 2014-12-30 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US9456889B2 (en) | 2005-02-18 | 2016-10-04 | Covidien Lp | Rapid exchange catheters and embolic protection devices |
US7955351B2 (en) | 2005-02-18 | 2011-06-07 | Tyco Healthcare Group Lp | Rapid exchange catheters and embolic protection devices |
US10537418B2 (en) | 2005-02-18 | 2020-01-21 | Covidien Lp | Rapid exchange catheters and embolic protection devices |
US8221446B2 (en) | 2005-03-15 | 2012-07-17 | Cook Medical Technologies | Embolic protection device |
US8945169B2 (en) | 2005-03-15 | 2015-02-03 | Cook Medical Technologies Llc | Embolic protection device |
US20060253023A1 (en) * | 2005-04-20 | 2006-11-09 | Scimed Life Systems, Inc. | Neurovascular intervention device |
US8467854B2 (en) * | 2005-04-20 | 2013-06-18 | Scimed Life Systems, Inc. | Neurovascular intervention device |
US9649495B2 (en) | 2005-04-25 | 2017-05-16 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US10549101B2 (en) | 2005-04-25 | 2020-02-04 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US9415225B2 (en) | 2005-04-25 | 2016-08-16 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US7935075B2 (en) * | 2005-04-26 | 2011-05-03 | Cardiac Pacemakers, Inc. | Self-deploying vascular occlusion device |
US20060241735A1 (en) * | 2005-04-26 | 2006-10-26 | Cardiac Pacemakers, Inc. | Self-deploying vascular occlusion device |
US20110184282A1 (en) * | 2005-04-26 | 2011-07-28 | Tockman Bruce A | Self-deploying vascular occlusion device |
US10478291B2 (en) | 2005-05-13 | 2019-11-19 | Medtronic CV Luxembourg S.a.r.l | Heart valve prosthesis and methods of manufacture and use |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US11284997B2 (en) | 2005-05-13 | 2022-03-29 | Medtronic CV Luxembourg S.a.r.l | Heart valve prosthesis and methods of manufacture and use |
US8226710B2 (en) | 2005-05-13 | 2012-07-24 | Medtronic Corevalve, Inc. | Heart valve prosthesis and methods of manufacture and use |
US9060857B2 (en) | 2005-05-13 | 2015-06-23 | Medtronic Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
USD732666S1 (en) | 2005-05-13 | 2015-06-23 | Medtronic Corevalve, Inc. | Heart valve prosthesis |
US9504564B2 (en) | 2005-05-13 | 2016-11-29 | Medtronic Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
USD812226S1 (en) | 2005-05-13 | 2018-03-06 | Medtronic Corevalve Llc | Heart valve prosthesis |
US8398537B2 (en) | 2005-06-10 | 2013-03-19 | Cardiokinetix, Inc. | Peripheral seal for a ventricular partitioning device |
US8109962B2 (en) | 2005-06-20 | 2012-02-07 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US8845677B2 (en) | 2005-06-20 | 2014-09-30 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US7850708B2 (en) | 2005-06-20 | 2010-12-14 | Cook Incorporated | Embolic protection device having a reticulated body with staggered struts |
US7867247B2 (en) | 2005-07-12 | 2011-01-11 | Cook Incorporated | Methods for embolic protection during treatment of a stenotic lesion in a body vessel |
US7771452B2 (en) | 2005-07-12 | 2010-08-10 | Cook Incorporated | Embolic protection device with a filter bag that disengages from a basket |
US7766934B2 (en) | 2005-07-12 | 2010-08-03 | Cook Incorporated | Embolic protection device with an integral basket and bag |
US8187298B2 (en) | 2005-08-04 | 2012-05-29 | Cook Medical Technologies Llc | Embolic protection device having inflatable frame |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
US8136659B2 (en) | 2005-09-13 | 2012-03-20 | Sadra Medical, Inc. | Two-part package for medical implant |
US9393094B2 (en) | 2005-09-13 | 2016-07-19 | Boston Scientific Scimed, Inc. | Two-part package for medical implant |
US10370150B2 (en) | 2005-09-13 | 2019-08-06 | Boston Scientific Scimed Inc. | Two-part package for medical implant |
US8377092B2 (en) | 2005-09-16 | 2013-02-19 | Cook Medical Technologies Llc | Embolic protection device |
US8506620B2 (en) | 2005-09-26 | 2013-08-13 | Medtronic, Inc. | Prosthetic cardiac and venous valves |
US8632562B2 (en) | 2005-10-03 | 2014-01-21 | Cook Medical Technologies Llc | Embolic protection device |
US8182508B2 (en) | 2005-10-04 | 2012-05-22 | Cook Medical Technologies Llc | Embolic protection device |
US8252017B2 (en) | 2005-10-18 | 2012-08-28 | Cook Medical Technologies Llc | Invertible filter for embolic protection |
US8216269B2 (en) | 2005-11-02 | 2012-07-10 | Cook Medical Technologies Llc | Embolic protection device having reduced profile |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US8152831B2 (en) | 2005-11-17 | 2012-04-10 | Cook Medical Technologies Llc | Foam embolic protection device |
US10314701B2 (en) | 2005-12-22 | 2019-06-11 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US10299922B2 (en) | 2005-12-22 | 2019-05-28 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US9078781B2 (en) | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
US9572557B2 (en) | 2006-02-21 | 2017-02-21 | Kardium Inc. | Method and device for closing holes in tissue |
US8337524B2 (en) | 2006-02-21 | 2012-12-25 | Kardium Inc. | Method and device for closing holes in tissue |
US7749249B2 (en) | 2006-02-21 | 2010-07-06 | Kardium Inc. | Method and device for closing holes in tissue |
US10058421B2 (en) | 2006-03-28 | 2018-08-28 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US9331328B2 (en) | 2006-03-28 | 2016-05-03 | Medtronic, Inc. | Prosthetic cardiac valve from pericardium material and methods of making same |
US8075615B2 (en) | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US20080275485A1 (en) * | 2006-04-03 | 2008-11-06 | Possis Medical, Inc. | Guidewire with collapsible filter system and method of use |
US7846175B2 (en) | 2006-04-03 | 2010-12-07 | Medrad, Inc. | Guidewire and collapsable filter system |
US7740655B2 (en) | 2006-04-06 | 2010-06-22 | Medtronic Vascular, Inc. | Reinforced surgical conduit for implantation of a stented valve therein |
US9192468B2 (en) | 2006-06-28 | 2015-11-24 | Kardium Inc. | Method for anchoring a mitral valve |
US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
US8672998B2 (en) | 2006-06-28 | 2014-03-18 | Kardium Inc. | Method for anchoring a mitral valve |
US11033392B2 (en) | 2006-08-02 | 2021-06-15 | Kardium Inc. | System for improving diastolic dysfunction |
US7837610B2 (en) | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
US8226728B2 (en) * | 2006-08-04 | 2012-07-24 | Ceramtec Gmbh | Insertion of vibration-damping elements in prosthetic systems for the manipulation and damping of natural frequencies |
US20090326669A1 (en) * | 2006-08-04 | 2009-12-31 | Roman Preuss | Insertion of vibration-damping elements in prosthetic systems for the manipulation and damping of natural frequencies |
US8460335B2 (en) | 2006-09-11 | 2013-06-11 | Embrella Cardiovascular, Inc. | Method of deflecting emboli from the cerebral circulation |
US9480548B2 (en) | 2006-09-11 | 2016-11-01 | Edwards Lifesciences Ag | Embolic protection device and method of use |
US20100179585A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Embolic deflection device |
US9339367B2 (en) * | 2006-09-11 | 2016-05-17 | Edwards Lifesciences Ag | Embolic deflection device |
US10426591B2 (en) | 2006-09-11 | 2019-10-01 | Edwards Lifesciences Ag | Embolic deflection device |
US20080065145A1 (en) * | 2006-09-11 | 2008-03-13 | Carpenter Judith T | Embolic protection device and method of use |
US20100179583A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of deploying and retrieving an embolic diversion device |
US20100179647A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure |
US10004601B2 (en) | 2006-09-19 | 2018-06-26 | Medtronic Ventor Technologies Ltd. | Valve prosthesis fixation techniques using sandwiching |
US9913714B2 (en) | 2006-09-19 | 2018-03-13 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US9138312B2 (en) | 2006-09-19 | 2015-09-22 | Medtronic Ventor Technologies Ltd. | Valve prostheses |
US8052750B2 (en) | 2006-09-19 | 2011-11-08 | Medtronic Ventor Technologies Ltd | Valve prosthesis fixation techniques using sandwiching |
US10543077B2 (en) | 2006-09-19 | 2020-01-28 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US8771345B2 (en) | 2006-09-19 | 2014-07-08 | Medtronic Ventor Technologies Ltd. | Valve prosthesis fixation techniques using sandwiching |
US8771346B2 (en) | 2006-09-19 | 2014-07-08 | Medtronic Ventor Technologies Ltd. | Valve prosthetic fixation techniques using sandwiching |
US9827097B2 (en) | 2006-09-19 | 2017-11-28 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US9387071B2 (en) | 2006-09-19 | 2016-07-12 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US11304802B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US10195033B2 (en) | 2006-09-19 | 2019-02-05 | Medtronic Ventor Technologies Ltd. | Valve prosthesis fixation techniques using sandwiching |
US8414643B2 (en) | 2006-09-19 | 2013-04-09 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8348995B2 (en) | 2006-09-19 | 2013-01-08 | Medtronic Ventor Technologies, Ltd. | Axial-force fixation member for valve |
US8348996B2 (en) | 2006-09-19 | 2013-01-08 | Medtronic Ventor Technologies Ltd. | Valve prosthesis implantation techniques |
US9642704B2 (en) | 2006-09-19 | 2017-05-09 | Medtronic Ventor Technologies Ltd. | Catheter for implanting a valve prosthesis |
US8876894B2 (en) | 2006-09-19 | 2014-11-04 | Medtronic Ventor Technologies Ltd. | Leaflet-sensitive valve fixation member |
US8876895B2 (en) | 2006-09-19 | 2014-11-04 | Medtronic Ventor Technologies Ltd. | Valve fixation member having engagement arms |
US8747460B2 (en) | 2006-09-19 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Methods for implanting a valve prothesis |
US9907639B2 (en) | 2006-09-19 | 2018-03-06 | Cook Medical Technologies Llc | Apparatus and methods for in situ embolic protection |
US9301834B2 (en) | 2006-09-19 | 2016-04-05 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US11304801B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8784478B2 (en) | 2006-10-16 | 2014-07-22 | Medtronic Corevalve, Inc. | Transapical delivery system with ventruculo-arterial overlfow bypass |
US8747459B2 (en) | 2006-12-06 | 2014-06-10 | Medtronic Corevalve Llc | System and method for transapical delivery of an annulus anchored self-expanding valve |
US9295550B2 (en) | 2006-12-06 | 2016-03-29 | Medtronic CV Luxembourg S.a.r.l. | Methods for delivering a self-expanding valve |
US7871436B2 (en) | 2007-02-16 | 2011-01-18 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
US9504568B2 (en) | 2007-02-16 | 2016-11-29 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
US9901434B2 (en) | 2007-02-27 | 2018-02-27 | Cook Medical Technologies Llc | Embolic protection device including a Z-stent waist band |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US9585754B2 (en) | 2007-04-20 | 2017-03-07 | Medtronic, Inc. | Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof |
US9237886B2 (en) | 2007-04-20 | 2016-01-19 | Medtronic, Inc. | Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof |
US10188516B2 (en) | 2007-08-20 | 2019-01-29 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US9393112B2 (en) | 2007-08-20 | 2016-07-19 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US8252018B2 (en) | 2007-09-14 | 2012-08-28 | Cook Medical Technologies Llc | Helical embolic protection device |
US8419748B2 (en) | 2007-09-14 | 2013-04-16 | Cook Medical Technologies Llc | Helical thrombus removal device |
US9398946B2 (en) | 2007-09-14 | 2016-07-26 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US9138307B2 (en) | 2007-09-14 | 2015-09-22 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US10966823B2 (en) | 2007-10-12 | 2021-04-06 | Sorin Group Italia S.R.L. | Expandable valve prosthesis with sealing mechanism |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US10639182B2 (en) | 2008-01-24 | 2020-05-05 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US10820993B2 (en) | 2008-01-24 | 2020-11-03 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US11607311B2 (en) | 2008-01-24 | 2023-03-21 | Medtronic, Inc. | Stents for prosthetic heart valves |
US10016274B2 (en) | 2008-01-24 | 2018-07-10 | Medtronic, Inc. | Stent for prosthetic heart valves |
US9339382B2 (en) | 2008-01-24 | 2016-05-17 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9333100B2 (en) | 2008-01-24 | 2016-05-10 | Medtronic, Inc. | Stents for prosthetic heart valves |
US10646335B2 (en) | 2008-01-24 | 2020-05-12 | Medtronic, Inc. | Stents for prosthetic heart valves |
US8157853B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US8157852B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9089422B2 (en) | 2008-01-24 | 2015-07-28 | Medtronic, Inc. | Markers for prosthetic heart valves |
US9925079B2 (en) | 2008-01-24 | 2018-03-27 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US11284999B2 (en) | 2008-01-24 | 2022-03-29 | Medtronic, Inc. | Stents for prosthetic heart valves |
US11083573B2 (en) | 2008-01-24 | 2021-08-10 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US8685077B2 (en) | 2008-01-24 | 2014-04-01 | Medtronics, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US8673000B2 (en) | 2008-01-24 | 2014-03-18 | Medtronic, Inc. | Stents for prosthetic heart valves |
US10758343B2 (en) | 2008-01-24 | 2020-09-01 | Medtronic, Inc. | Stent for prosthetic heart valves |
US7972378B2 (en) | 2008-01-24 | 2011-07-05 | Medtronic, Inc. | Stents for prosthetic heart valves |
US11259919B2 (en) | 2008-01-24 | 2022-03-01 | Medtronic, Inc. | Stents for prosthetic heart valves |
US11786367B2 (en) | 2008-01-24 | 2023-10-17 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
US8628566B2 (en) | 2008-01-24 | 2014-01-14 | Medtronic, Inc. | Stents for prosthetic heart valves |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11154398B2 (en) | 2008-02-26 | 2021-10-26 | JenaValve Technology. Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US8961593B2 (en) | 2008-02-28 | 2015-02-24 | Medtronic, Inc. | Prosthetic heart valve systems |
US8613765B2 (en) | 2008-02-28 | 2013-12-24 | Medtronic, Inc. | Prosthetic heart valve systems |
US11278408B2 (en) | 2008-03-18 | 2022-03-22 | Medtronic Venter Technologies, Ltd. | Valve suturing and implantation procedures |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US9592120B2 (en) | 2008-03-18 | 2017-03-14 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US11602430B2 (en) | 2008-03-18 | 2023-03-14 | Medtronic Ventor Technologies Ltd. | Valve suturing and implantation procedures |
US10856979B2 (en) | 2008-03-18 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Valve suturing and implantation procedures |
US20090248060A1 (en) * | 2008-03-19 | 2009-10-01 | Schneider M Bret | Electrostatic vascular filters |
US8246649B2 (en) * | 2008-03-19 | 2012-08-21 | Schneider M Bret | Electrostatic vascular filters |
US10245142B2 (en) | 2008-04-08 | 2019-04-02 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US8511244B2 (en) | 2008-04-23 | 2013-08-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US9744038B2 (en) | 2008-05-13 | 2017-08-29 | Kardium Inc. | Medical device for constricting tissue or a bodily orifice, for example a mitral valve |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US8491649B2 (en) | 2008-07-29 | 2013-07-23 | Aga Medical Corporation | Medical device including corrugated braid and associated method |
US20100030321A1 (en) * | 2008-07-29 | 2010-02-04 | Aga Medical Corporation | Medical device including corrugated braid and associated method |
US8998981B2 (en) | 2008-09-15 | 2015-04-07 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US10806570B2 (en) | 2008-09-15 | 2020-10-20 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US9943407B2 (en) | 2008-09-15 | 2018-04-17 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US11026786B2 (en) | 2008-09-15 | 2021-06-08 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US10321997B2 (en) | 2008-09-17 | 2019-06-18 | Medtronic CV Luxembourg S.a.r.l. | Delivery system for deployment of medical devices |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US9532873B2 (en) | 2008-09-17 | 2017-01-03 | Medtronic CV Luxembourg S.a.r.l. | Methods for deployment of medical devices |
US11166815B2 (en) | 2008-09-17 | 2021-11-09 | Medtronic CV Luxembourg S.a.r.l | Delivery system for deployment of medical devices |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
US20120046683A1 (en) * | 2008-10-31 | 2012-02-23 | Scott Wilson | Devices and methods for temporarily opening a blood vessel |
US10098733B2 (en) | 2008-12-23 | 2018-10-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US8657849B2 (en) | 2008-12-29 | 2014-02-25 | Cook Medical Technologies Llc | Embolic protection device and method of use |
US8388644B2 (en) | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
US11364106B2 (en) | 2009-01-16 | 2022-06-21 | Boston Scientific Scimed, Inc. | Intravascular blood filter |
US9326843B2 (en) | 2009-01-16 | 2016-05-03 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US9636205B2 (en) | 2009-01-16 | 2017-05-02 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US11284986B2 (en) | 2009-01-16 | 2022-03-29 | Claret Medical, Inc. | Intravascular blood filters and methods of use |
US11607301B2 (en) | 2009-01-16 | 2023-03-21 | Boston Scientific Scimed, Inc. | Intravascular blood filters and methods of use |
US10743977B2 (en) | 2009-01-16 | 2020-08-18 | Boston Scientific Scimed, Inc. | Intravascular blood filter |
US8512397B2 (en) | 2009-04-27 | 2013-08-20 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit |
US8974489B2 (en) | 2009-07-27 | 2015-03-10 | Claret Medical, Inc. | Dual endovascular filter and methods of use |
US10130458B2 (en) | 2009-07-27 | 2018-11-20 | Claret Medical, Inc. | Dual endovascular filter and methods of use |
US11191631B2 (en) | 2009-07-27 | 2021-12-07 | Boston Scientific Scimed, Inc. | Dual endovascular filter and methods of use |
US9204964B2 (en) | 2009-10-01 | 2015-12-08 | Kardium Inc. | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US10813758B2 (en) | 2009-10-01 | 2020-10-27 | Kardium Inc. | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US10687941B2 (en) | 2009-10-01 | 2020-06-23 | Kardium Inc. | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US9867703B2 (en) | 2009-10-01 | 2018-01-16 | Kardium Inc. | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US8790242B2 (en) | 2009-10-26 | 2014-07-29 | Cardiokinetix, Inc. | Ventricular volume reduction |
US9039597B2 (en) | 2009-10-26 | 2015-05-26 | Cardiokinetix, Inc. | Ventricular volume reduction |
US10028835B2 (en) | 2009-10-26 | 2018-07-24 | Edwards Lifesciences Corporation | Ventricular volume reduction |
US9364327B2 (en) | 2009-10-26 | 2016-06-14 | Cardiokinetix, Inc. | Ventricular volume reduction |
US9808332B2 (en) | 2009-12-02 | 2017-11-07 | Surefire Medical, Inc. | Dynamic microvalve protection device |
US10813739B2 (en) | 2009-12-02 | 2020-10-27 | Surefire Medical, Inc. | Dynamic microvalve protection device |
US20110130657A1 (en) * | 2009-12-02 | 2011-06-02 | Chomas James E | Protection Device and Method Against Embolization Agent Reflux |
WO2011068924A1 (en) * | 2009-12-02 | 2011-06-09 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
CN102665608A (en) * | 2009-12-02 | 2012-09-12 | 神火医药公司 | Microvalve protection device and method of use for protection against embolization agent reflux |
US20110137399A1 (en) * | 2009-12-02 | 2011-06-09 | Chomas James E | Microvalve Protection Device and Method of Use for Protection Against Embolization Agent Reflux |
US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
US8500775B2 (en) | 2009-12-02 | 2013-08-06 | Surefire Medical, Inc. | Protection device and method against embolization agent reflux |
US8696698B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US8696699B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US9295540B2 (en) | 2009-12-02 | 2016-03-29 | Surefire Medical, Inc. | Dynamic microvalve protection device with associated balloon element for therapeutic intravascular procedures |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US11554010B2 (en) | 2010-04-01 | 2023-01-17 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US10716665B2 (en) | 2010-04-01 | 2020-07-21 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US9925044B2 (en) | 2010-04-01 | 2018-03-27 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US11833041B2 (en) | 2010-04-01 | 2023-12-05 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US20110288529A1 (en) * | 2010-05-19 | 2011-11-24 | Fulton Richard E | Augmented delivery catheter and method |
US10335577B2 (en) | 2010-05-19 | 2019-07-02 | Nfinium Vascular Technologies, Llc | Augmented delivery catheter and method |
US11623070B2 (en) | 2010-05-19 | 2023-04-11 | Vascular Development Corp, Llc | Augmented delivery catheter and method |
US9126016B2 (en) * | 2010-05-19 | 2015-09-08 | Nfusion Vascular Systems Llc | Augmented delivery catheter and method |
US9248017B2 (en) | 2010-05-21 | 2016-02-02 | Sorin Group Italia S.R.L. | Support device for valve prostheses and corresponding kit |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US9918706B2 (en) | 2010-06-07 | 2018-03-20 | Kardium Inc. | Closing openings in anatomical tissue |
US9050066B2 (en) | 2010-06-07 | 2015-06-09 | Kardium Inc. | Closing openings in anatomical tissue |
US10603022B2 (en) | 2010-06-07 | 2020-03-31 | Kardium Inc. | Closing openings in anatomical tissue |
US10111645B2 (en) | 2010-06-30 | 2018-10-30 | Muffin Incorporated | Percutaneous, ultrasound-guided introduction of medical devices |
CN103079497A (en) * | 2010-06-30 | 2013-05-01 | 玛芬股份有限公司 | Percutaneous, ultrasound-guided introduction of medical devices |
EP4151154A3 (en) * | 2010-06-30 | 2023-06-07 | Muffin Incorporated | Percutaneous, ultrasound-guided introduction of medical devices |
US9918833B2 (en) | 2010-09-01 | 2018-03-20 | Medtronic Vascular Galway | Prosthetic valve support structure |
US10835376B2 (en) | 2010-09-01 | 2020-11-17 | Medtronic Vascular Galway | Prosthetic valve support structure |
US11786368B2 (en) | 2010-09-01 | 2023-10-17 | Medtronic Vascular Galway | Prosthetic valve support structure |
US10201418B2 (en) | 2010-09-10 | 2019-02-12 | Symetis, SA | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
US10869760B2 (en) | 2010-09-10 | 2020-12-22 | Symetis Sa | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
US8940002B2 (en) | 2010-09-30 | 2015-01-27 | Kardium Inc. | Tissue anchor system |
US20120095500A1 (en) * | 2010-10-14 | 2012-04-19 | Heuser Richard R | Concentric wire embolism protection device |
US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US9017364B2 (en) | 2010-12-30 | 2015-04-28 | Claret Medical, Inc. | Deflectable intravascular filter |
US9943395B2 (en) | 2010-12-30 | 2018-04-17 | Claret Medical, Inc. | Deflectable intravascular filter |
US9259306B2 (en) | 2010-12-30 | 2016-02-16 | Claret Medical, Inc. | Aortic embolic protection device |
US9345565B2 (en) | 2010-12-30 | 2016-05-24 | Claret Medical, Inc. | Steerable dual filter cerebral protection system |
US8876796B2 (en) | 2010-12-30 | 2014-11-04 | Claret Medical, Inc. | Method of accessing the left common carotid artery |
US9492264B2 (en) | 2010-12-30 | 2016-11-15 | Claret Medical, Inc. | Embolic protection device for protecting the cerebral vasculature |
US9980805B2 (en) | 2010-12-30 | 2018-05-29 | Claret Medical, Inc. | Aortic embolic protection device |
US10058411B2 (en) | 2010-12-30 | 2018-08-28 | Claret Madical, Inc. | Method of isolating the cerebral circulation during a cardiac procedure |
US9055997B2 (en) | 2010-12-30 | 2015-06-16 | Claret Medical, Inc. | Method of isolating the cerebral circulation during a cardiac procedure |
US11141258B2 (en) | 2010-12-30 | 2021-10-12 | Claret Medical, Inc. | Method of isolating the cerebral circulation during a cardiac procedure |
WO2012094195A1 (en) * | 2011-01-07 | 2012-07-12 | Merhi William M | Angiography catheter |
KR102094046B1 (en) * | 2011-01-07 | 2020-03-26 | 이너베이티브 카디오배스큘러 솔류션스, 엘엘씨 | Angiography catheter |
AU2011353593B2 (en) * | 2011-01-07 | 2015-10-08 | Innovative Cardiovascular Solutions, Llc | Angiography catheter |
US8948848B2 (en) | 2011-01-07 | 2015-02-03 | Innovative Cardiovascular Solutions, Llc | Angiography catheter |
KR20140034752A (en) * | 2011-01-07 | 2014-03-20 | 이너베이티브 카디오배스큘러 솔류션스, 엘엘씨 | Angiography catheter |
US9161836B2 (en) | 2011-02-14 | 2015-10-20 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9289289B2 (en) | 2011-02-14 | 2016-03-22 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US10456255B2 (en) | 2011-03-21 | 2019-10-29 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus and method for the treatment of valve dysfunction |
US8728155B2 (en) | 2011-03-21 | 2014-05-20 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus and method for the treatment of valve dysfunction |
US10058318B2 (en) | 2011-03-25 | 2018-08-28 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US11771544B2 (en) | 2011-05-05 | 2023-10-03 | Symetis Sa | Method and apparatus for compressing/loading stent-valves |
US8998976B2 (en) | 2011-07-12 | 2015-04-07 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
US9089668B2 (en) | 2011-09-28 | 2015-07-28 | Surefire Medical, Inc. | Flow directional infusion device |
US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US9555219B2 (en) | 2011-11-10 | 2017-01-31 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US9642705B2 (en) | 2011-11-15 | 2017-05-09 | Boston Scientific Scimed Inc. | Bond between components of a medical device |
US10478300B2 (en) | 2011-11-15 | 2019-11-19 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US9370421B2 (en) | 2011-12-03 | 2016-06-21 | Boston Scientific Scimed, Inc. | Medical device handle |
US9277993B2 (en) | 2011-12-20 | 2016-03-08 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
US8685084B2 (en) | 2011-12-29 | 2014-04-01 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit and assembly method |
US9138314B2 (en) | 2011-12-29 | 2015-09-22 | Sorin Group Italia S.R.L. | Prosthetic vascular conduit and assembly method |
US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
US9089341B2 (en) | 2012-02-28 | 2015-07-28 | Surefire Medical, Inc. | Renal nerve neuromodulation device |
US9888994B2 (en) | 2012-05-15 | 2018-02-13 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US11382739B2 (en) | 2012-06-19 | 2022-07-12 | Boston Scientific Scimed, Inc. | Replacement heart valve |
US10555809B2 (en) | 2012-06-19 | 2020-02-11 | Boston Scientific Scimed, Inc. | Replacement heart valve |
US20150305850A1 (en) * | 2012-12-21 | 2015-10-29 | The Regents Of The University Of California | In Vivo Positionable Filtration Devices and Methods Related Thereto |
US11406485B2 (en) * | 2012-12-21 | 2022-08-09 | The Regents Of The University Of California | In vivo positionable filtration devices and methods related thereto |
US20140214072A1 (en) * | 2013-01-29 | 2014-07-31 | St. Jude Medical, Cardiology Division, Inc. | Aortic great vessel protection |
US9962252B2 (en) | 2013-01-29 | 2018-05-08 | St. Jude Medical, Cardiology Division, Inc. | Aortic great vessel protection |
US9186238B2 (en) * | 2013-01-29 | 2015-11-17 | St. Jude Medical, Cardiology Division, Inc. | Aortic great vessel protection |
US20140257362A1 (en) * | 2013-03-07 | 2014-09-11 | St. Jude Medical, Cardiology Division, Inc. | Filtering and removing particulates from bloodstream |
US11793637B2 (en) | 2013-05-03 | 2023-10-24 | Medtronic, Inc. | Valve delivery tool |
US9629718B2 (en) | 2013-05-03 | 2017-04-25 | Medtronic, Inc. | Valve delivery tool |
US10568739B2 (en) | 2013-05-03 | 2020-02-25 | Medtronic, Inc. | Valve delivery tool |
EP3964168A1 (en) * | 2013-05-10 | 2022-03-09 | Medtronic, Inc. | System for deploying a device to a distal location across a diseased vessel |
US20160100928A1 (en) * | 2013-05-14 | 2016-04-14 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US9888995B2 (en) * | 2013-05-14 | 2018-02-13 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US10154906B2 (en) | 2013-07-17 | 2018-12-18 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US11510780B2 (en) | 2013-07-17 | 2022-11-29 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US9554899B2 (en) | 2013-07-17 | 2017-01-31 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US10149761B2 (en) | 2013-07-17 | 2018-12-11 | Cephea Valve Technlologies, Inc. | System and method for cardiac valve repair and replacement |
US9561103B2 (en) | 2013-07-17 | 2017-02-07 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US10624742B2 (en) | 2013-07-17 | 2020-04-21 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
CN106102654A (en) * | 2014-01-10 | 2016-11-09 | 企斯动哈特有限公司 | Dissect independent deflector |
US11135361B2 (en) | 2014-03-25 | 2021-10-05 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US9889031B1 (en) | 2014-03-25 | 2018-02-13 | Surefire Medical, Inc. | Method of gastric artery embolization |
US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US20150297250A1 (en) * | 2014-04-16 | 2015-10-22 | Covidien Lp | Systems and methods for catheter advancement |
US10413309B2 (en) | 2014-04-16 | 2019-09-17 | Covidien Lp | Systems and methods for catheter advancement |
US11690720B2 (en) | 2014-09-28 | 2023-07-04 | Edwards Lifesciences Corporation | Systems and methods for treating cardiac dysfunction |
US10751183B2 (en) | 2014-09-28 | 2020-08-25 | Edwards Lifesciences Corporation | Apparatuses for treating cardiac dysfunction |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
US10869755B2 (en) | 2014-12-09 | 2020-12-22 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US10433953B2 (en) | 2014-12-09 | 2019-10-08 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US10548721B2 (en) | 2014-12-09 | 2020-02-04 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US11147665B2 (en) | 2014-12-09 | 2021-10-19 | Cepha Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US9439757B2 (en) | 2014-12-09 | 2016-09-13 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US9492273B2 (en) | 2014-12-09 | 2016-11-15 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US10449043B2 (en) | 2015-01-16 | 2019-10-22 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US20180049726A1 (en) * | 2015-02-02 | 2018-02-22 | Centre National De La Recherche Scientifique | Microdevice for the In Vivo Capture of Circulating Cellular Biomarkers |
US11457900B2 (en) * | 2015-02-02 | 2022-10-04 | Centre National De La Recherche Scientifique | Microdevice for the in vivo capture of circulating cellular biomarkers |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US10201417B2 (en) | 2015-02-03 | 2019-02-12 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
US11065113B2 (en) | 2015-03-13 | 2021-07-20 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
US11090460B2 (en) | 2015-03-31 | 2021-08-17 | Surefire Medical, Inc. | Method for infusing an immunotherapy agent to a solid tumor for treatment |
US10449028B2 (en) | 2015-04-22 | 2019-10-22 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
US9566144B2 (en) | 2015-04-22 | 2017-02-14 | Claret Medical, Inc. | Vascular filters, deflectors, and methods |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11786373B2 (en) | 2015-05-14 | 2023-10-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
US10470881B2 (en) | 2015-05-14 | 2019-11-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11617646B2 (en) | 2015-05-14 | 2023-04-04 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10849746B2 (en) | 2015-05-14 | 2020-12-01 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
US10555808B2 (en) | 2015-05-14 | 2020-02-11 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10143552B2 (en) | 2015-05-14 | 2018-12-04 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11730595B2 (en) | 2015-07-02 | 2023-08-22 | Boston Scientific Scimed, Inc. | Adjustable nosecone |
US10335277B2 (en) | 2015-07-02 | 2019-07-02 | Boston Scientific Scimed Inc. | Adjustable nosecone |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10856973B2 (en) | 2015-08-12 | 2020-12-08 | Boston Scientific Scimed, Inc. | Replacement heart valve implant |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10779940B2 (en) | 2015-09-03 | 2020-09-22 | Boston Scientific Scimed, Inc. | Medical device handle |
JP2018531771A (en) * | 2015-10-09 | 2018-11-01 | トランスバース メディカル インコーポレイテッドTransverse Medical, Inc. | Catheter-based devices and methods |
US10064637B2 (en) | 2015-10-09 | 2018-09-04 | Transverse Medical, INC | Catheter-based apparatuses and methods |
WO2017062036A1 (en) * | 2015-10-09 | 2017-04-13 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US10987118B2 (en) | 2015-10-09 | 2021-04-27 | Transverse Medical Inc. | Catheter-based apparatuses and methods |
AU2019203364B2 (en) * | 2015-10-09 | 2021-05-27 | Transverse Medical, Inc. | Catheter-based apparatuses and methods |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
US11382742B2 (en) | 2016-05-13 | 2022-07-12 | Boston Scientific Scimed, Inc. | Medical device handle |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
US20170325938A1 (en) | 2016-05-16 | 2017-11-16 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
US10709552B2 (en) | 2016-05-16 | 2020-07-14 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
US11331187B2 (en) | 2016-06-17 | 2022-05-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
US11389168B2 (en) | 2016-09-01 | 2022-07-19 | Microvention, Inc. | Temporary aortic occlusion device |
US11389169B2 (en) | 2016-09-01 | 2022-07-19 | Microvention, Inc. | Temporary aortic occlusion device |
US10780250B1 (en) | 2016-09-19 | 2020-09-22 | Surefire Medical, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US11400263B1 (en) | 2016-09-19 | 2022-08-02 | Trisalus Life Sciences, Inc. | System and method for selective pressure-controlled therapeutic delivery |
EP3323360A1 (en) * | 2016-11-21 | 2018-05-23 | Cook Medical Technologies LLC | Implantable medical device with atraumatic tip |
WO2018102651A1 (en) * | 2016-12-01 | 2018-06-07 | Mayo Foundation For Medical Education And Research | Percutaneously-deployable intravascular embolic protection devices and methods |
US11298218B2 (en) | 2017-01-20 | 2022-04-12 | W. L. Gore & Associates, Inc. | Embolic filter system |
WO2018136724A3 (en) * | 2017-01-20 | 2018-09-13 | W. L. Gore & Associates, Inc. | Embolic filter system |
JP2020506752A (en) * | 2017-01-20 | 2020-03-05 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Embolic filter system |
US11058535B2 (en) | 2017-01-23 | 2021-07-13 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11090158B2 (en) | 2017-01-23 | 2021-08-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10828153B2 (en) | 2017-01-23 | 2020-11-10 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10368990B2 (en) | 2017-01-23 | 2019-08-06 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10568737B2 (en) | 2017-01-23 | 2020-02-25 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11633278B2 (en) | 2017-01-23 | 2023-04-25 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11337790B2 (en) | 2017-02-22 | 2022-05-24 | Boston Scientific Scimed, Inc. | Systems and methods for protecting the cerebral vasculature |
CN110392556A (en) * | 2017-03-13 | 2019-10-29 | 东丽株式会社 | Filter means |
EP3597147A4 (en) * | 2017-03-13 | 2020-11-18 | Toray Industries, Inc. | Filter device |
US10588636B2 (en) * | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
US20200163685A1 (en) * | 2017-03-27 | 2020-05-28 | Transverse Medical, Inc. | Filter apparatuses and methods |
US11246698B2 (en) * | 2017-03-27 | 2022-02-15 | Transverse Medical, Inc. | Filter apparatuses and methods |
US10898330B2 (en) | 2017-03-28 | 2021-01-26 | Edwards Lifesciences Corporation | Positioning, deploying, and retrieving implantable devices |
WO2018187413A1 (en) * | 2017-04-05 | 2018-10-11 | Boston Scientific Scimed, Inc. | Emboli-capturing centering device |
US11166803B2 (en) | 2017-04-05 | 2021-11-09 | Boston Scientific Scimed, Inc. | Emboli-capturing centering device |
US10828154B2 (en) | 2017-06-08 | 2020-11-10 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
US10898325B2 (en) | 2017-08-01 | 2021-01-26 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
US10939996B2 (en) | 2017-08-16 | 2021-03-09 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11191630B2 (en) | 2017-10-27 | 2021-12-07 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11154390B2 (en) | 2017-12-19 | 2021-10-26 | Claret Medical, Inc. | Systems for protection of the cerebral vasculature during a cardiac procedure |
WO2020242545A1 (en) | 2017-12-28 | 2020-12-03 | Groh Mark | Embolic protection catheter and related devices and methods |
EP3975922A4 (en) * | 2017-12-28 | 2023-06-07 | EmStop Inc. | Embolic protection catheter and related devices and methods |
US11191641B2 (en) | 2018-01-19 | 2021-12-07 | Boston Scientific Scimed, Inc. | Inductance mode deployment sensors for transcatheter valve system |
US11246625B2 (en) | 2018-01-19 | 2022-02-15 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
US11147668B2 (en) | 2018-02-07 | 2021-10-19 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
US11439732B2 (en) | 2018-02-26 | 2022-09-13 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
US11071844B2 (en) | 2018-03-07 | 2021-07-27 | Innovative Cardiovascular Solutions, Llc | Embolic protection device |
US11717390B2 (en) | 2018-03-07 | 2023-08-08 | Innovative Cardiovascular Solutions, Llc | Embolic protection device |
US11439491B2 (en) | 2018-04-26 | 2022-09-13 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
US11229517B2 (en) | 2018-05-15 | 2022-01-25 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
US11351023B2 (en) | 2018-08-21 | 2022-06-07 | Claret Medical, Inc. | Systems and methods for protecting the cerebral vasculature |
WO2020069810A1 (en) | 2018-10-04 | 2020-04-09 | Universitätsspital Basel | Protective device for open heart aortic valve replacement surgery and kit comprising the same |
EP3632374A1 (en) | 2018-10-04 | 2020-04-08 | Universitätsspital Basel | Protective device for open heart aortic valve replacement surgery and kit comprising the same |
US11338117B2 (en) | 2018-10-08 | 2022-05-24 | Trisalus Life Sciences, Inc. | Implantable dual pathway therapeutic agent delivery port |
US11241312B2 (en) | 2018-12-10 | 2022-02-08 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
US11931252B2 (en) | 2019-07-15 | 2024-03-19 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus and method for the treatment of valve dysfunction |
WO2022087136A1 (en) * | 2020-10-20 | 2022-04-28 | Legacy Ventures LLC | Clot retrieval system |
CN115670738A (en) * | 2022-12-28 | 2023-02-03 | 北京华脉泰科医疗器械股份有限公司 | Thrombolytic catheter filter and thrombolytic filter combination kit |
Also Published As
Publication number | Publication date |
---|---|
CA2304463A1 (en) | 1999-04-08 |
AU9321498A (en) | 1999-04-23 |
US6361545B1 (en) | 2002-03-26 |
WO1999016382A3 (en) | 1999-08-05 |
WO1999016382A2 (en) | 1999-04-08 |
EP1017333A2 (en) | 2000-07-12 |
AU749573B2 (en) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6361545B1 (en) | Perfusion filter catheter | |
US6090097A (en) | Aortic occluder with associated filter and methods of use during cardiac surgery | |
US6395014B1 (en) | Cerebral embolic protection assembly and associated methods | |
US5980555A (en) | Method of using cannula with associated filter during cardiac surgery | |
US6136016A (en) | Cannula with associated filter and methods of use during cardiac surgery | |
AU752267B2 (en) | Perfusion shunt apparatus and method | |
US6254563B1 (en) | Perfusion shunt apparatus and method | |
US20040049210A1 (en) | Filter apparatus for ostium of left atrial appendage | |
US20020077596A1 (en) | Perfusion shunt apparatus and method | |
WO1997042879A9 (en) | Aortic occluder with associated filter and methods of use during cardiac surgery | |
EP3331458A1 (en) | Axially lengthening thrombus capture system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CARDEON CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MACOVIAK, JOHN A.;LEARY, JAMES L.;SAMSON, WILFRED J.;REEL/FRAME:013010/0980 Effective date: 20020612 |
|
AS | Assignment |
Owner name: GATX VENTURES, INC., CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:CARDEON CORPORATION;REEL/FRAME:013718/0555 Effective date: 20030129 Owner name: SILICON VALLEY BANK, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:CARDEON CORPORATION;REEL/FRAME:013718/0555 Effective date: 20030129 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |